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ABSTRACT
Analytical methods for extraction, detection, and
quantitation of sulfadimethoxine (SDM) residues in channel
catfish muscle and plasma were developed for a tiered
residue monitoring program.

The plasma and muscle

concentrations of SDM and its primary metabolite in.
channel catfish, 4-N-acetylsulfadimethoxine (N-acetyl
SDM), were determined in SDM medicated fish.

Drug

extraction methods using matrix solid phase dispersion
(MSPD), drug screening methods using enzyme-linked
immunoassay (ELISA), and drug residue quantitation methods
using high pressure liquid chromatography (LC) are
presented.

All methods were developed for the

simultaneous extraction and analysis of the parent
compound and metabolite.

MSPD extracts of muscle or

plasma were reconstituted in mobile phase for LC analysis
or in a buffer suitable for use in an ELISA system.

The

performances of four commercially available ELISAs as
screening assays were evaluated using MSPD derived
extracts of catfish muscle fortified at concentrations of
0, 25, 50, 100, 250 ng/g.

Overall sensitivities of 98-

100% and specificities of 71-94% were obtained for the
four ELISAs examined.
compounds was examined.

Cross-reactivity with a number of
All four assays reacted equally

well with SDM or N-acetyl SDM.

Performance results

xi
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indicated that MSPD extracts can be used in these
immunoassays for screening catfish muscle for violative
SDM residue levels (>100 ng parent and metabolite/g).
Methods for the LC analysis of MSPD derived muscle and
plasma extracts are presented and evaluated.

Results of

the LC analysis of MSPD extracts of catfish muscle and
plasma indicated that these extracts may be used for
quantitation of SDM and N-acetyl SDM residues at
concentrations of 50-1000 PPB.

Drug concentration ratios

were determined for total SDM residues in channel catfish
plasma and muscle.

Fish maintained in 27°C water were

dosed once daily for five days and sampled at intervals of
6, 12, 24, 48, 72, 96 hours after the last dose.

The mean

plasmaimuscle total SDM residue ratio was 1.8:1.

The 95%

confidence interval for individual fish was (1.2:1,2.4:1).
Such a tissue concentration ratio enables one to use a
rapid screening method, such as an immunoassay, with a
reference body fluid as an indicator of the presence of
violative drug residues in an edible target tissue.

xii
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CHAPTER 1
GENERAL INTRODUCTION

BACKGROUND

Aquaculture is a large and rapidly growing industry.
Seafood consumption has shown tremendous growth in the
last 10 years and is expected to continue.

This increase

in seafood consumption and a decline in landings from wild
fishery stocks has led to an increased demand for
aquaculture products [1.1].

Accompanying the increase in

seafood consumption is a heightened concern regarding the
safety of this food source from pathogenic bacteria and
viruses, parasites, biotoxins, and chemical residue
hazards [1.2-1.4].

However, with the exception of certain

shellfish, continuous and systematic seafood inspection is
not required in the United States [1.2].
Regulatory authority for seafood safety in the United
States is divided among a number of local, state, and
federal agencies.

The U.S. National Marine Fisheries

Service offers a voluntary federal seafood inspection
program.

However, this voluntary program is primarily a

product grading system and plant sanitation inspection
service with only a quite limited number of food safety

1
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analyses performed annually.

The U.S. Food and Drug

Administration has the regulatory authority to require the
inspection of any domestic or imported seafood product but
such inspection is at the discretion of the agency and is
not performed on a systematic or continuous basis [1.2].
Further, analytical methods for only two drugs chloramphenicol in shrimp and oxolinic acid in salmon have been validated for regulatory use by these agencies
for monitoring drug residues in aquatic food resources
[1.5-1.8].

Because of the lack of validated analytical

methods for enforcement purposes the FDA is in the process
of developing methods for a number of veterinary drugs
used in a variety of cultured aquatic species [1.9].

The

growth and increased visibility of the seafood and
aquaculture industries and a public perception that the
nations seafood supply is not adequately inspected have
led to calls for a mandatory federal seafood inspection
program similar to the ones that now exist for red meat
and poultry [1.2-1.3].

RESIDUE ANALYSIS

Pending U.S. federal legislation concerning
establishment of such an inspection program for seafood
will require analytical methods that are rapid, accurate,

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.
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sensitive, and specific for determination of chemical
residues in food fish [1.10].

Traditional drug residue

screening methods, such as microbial inhibition tests,
thin layer chromatography, and colorimetric assays, as
presently used in poultry and red meat inspection, lack
one or more of these characteristics.

There is also a

lack of residue screening methods suitable for use in a
field setting by an aquaculturist for the pre-harvest
detection of violative drug residues, a practice which
would greatly reduce violations and consequent producer
losses from condemnation.
A tiered approach to residue monitoring utilizes
analytical techniques of varying sensitivity, specificity,
and precision for chemical residue detection,
quantitation, and identification.

Such methods may be

generally classified as 1) rapid initial screening assays
such as microbiological inhibition tests (MIT), thin layer
chromatography, or receptor-based assays, 2) quantitative
methods such as high performance liquid chromatography
(LC), gas-liquid chromatography (GLC), high performance
thin layer chromatography, and some MITs, and 3) residue
identity confirmatory methods such as mass spectrometry
and infra-red spectrometry [1.11].

All require varying

degrees of sample extraction and manipulation to remove
target analytes.

With recent improvements in analytical

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout p erm ission .
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instrumentation and the introduction of new rapid
screening and determinative methods, a major limiting
factor in the efficient utilization of such assays has
been identified as the process for the extraction and
isolation of the analyte(s) from tissues.
The classical methods of extraction that have
traditionally been employed for analyte isolation from
various tissue matrices involve mechanical homogenization
and repeated sample manipulations.

Such techniques are

labor and solvent-use intensive and limit the number of
samples that can be practically analyzed in a day.

Newer

methods of analyte isolation that eliminate many of the
disadvantages of traditional extraction methods are needed
if one is to fully benefit from recent advances in the
determinative aspects of residue analysis.

Isolation

techniques that have recently become available include
supercritical fluid extraction, solid phase extraction,
and matrix solid phase dispersion (MSPD). Matrix solid
phase dispersion, in particular, offers a technique for
greatly decreasing extraction time, solvent volumes, and
tissue mass when compared to traditional methods [1.12].
The relative advantages of these methods are reviewed in
Chapter 2.
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Sulfonamides are a class of anti-bacterial compounds
widely used for therapeutic and prophylactic purposes in
animal agriculture.

However, the use of these compounds

in food animals may result in unwanted sulfonamide
residues in edible tissues.

The presence of such residues

in animal origin foods may pose a health hazard to
consumers.

Chronic consumption of foods containing sub-

therapeutic levels of sulfonamides may lead to the
development of plasmid-mediated bacterial drug resistance.
Further, sulfamethazine has been implicated as a potential
carcinogen.

Because of these concerns, the FDA has set

the maximum residue limit for most sulfonamides at 100
ng/g in meat, poultry, and aquaculture products.
Drug residue violations in the United States red meat
and poultry industries most commonly occur with approved
drugs not used in accordance with label directions
[1.13,1.14].

If a similar trend holds for violations in

the aquaculture industry, then the greatest number of drug
residue violations would be expected for approved drugs
that have been used in a non-approved manner.

Therefore,

efforts to develop methods for drug residue detection for
domestically produced aquaculture products should
initially focus on extraction and detection methods for
the limited number of currently approved drugs.
compound is sulfadimethoxine.

One such

Sulfadimethoxine is the
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sulfonamide component of the potentiated sulfonamide
Romet-30®, which is commonly used in channel catfish
aquaculture.

Sulfadimethoxine may, therefore, serve as a

model for the application of new extraction and detection
technologies to monitoring of residues in food animals and
for the design of an overall approach to aquaculture drug
monitoring.
One technique with potential as a residue screening
method for regulatory laboratory and field use is the
enzyme-linked immunosorbent assay (ELISA).

Enzyme-linked

immunosorbent assays for detection of chemical residues
are relatively inexpensive, easy to use, require no
special equipment, and are commercially available.

They

also provide the sensitivity and specificity required for
residue monitoring at tolerance [1.15],

The sequential

use of MSPD for drug extraction and ELISA for drug
detection can accommodate the need for rapid, practical,
and efficient extraction, and also provide the sensitivity
and specificity required for a drug residue monitoring or
surveillance program.

Application of combined techniques

to food animal tissues would result in a more efficient
residue monitoring program by increasing the number of
samples analyzed, by decreasing the turnaround time for
sample analysis, and by providing a method for pre-harvest
residue determination on site.
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However, the simplest residue screening method is one
that uses the presence of the drug and/or its
metabolite(s) in a reference biological fluid to indicate
the presence of violative residues in a target tissue(s)
and does not require tissue extraction.

Before such a

technique can be implemented, a relatively constant
relationship between the drug concentration in the target
tissue and the reference biological fluid must be
demonstrated.

The correlation between plasma drug

concentration (central compartment) and muscle drug
concentration (peripheral compartment) is the basis for
pharmacokinetic principles and residue depletion time
estimation [1.16,1.17].

For compounds where a stable

correlation between plasma/muscle concentrations can be
experimentally determined, plasma may be used directly in
a screening assay, such as an ELISA, for prediction of
violative drug residues in muscle.
Tolerances for animal drugs, as set by the FDA, are
often based on total residue present, including parent
drug and all metabolites, in edible tissues [1.18].

A

marker residue, parent compound or metabolite, is often
used to indicate the total residue present in the target
tissue of interest.

To establish such a marker residue, a

constant relationship between marker residue concentration
and total residue in the target tissue(s) over the
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concentration range of interest must be known.
Nonetheless, such information is often lacking for drug
behavior in non-approved species or for non-approved drug
uses.

In the absence of such information, extraction,

detection, quantitation, and confirmatory methods should
be capable of simultaneous extraction or analysis of the
parent drug and its important metabolites.
The primary metabolite of sulfadimethoxine (SDM) in
channel catfish is 4-N-acetylsulfadimethoxine (N-acetyl
SDM)[1.19].

However, because the ratio of parent SDM:N-

acetyl SDM over a range of tissue concentrations,
including tolerance (100 ng SDM/g), is not known, there is
a need for a chromatographic assay to quantify these two
compounds simultaneously about tolerance.

Such a

chromatographic system would also enable determination of
recovery of both compounds when using MSPD extraction.
Additionally, information concerning the relative degree
of cross reactivity of this metabolite and other compounds
with available ELISAs is required to properly interpret
test results.
Suspect samples, identified by screening assays
require further confirmation of the concentration and
identity of the drug/metabolite for regulatory action.
Quantification and identification of veterinary drug
residues is most commonly accomplished with high
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performance liquid chromatography (LC) or gas-liquid
chromatography (GLC) combined with mass spectrometry.
However, there are presently no LC methods available for
the simultaneous determination of SDM and N-acetyl SDM in
channel catfish.

PURPOSE

In summary, a model residue monitoring program
applying new or improved methods for extraction,
screening, quantification, and identification of drug
residues in aquaculture species is needed.

Protocols for

such a program may include MSPD for drug isolation, ELISAs
for initial detection, and LC methods for quantification
and presumptive identification.

Alternately, where a

tissue concentration relationship between a biological
fluid (plasma) and target tissue (muscle) can be
demonstrated, the use of such a fluid, not requiring
extraction, may be used for initial residue screening.
It is the purpose of this research to develop the
analytical methods and basic tissue compartment
concentration relationships required for a drug residue
monitoring program for sulfadimethoxine residues in
channel catfish.

Specific research needs for the creation

of such a program include the development of matrix solid
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phase dispersion techniques for the simultaneous
extraction of SOM and N-acetyl SDM in plasma and muscle,
evaluation of MSPD-derived extracts in commercially
available immunoassays, development of LC methods for
plasma and muscle for the simultaneous analysis of SDM and
N-acetyl SDM, and a residue depletion study with groups of
fish sacrificed at various time points in order to
characterize the relationship of SDM concentrations in
channel catfish plasma and muscle.

The following chapters

offer a review of the literature concerning historical and
present seafood inspection protocols for chemical residues
in aquatic food resources and present the results of
methods development research for development of a model
drug residue monitoring program for aquaculture.
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CHAPTER 2
REVIEW OF LITERATURE
EXTRACTION AND ANALYSIS OF DRUGS
IN AQUATIC SPECIES

INTRODUCTION

Aquatic resources are monitored for the presence of
tissue residues of chemical agents for two main reasons:
1) for food safety— to identify and remove from commercial
markets any edible tissues that contain potentially
hazardous levels of drug or other chemical residues and 2)
for environmental monitoring— to help identify
geographical areas where environmental quality may have
been significantly compromised.

This review will focus

primarily on the food safety aspects of veterinary drug
residues in aquaculture products.
With increasing reliance on aquatic species as a
source of dietary protein there is a strong public
interest in the safety of edible aquatic resources.

This

interest is based on concerns about potential unacceptable
health risks associated with eating fish containing
residues of veterinary drugs, agricultural pesticides, and
environmental pollutants [2.1].

Such residues may exist

13
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in fish bought by consumers in commercial markets or in
fish caught for recreational purposes from rivers, lakes,
and oceans.

Further, seafood sold in the markets of one

country may often have been imported from another with
different regulatory policies concerning drug and
pesticide use in aquatic environments.

For example,

imports accounted for over 60% of the fish and shellfish
consumed in the United States in 1990 [2.2].

Therefore,

analytical methods are needed for compounds that may be
present in domestic or international products.

There is

also a need for an international consensus regarding
residue levels and concerns.
In this regard, the Joint Food and Agriculture
Organization (FAO)/World Health Organization (WHO) Expert
Committee on Food Additives (JECFA) serves as a scientific
advisory body to FAO, WHO, the Codex Committee on Residues
of Veterinary Drugs in Foods (CCRVDF), and the Codex
Committee on Food Additives and Contaminants, concerning
the safety of residues of food additives, contaminants,
and veterinary drugs.

Recommended acceptable daily intake

and maximum residue level (MRL) for many of these
substances have been proposed by JECFA and are used by
many countries to formulate regulations regarding chemical
residues in foods— including aquatic food resources.

The

analytical needs of an effective residue monitoring
program are in part determined by the MRLs as set by a
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nation's regulatory authorities.

Appropriate analytical

methods for these programs are recommended by the CCRVDF.
A listing of reports and other documents published by the
JECFA is available [2.3].
Although aquatic species are sporadically monitored
for veterinary drugs and various environmental
contaminants, fish products are not required to pass
unified continuous federal inspection.

Additionally, some

of the existing seafood inspection efforts are not
designed to be of direct use in evaluating many aspects of
seafood safety concerns.

This is due in part to the fact

that the present voluntary seafood inspection program
administered by the National Marine Fisheries Service of
the U.S. Department of Commerce is primarily a plant
sanitation and product grade inspection program.

It is

not designed to be of direct use in evaluating the safety
of aquatic food products in regards to chemical residues,
although a limited number of chemical residue analyses are
done [2.4].

The U.S. Food and Drug Administration has

regulatory authority under the Food Drug and Cosmetic Act,
the Public Health Service Act, and other acts to assure
seafood product wholesomeness.

This authority includes

mandatory inspection of seafood processing plants and
products, and regulation of aquaculture products, drug
use, and aquaculture production practices [2.4,2.5].

The

FDA has announced its intention to implement a Hazard
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Analysis Critical Control Point (HAACP) program to help
ensure seafood product safety and has begun testing
domestic and imported aquaculture products for residues of
the veterinary antibacterials chloramphenicol and oxolinic
acid [2.6,2.7].

The FDA is also in the process of

developing additional analytical methods for a numbe r of
veterinary drugs used in aquaculture [2.8]

Nonetheless,

fish products are not at present monitored on a continuous
basis by any regulatory agency for residues of the
veterinary drugs used domestically or internationally in
aquaculture.

Further, efforts at drug residue monitoring

are hampered by a lack of personnel and a dearth of
legally defensible methods of residue analysis [2.4].
As a result of public concern over the safety of
seafood, the failure of environmental and drug monitoring
programs to contribute valuable residue data for human
food analysis, and the fact that present seafood
monitoring and inspection programs lack both the frequency
and direction sufficient to ensure effective
implementation of current regulatory limits for seafood
safety, several governmental bodies, including the U.S.
government, have declared their intention to develop a new
seafood inspection system [2.4,2.5].

There is early

recognition that the key to the success of this new system
will be development and application of more efficient and
cost-effective analytical methods.
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Several classes of chemicals that will need to be
included in any aquatic food safety program and in
existing and future environmental monitoring programs are
veterinary drugs, agricultural pesticides, and industrial
pollutants [2.4,2.9].

This review offers an overview of

present methods of veterinary drug residue analysis as
used in domestic farm animals, their potential
applicability to aquatic species, and a summary of
existing methods for the analysis of many of the drugs
used in aquatic species.

Several major drawbacks of the

methods are discussed and three relatively new methods
that offer solutions to these problems are described.

DRUG RESIDUE PROBLEMS IN AQUACULTURE

Diseases are the single most important cause of
economic loss in intensive aquaculture and necessitate the
use of antibacterial and other therapeutic compounds to
maintain the health and production of cultured species
[2.2],

Although there is a degree of variability there

are numerous therapeutants which are consistently used
worldwide in aquaculture [2.10-2.13].

These agents belong

to a wide range of chemical and therapeutic classes such
as antibacterials (e.g., sulfonamides and potentiated
sulfonamides, aminoglycocides, j8-lactams, tetracyclines,
quinolones, macrolides, etc.), parasiticides (e.g.,
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mebendazole and dichlorvos), disinfectants, pisicides,
herbicides, algacides, anesthetics, water treatments, and
dyes.

This large range of chemical classes presents a

problem for effective residue monitoring, and requires the
use of screening tests to adequately detect the presence
of illegal residues.
A residue may be defined as "any compound present in
edible tissues of the target animal that results from the
use of the sponsored compound, including the sponsored
compound, its metabolites and any other substances formed
in or on food because of the sponsored compound's use"
[2.14,2.15].

Metabolites are considered to be as toxic as

the parent compound unless shown otherwise [2.14,2.15].
Under the FDAs general food safety requirements for
metabolism studies, individual metabolite identification,
concentration, and persistence should be obtained for
metabolites comprising 100 ppb or >10% of the total
residue (whichever is lower) at zero withdrawal [2.16].
For approved veterinary drugs used in accordance with
label directions, a marker residue (Rm)(parent compound or
metabolite) is often used to indicate the total residue
level in a target tissues(s).

However, for drug residue

surveillance in cases of extra-label drug use where such
concentration relationships are lacking, the extraction
and analytical methods used must be capable of providing
extraction and analysis for both the parent drug and its
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important metabolites present at or less than MRLs in the
tissues of interest.
However, MRLs are not always static.

Toxicological

data are always being updated and the JECFA periodically
issues recommendations for MRLs based on such available
toxicology information for selected veterinary drugs,
including those used in aquaculture.

Many countries have

established MRLs based on JECFA recommendations for a
number of these compounds.

A listing of WHO publications

containing JECFA recommended MRLs is available [2.3].
The use of therapeutants in aquaculture not only may
result in unacceptable residues in edible tissues but also
in the environment.

Drugs used in aquaculture may be

directly introduced into the environment, as with
ectoparasiticides, or indirectly introduced in medicated
feeds (via non-consumption of the feed, poor
bioavailability, and limited biotransformation). The
environmental degradation, accumulation, and persistence
of these agents is affected by water temperature, sediment
microenvironment, and factors affecting dispersion [2.17].
It has been estimated that 70 to 80% of orally
administered oxytetracycline remains in the environment
[2.18].

Furthermore, there are large variations in the

persistence of antibiotics in sediments from fish farms.
Furazolidone exhibits a very short half-life (18 hr.)
[2.19] and oxytetracycline a half-life of 32 to 64 days
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depending on sediment conditions [2.18].

The

environmental fates [2.17-2.26] and effects [2.19,2.272.32] of several compounds commonly used in aquaculture
have been the subject of recent studies.

However, the

environmental metabolism, fate, and effects of most drugs
introduced into the aquatic environment is poorly
understood and relatively few methods are available for
the multitude of compounds, environmental matrices, and
environmental conditions that are of importance in
assessing the environmental impact of these compounds.
The National Environmental Policy Act of 1969 requires an
environmental impact assessment for aquaculture drug
approval in the United States [2.33,2.34], and the FDA has
proposed a requirement that each new animal application
include a section on the environmental effects of the use
of the drug [2.35].

Additionally, periodic monitoring of

fish farm effluents for drug residues may be required.
Therefore, methods of analysis of therapeutic agents in
environmental samples are now part of the drug approval
process and should be part of our continuing environmental
concern.
Development of new methods of analysis of
therapeutants was identified at a recent joint FDA-U.S.
Department of Agriculture (USDA) sponsored Interregional
Research Project Number 4 (IR-4) meeting as a priority
need in aquaculture [2.36].

In general, new methods for
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veterinary drug residue analysis in aquatic species are
needed for screening, quantitating, and confirming tissue
residues of drugs used domestically and those present in
imported aquacultural products.

The methods should also

be suitable for analyzing environmental samples for drug
and contaminant residues.
Because efficient, cost-effective, universal methods
for the extraction, detection, quantitation, and
confirmation of these residues in aquatic matrices do not
exist, the need for a better approach to analysis has
recently been acknowledged.

The research and development

plans of regulatory agencies, such as the FDA, currently
include commitments to increase and improve capabilities
for testing for veterinary drug residues in aquaculture
products [2.8,2.37,2.38].

METHODS OF DRUG RESIDUE ANALYSIS IN AQUATIC
SPECIES

Regulatory agencies require practical analytical
methods for detecting, quantifying, and identifying
violative residues that may occur in food animal tissues.
These agencies use available methodology for monitoring
and surveillance and for enforcement action.

However,

practical methods are not available for many compounds of
interest that may occur as tissue residues.

Further, the
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reliability of analytical results obtained with some
'official' methods may be questioned.

For enforcement of

regulatory limits for chemical residues in any food
animal, analyses employed must withstand legal challenges
for reliability and accuracy.
Accordingly, the FSIS categorizes analytical methods
into three levels according to their intended use for
screening, quantitation, or confirmation; and within each
level by the method's relative degree of validation, the
confidence that may be placed in test results, and it's
suitability for regulatory action.

Validation is the

process of assuring that an analytical method is capable
of performing as intended with acceptable accuracy and
sensitivity.

The most widely accepted procedure for

validation is the interlaboratory collaborative
[2.39].

However, interlaboratory validation

study

is oftennot

possible for the multitude of compounds and matrices a
regulatory laboratory must examine.

Therefore, standard

evaluation criteria for detection and quantitation of
analytes may be used [2.40].

The term 'official

validation' may refer to validation by the Association of
Official Analytical Chemists International (AOAC) or
validation by a regulatory agency.

The US Department of

Agriculture, Food Safety and Inspection Service (FSIS)
classifications for method status are listed

as follows in

decreasing order of confidence of result:
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A.

AOAC Official Methods.

These are methods published

in the AOAC publication Official Methods of Analysis
[2.41].

Interlaboratory validation of these methods has

been obtained with five or more participating
laboratories.

Such methods are considered the most

authoritative and legally defensible methods for residue
analysis [2.39].

Seven methods are listed as AOAC

Official Methods of Analysis (AOAC/OMA) for the detection
of antibacterials in milk, but only three official methods
are listed for the detection of antibacterial residues in
other food animal tissues, and no methods are listed for
veterinary drug residue determination in aquatic food
resources [2.41].
B.

Validated Methods.

These methods have been subjected

to an interlaboratory study in two or three laboratories
with at least three independent analysts and the results
peer-reviewed by government scientists.
C.

Federal Register Methods.

This group includes

analytical methods published in the Federal Register and
later incorporated into the Code of Federal Regulations.
D.

Historical Official Methods.

Methods that were

regarded as the best available at the time of initial
acceptance and are in continued use due to the absence of
improved methods.
E.

Non-Validated Methods.

Methods for quantitation

and/or identity confirmation that have not undergone a
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collaborative study involving at least three independent
analysts.
F.

Published Methods.

These methods have undergone

study by a single analyst or laboratory and the data peerreviewed by government scientists.
G.

Correlated Methods.

These methods have not been

subjected to interlaboratory study, but results obtained
with the method have been compared to results obtained
with a current method for regulatory enforcement using the
same samples and the data peer-reviewed by government
scientists.
A tiered approach to residue monitoring employs
methods for screening, quantitation, and confirmation.
The FSIS has classified analytical methods into three
levels based on relative combinations of accuracy,
specificity, and practicality.

Each of the three levels

may contain methods classified by validation status as
given above.
Level I — These are assays that provide unequivocal
data concerning concentration and identity of the analyte
at the level of interest.

Level I methods have the

highest level of credibility and are often combinations of
two or more assays such as gas liquid chromatography/mass
spectrometry or high performance liquid chromatography/
mass spectrometry.
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Level II — These are assays used to determine analyte
concentration and perhaps provide presumptive
identification based on retention time, UV spectrum, or
biochemical characteristics but do not provide unequivocal
results.

Level II methods include various chromatographic

and microbial inhibition assays.
Level III — This level includes screening methods to
indicate the presence or absence of an analyte or class of
compounds in food animal tissues.

These assays are used

because of their high throughput or field applicability,
but results from these tests require verification by Level
I or II methods for regulatory action [2.9].

Alternately,

some Level II methods may be used as screening assays when
they are applied to reference biological fluids to
indicate the residue level in the target tissue of
interest [2.42].
All official methods for the analysis of drugs in
animal tissues published in the AOAC/OMA [2.41], FDA
Animal Drug Analysis Manual (ADAM) [2.43], or the FSIS
Compound Evaluation and Analytical Capability Manual
(CEACM) [2.9] are for use with red meat, poultry, or milk,
although some of the methods could likely be adapted for
use with tissues from aquatic species.

The FDA's 1973

Food Additives Analytical Manual (FAAM) [2.44] contains
methods of residue analysis supplied by the manufacturer
as a part of a new animal drug application - including
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drugs for use in aquaculture.

Some FAAM methods have been

evaluated in FDA laboratories, but very few have undergone
complete AOAC validation.

The FAAM will be inactivated

once the methods listed in the FAAM are incorporated in
the ADAM [2.43].
Many of the methods currently being used by
monitoring agencies for residue analysis in red meat and
poultry are based on 'classical' methods of extraction and
analysis [2.9].

Some of these methods have undergone

rigorous multi-laboratory calibration studies and work
well under certain conditions and for certain purposes.
Perhaps the greatest drawback to their continued use is
their inefficiency as screening methods.

Some of the

methods are sufficiently complex as to not allow the
generation of relevant data in time to prevent
contaminated foods from entering the marketplace and
analytical results are often obtained too late to prevent
enforceable removal of the contaminated product.
Additionally, the complexity of these methods and the
length of time required to perform them limits the number
of samples that can be practically analyzed in a day.
A variety of methods for the analysis of drugs in
aquatic species have been published in the literature.
However, a review of the literature for analytical methods
used to extract and quantitate residues of therapeutic
agents used in aquatic species reflects the confusion
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currently felt in the field concerning which protocols are
most efficient, accurate, reliable, and cost-effective
(Table 2.1 [2.45-2.97]).

Additionally, only one inter

laboratory validation study for a veterinary drug residue
analytical method for use with aquatic food products was
found [2.98] although a second validated method is in
press [2.99].
Since there is presently only one validated method
for the analysis of veterinary drugs in aquatic species,
an opportunity exists to introduce analytical methods for
this purpose which utilize improved methods of extraction,
screening, and determination rather than simply adapting
existing methods used in other inspection programs.

A

number of analytical techniques developed in the last
decade can potentially be employed in a drug residue
monitoring program for food fish.
Recently introduced drug screening methods include
radioimmunoassay, competitive bacterial receptor binding
assay, enzyme immunoassay, high performance thin layer
chromatography, and several forms of bioautography.

At

present such residue screening methods are not validated
by any federal agency [2.100].

The development of rapid

screening tests that are practical and rugged would allow
for routine monitoring and surveillance of larger numbers
of samples in a shorter time period with greater
sensitivity and selectivity than is often currently
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available using conventional methods.

Use of screening

methodology also allows chromatographic instrumentation to
be reserved for confirming positive samples.

The

development of such screening tests may soon be required
by many governments as a part of the methods package
needed for drug approval of new animal drugs [2.14].
Further, present methods of analysis as used by
several regulatory agencies have failed to fully utilize
the dramatic improvements in reliability and sensitivity
that determinative methods such as LC, GLC, and MSD have
undergone in the last decade.

Likewise, advances in

extraction methodology have not been fully implemented.

A

review of traditional and recently introduced methods for
veterinary drug residue isolation and determination
follows this section.

MICROBIAL INHIBITION TESTS

Antibacterials have historically been detected in
animal tissues and fluids by microbial inhibition tests
(MIT) and these tests continue to be in wide use.

All

MIT's are based on the inhibition of bacterial growth by
residues of antibacterial compound(s) present in a
biological fluid or tissue.

Early assays for

chlortetracycline and oxytetracycline residues in milk
utilized reduction of methylene blue as an indicator of
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bacterial growth, and therefore, the absence of the drug
[2.101,2.102],

Numerous MITs for the detection and

quantitation of antibacterials in fish tissues have since
been described [2.103-2.111].

MITs are relatively simple

to use, detect many classes of antibacterial compounds,
and selective sensitivity for specific classes of
antibacterials can be obtained by changes in the culture
medium, indicator bacteria, or pH [2.112,2.113].

However,

these methods often lack the specificity and sensitivity
required for residue detection at MRLs, may be affected by
non-specific inhibitors, do not detect microbiologically
inactive metabolites [2.114], and often have a 20-24 hour
incubation time.

Imprecision occurs as a result of zone

size differences between replicate plates.

Zone size may

vary as a result of differences in agar layer thickness,
agar quality, uneven seeding of bacterial spores on the
agar surface, or incubator temperature variation [2.115].
Additionally, bacteriostatic drugs such as sulfonamides
result in a diffuse zone while bacteriocidal drugs provide
a sharply defined zone of inhibition.
Plate assay MITs are performed by streaking a uniform
suspension of indicator bacterial spores over an agar
medium.

Swabs or disks soaked in a body fluid are placed

on the plate and incubated.

A positive control is

provided by a neomycin sensitivity disk.

The observed end

point can be a zone of inhibition surrounding a sample or
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a color change resulting from pH changes.

MITs currently

in use by the USDA-FSIS for screening red meat and poultry
tissues for antibacterial residues are the Swab Test On
Premises (STOP), Live Animal Swab Test (LAST), and the
Calf Antibiotic and Sulfa Test (CAST) [2.116]. The USDAFSIS is currently evaluating the Fast Antibiotic Screen
Test (FAST) as a replacement for the STOP and CAST methods
[2.117].

All of these MITs can potentially be adapted for

use with aquatic animal tissues.

SWAB TEST ON PREMISES

The STOP test is used to detect antibiotic residues
in kidney and other tissues of slaughter animals [2.118].
The STOP method is relatively simple and requires only a
few minutes of analyst time [2.119].

A cotton swab is

inserted directly into the meat sample, left in place for
thirty minutes, and the cotton tip placed on a test plate
containing Difco Antibiotic Medium No. 5 previously
streaked with a spore suspension of Bacillus subtilis.
The plate is incubated at 29°C overnight (16-20h) and
observed for inhibition of bacterial growth surrounding
the swab.

Johnston et al, reported 94% agreement with

results of STOP and standard microbial assays [2.120].
Korsrud and MacNeil [2.112] reported varying sensitivity
with different media using standard solutions of
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tetracyclines.

With the standard Antibiotic Medium No. 5,

limits of detection (LOD's, ppm) were 6.2 (CTC), 3.1
(OTC), and 1.6 (TC). With Antibiotic Medium No. 2, LODs
were 0.06 (CTC) and 1.6 (OTC and TC). Minimal detectable
levels using Antibiotic Medium No. 5 as reported by
Johnston, et al. [2.118], were 0.01 ppm (CTC) and 0.08 ppm
for OTC and TC.

In a comparison of STOP, high performance

liquid chromatography (LC), MIT, and thin-layer
chromatography-bioautography (TLCB) by MacNeil, et al.
[2.120], STOP lacked the sensitivity of LC but had greater
or lesser sensitivity for OTC than TLCB or MIT depending
on the growth medium used.

CALF ANTIBIOTIC AND SULFA TEST

The CAST procedure was introduced by the USDA to
increase sulfonamide detection sensitivity in bob veal
calves and was the first test available for pre-slaughter
determination of sulfonamide and antibiotic residues.
This test is also sensitive to a variety of other
antimicrobials including tetracyclines, and the degree of
inhibition varies with the compound tested [2.121].

The

CAST procedure is similar to the STOP and LAST but uses
Mueller-Hinton Medium and Bacillus megaterium ATCC 9885 as
the indicator bacteria, and is incubated at 44°C [2.122].
Plates are read as for the STOP procedure and kidney is
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used as the sample tissue.

Korsrud and MacNeil [2.112]

reported the CAST procedure was more sensitive than the
STOP procedure for standard solutions of 22 antibiotics
tested including CTC, OTC, and TC.

Minimum detectable

levels (ppm) were 0.2 (CTC), 0.8 (OTC), and 0.4 (TC).

LIVE ANIMAL SWAB TEST

The LAST procedure is a modification of the STOP
procedure differing only in the amount of B. subtilis used
[2.123].

It is used for preslaughter field screening of

residues in urine and for prediction of residues in edible
tissues.

It was the first on-farm test available for

screening live cattle for possible residues and is based
on the correlation between urine and tissue residue
levels.

Urine or blood samples may be used [2.123,2.124].

Two sterile swabs are dipped in a urine sample and placed
on the LAST plate containing Antibiotic Medium No. 5
streaked with B. subtilis ATCC 6633 spores.

A neomycin

disc is used as a positive control, and incubation and
test interpretations are carried out as is done for the
STOP procedure.

Several reports indicate a high incidence

of false positive results using the LAST assay.

In one

study 75% (15 of 20) of untreated cows showed a positive
result [2.125].

Tritschler et al. [2.123], reported 5.4%

positive results and 19.9% questionable results from 221
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untreated dairy cows and heifers.

TerHune and Upson

[2.126] had varying results for LAST detection of OTC when
compared to standard quantitative OTC MIT procedures.
LAST was 100% accurate when urine OTC concentration was
>4.3 iiq/Tnl and 60% accurate when urine OTC concentration
was <4.3 ficf/ml. Some 20% of LAST results were false
positive and 20% were false negative.

False positive

results were associated with high urine osmolarity and
high urine pH, apparently resulting in inhibition of
bacterial growth.

False negative samples were associated

with dilute urine.

In this study LAST was 100% accurate

in detecting OTC in the urine and predicting tissue OTC
residues when OTC concentration was at therapeutic levels.
However, LAST did not detect OTC in the urine or predict
OTC concentrations of 0.1-0.4 ppm in tissue.

FAST ANTIBIOTIC SCREEN TEST

The Fast Antibiotic Screen Test (FAST) is a new
procedure under evaluation by USDA-FSIS and provides
results within 6 hours.

It has undergone field trials

involving 10,000 samples for comparison with STOP and CAST
for sensitivity.

The FAST assay is similar to the CAST

procedure but the FAST growth medium contains sugar and a
purple dye.

Bacterial metabolism of the sugar results in

acid production causing a color change from purple to
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yellow for the pH-sensitive dye used.

A sterile cotton

swab is saturated with fluid from a tissue sample and
placed on a plate of growth medium streaked with bacterial
spores and incubated for 6 hours.

A purple zone

surrounding the sample swab indicates the presence of
antimicrobial agent(s) [2.117].

DELVOTEST P

This test is a qualitative color reaction test based
on acid production by Bacillus stearothermophilius var.
calidolactis.

The lowered pH changes the color of

bromocreosol purple to yellow.

If antibacterials are

present, bacterial growth is inhibited and the purple
color remains.

Delvotest P is an AOAC Official Method for

0-lactams in milk.
IU/ml milk.

Sensitivity for 0-lactams is > 0.005

0-lactam residue is confirmed using

penicillinase [2.41].

It will also detect a wide range of

antibiotics including TC at 0.2 fig/ml and OTC at 0.3 fig/ml
[2.124].

Macaulay and Packard reported 11% false

positives with this test [2.127].

Delvo P is simple to

run and the color change is easily evaluated as blue vs
yellow.

A disadvantage is the 2.75 hr analysis time.
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BRILLIANT BLACK REDUCTION TEST

The Brilliant Black Reduction Test is another
qualitative color reaction test and can be used to detect
antibiotic residues in milk and tissue.

Bacillus

stearothermophilus is the test organism used with an assay
medium containing brilliant black indicator.

The assay

medium remains blue if bacterial growth is inhibited by
antibiotic residues, but if no residues are present the
growth of the bacteria reduces the indicator to a yellow
color.

Limit of detection of tissue extracts for OTC is

0.1 /jg/ml [2.128].

BIOAUTOGRAPHY

Several residue analysis methods employing a blend of
physicochemical separation procedures and bacterial growth
inhibition techniques have been reported.

Microbial

inhibition techniques applied to sample extracts separated
by various techniques include paper chromatographybioautography [2.129], thin layer chromatographybioautography (TLCB) [2.120,2.130-2.132], and
electrophoresis-bioautography [2.133].

In these

techniques developed chromatographic plates or
electrophoresis gels are placed on bacterial growth medium
seeded with B. subtilis.

The location of zones of
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inhibition are used to identify specific antibiotic
residues.

The sensitivity of the method can be adjusted

and antibiotic residue determination is quantitative.
Electrophoresis-bioautography is usually preceded by
a set of MITs and antibiotic identification is based on
initial MIT results, electrophoretic migration distance,
and the appearance of the zone of inhibition.

This assay

has been applied to milk and meat samples for residue
determination and provides qualitative or semiquantitative results.

It is however, unlikely to allow

resolution of related compounds within a drug class
[2.133]. TLCB is discussed under thin layer
chromatography.

COLORIMETRIC METHODS

The Bratton-Marshall method, first introduced in
1939, was the mainstay of sulfonamide residue test methods
for several decades [2.134-2.136].

However, because of

relatively high background readings from naturally
occurring primary aromatic amines and cross reactivity
with other primary aromatic amines, these methods
generally lack the sensitivity and specificity required
for residue analysis at tolerance [2.136],

As a result,

the FSIS has largely replaced these methods with TLC and
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immunoassay for sulfonamide analysis in domestic food
animal tissues [2.9].
A number of colorimetric assays based on the BrattonMarshall procedure have been published for several
compounds used in aquaculture in a variety of species.
These assays have also been frequently used in
experimental studies [2.137-2.140],

A 1981 review of

methods for sulfonamide residue analysis in animal tissues
is offered by Horwitz [2.135,2.136].

Specific

applications of the Bratton-Marshall method used with
aquatic species include the analysis of sulfamerazine in
rainbow trout [2.44,2.135], sulfadimethoxine in channel
catfish, salmonid, and lobster tissues [2.141], and
sulfachloropyridazine in channel catfish plasma [2.140].
Bratton-Marshall colorimetric methods have also been
reported for the analysis of the fish anesthetics tricaine
methane sulfonate [2.137] and benzocaine [2.138] as
residues in several fish species.

The limit of

quantitation of these assays is in the PPM range which
limits their usefulness for residue analysis at tolerance
[2.136,2.137].

RECEPTOR BASED ASSAYS

Ligand receptor techniques that show promise as
screening methods for aquatic species include immunoassays
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[2.142-2.144], bacterial cell receptor assays [2.145], and
radioimmunoassays [2.146,2.147].

These techniques have

great potential applicability to regulatory monitoring
programs, but their efficient utilization is often limited
by lengthy tissue preparation procedures.

To fully

utilize the speed and simplicity of these tests they must
be combined with newer extraction methods, or used with a
reference biological fluid not requiring extraction to
indicate the residue level in a target tissue.

Still, the

ability of these screening assays to accurately identify
positive and negative samples must be evaluated based on
performance parameters such as sensitivity, specificity,
cross-reactivity, predictive values (positive and
negative) and efficiency before the test can be included
in a residue monitoring program.

BACTERIAL CELL RECEPTOR ASSAY

The Charm II test is a proprietary competitive
microbial receptor binding assay that can detect residues
of seven classes of antibiotics and is the only AOAC
Official Method of Analysis for sulfonamides and
tetracyclines in milk [2.41].

Methods for examination of

other matrices such as serum, plasma, urine, honey and
extracts of egg, muscle, liver, or kidney are available
but are not validated by the AOAC.

The test instructions
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also contain a method for analysis of sulfadimethoxine
residues in fish muscle [2.145].

The Charm II test

requires 12-15 minutes per individual drug class test
[2.148].

In this assay, microbial cells possessing

specific antibacterial class receptor sites are added to
milk or tissue extract containing added 3H or 14C labelled
drug.

The radio-labelled drug competes with the residue

of compounds of a drug family that are present in the
sample for the available bacterial receptor sites.
Following centrifugation, the sample is decanted, the
precipitate resuspended, combined with scintillation fluid
and its activity measured using a scintillation counter.
Sample activity is compared to a decision point obtained
using the mean of six replicate fortified samples ± 15%.
The sample level of radioactivity is inversely related to
the residue level of the sample.

The level of

radioactivity used (0.5 /iCi/jmol, 0.052 /xCi/test) is
exempt from Nuclear Regulatory and Agreement State
regulations [2.145].

Limits of detection (ppb) in milk

are 3 (CTC), 6 (Democycline), 100 (DC), 4 (MC), 5 (OTC),
and 1 (TC).

Serum, urine, and egg LODs are 100 for TC

[2.145].
Several comparisons of the Charm II with other
methods of residue analysis for milk have been reported.
Brady and Katz reported confirmation of Charm II test
results for CTC by a comparison with MIT assays.

Nine
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samples positive for TC with the Charm II were confirmed
positive by MIT [2.149],

However, Collins-Thompson, et

al. reported that 40 of 48 milk samples positive for TC by
the Charm II test were negative by disc assay, and 8
showed indistinct zones of inhibition.

Increased

sensitivity of the Charm II and a possible unknown
interfering factor were suggested [2.150],

Charm and Chi

reported a 2.3% incidence of false positives for TC in
milk [2.148], and Senyk et al. reported no false positives
for TC in milk [2.151].
Because the bacterial receptors bind a functional
group of the drug, rather than a side chain as with
immunoassay tests, the Charm II test provides detection of
a class of antibacterial compounds rather than a single
compound.

Although this test can detect a number of drugs

within a class, the relative sensitivity of the test to
individual drugs varies.

The Charm II test sums, although

not in a linear manner, concentrations of various drugs
within the same class in a sample.

The Charm II test

performed inconsistently among analysts and laboratories
in FDA studies [2.152-2.154].

Although the Charm II has

been proposed as a confirmatory method [2.149,2.155], the
non-specific nature of the test, its variable sensitivity
for individual drugs within a drug class, and the
relatively high rate of false positive results restricts
this test to use as a screening assay.
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RADIOIMMUNOASSAY

Although radioimmunoassays (RIA) are characterized by
high sensitivity and specificity, relatively few methods
have been published for RIA detection of drug residues in
fish.

In a pharmacokinetic study, Rolf et al. used RIA

for gentamicin quantitation in channel catfish plasma
[2.146], and Rattenberger et al. used RIA to examine
chloramphenicol depletion in rainbow trout plasma and
muscle [2.147].

Additionally, RIA methods for detection

of chloramphenicol residues in several red meat and
poultry products and evaluations of their performance as
residue screening tests are available [2.156,2.157].

The

FSIS analytical manual lists RIA as a screening method for
residues of zeranol and it's metabolite taleranol in
cattle liver and muscle [2.9], and Daeseleire et al.
reported a combined LC and RIA procedure as a screening
method for 19-nortestosterone and methyltestosterone
residues in beef muscle tissue [2.158].
In addition to the Charm II Bacterial Receptor Test,
Charm Sciences, Inc. also markets Charm II Antibody Tests
for the detection of several antimicrobials in milk.
These RIAs may also be used with serum, plasma, urine,
tissue, and eggs.

Tissue and eggs however, require a

separate extraction procedure before testing.

Available

RIAs from Charm Sciences, Inc. include chloramphenicol,
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gentamicin, sulfadimethoxine, sulfamethazine, and
tetracycline.

In the Charm II Antibody test, ,4C or 3H

labeled drug competes with any drug residue present for a
specific antibody bound to microbial cells.

These tests

reportedly are rapid (12 minutes per test) and specific
with a level of detection of 10 ng/ml for drug residue in
milk.

The principal disadvantages of RIAs when compared

with other immunoassays involve the use and disposal of
radioactive compounds and the need for scintillation
counting equipment [2.41].

As a result, ELISA and

fluorescent labelled immunoassays are becoming more widely
used.

ENZYME IMMUNOASSAY

Immunoassays are widely used to monitor therapeutic
drugs and drugs of abuse in human medicine, for dog and
racehorse testing, and on dairy farms and processing
plants to screen milk samples for veterinary drug
residues.

Nonetheless, they have seen limited use for

analysis of veterinary drug residues in food animal
tissues.

The major market for these tests in agriculture

has been for dairy products.

However, with appropriate

extraction methodology many of these assays may be used
for residue analysis of food animal tissues, including
food fish.

Immunoassay offers a cost-effective and rapid
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alternative to conventional methodology for drug residue
screening.

Immunoassays can determine within minutes

whether edible tissue contains veterinary drug residues
above or below tolerance, and sample preparation for
immunoassay is typically shorter and less demanding than
the comparable preparation methods used for
chromatography.

The reduction in preparation time and

ability to simultaneously process many samples can greatly
increase a laboratory's throughput and provide relevant
residue concentration information in time to allow
retention or removal of potentially harmful products from
the food supply [2.159-2.161].
Like radioimmunoassay, enzyme immunoassays typically
possess high sensitivity and specificity.

The high

specificity of these assays may be advantageous or not
depending on the intended use of the test, i.e., detection
of a single analyte or a class of compounds.

Although an

assay using antibodies of moderate specificity may detect
a class of compounds, immunoassay does not readily lend
itself to multiresidue detection.

It is most useful for

screening a large sample set for one or a few drugs in a
given matrix.

Nonetheless, the high specificity of

immunoassays does permit minimal sample cleanup compared
to chromatographic methods.
Because of the ability to screen large numbers of
samples and detect analytes in the low parts per billion
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range, early and continuing interest in immunoassays has
centered on veterinary drug residues of greatest
toxicological and public health concern.

Compounds of

high regulatory concern, as designated by the FDA, include
chloramphenicol, nitrofurans, fluroquinolones, quinolones,
malachite green, nitroimidazoles, and sulfamethazine
[2.162,2.163],

Because of their wide use and toxicity and

carcinogenicity concerns the two drugs that have generated
the greatest interest in screening methods development are
chloramphenicol and sulfamethazine.
Chloramphenicol can induce an idiosyncratic, dose
independent aplastic anemia in man.

Of particular concern

in seafood is the use of chloramphenicol in shrimp
mariculture [2.6].

A number of ELISA methods for

detection of chloramphenicol residues and evaluations of
their performance in several food animal tissues have been
published [2.154,2.157,2.164-2.168].

Sulfamethazine

(sulphadimidine) is widely used in some food animals, is a
potential carcinogen, and is of high regulatory interest.
As such, ELISAs were developed early on for this compound
[2.169-2.172].

Other compounds for which ELISA analysis

of drug residues are reported include monensin,
cephalexin, penicillins, sulfathiazole; anabolic agents
such as nortestosterone and the /3-agonists clenbuterol,
cimateraol, and salbutamol [2.173-2.180].
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Only three reported applications of enzyme
immunoassay for detection of veterinary drug residues in
fish were found.

Kitagawa et al. developed an ELISA for

detection and quantitation of the peptide antibiotic
colistin in rainbow trout muscle, liver, kidney, spleen,
serum, and bile.

This assay reportedly can detect as

little as 3 ng per well [2.142].

The EZ-SCREEN® test for

sulfadimethoxine was evaluated by Wu et al. for detection
of sulfadimethoxine residues in channel catfish muscle and
liver.

Homogenization and ten-fold sample dilution

provided detection of sulfadimethoxine at the tolerance of
100 ng/g [2.143].

Walker and Barker evaluated four

commercially available ELISAs for detection of
sulfadimethoxine and 4-N-acetylsulfadimethoxine residues
at concentrations surrounding tolerance in channel catfish
muscle [2.144].

This study is presented in detail in

Chapter 3.
Commercially obtainable enzyme-linked immunosorbent
assays (ELISA) are available in kit form for several of
the antibacterials used in land- and water-based
agriculture.

Included are assays for chloramphenicol,

several /S-lactams, tetracyclines, tylosin, sulfamethazine,
and sulfadimethoxine.

These test kits utilize enzyme-

linked immunosorbent assays (ELISA) based on the principle
of direct competitive solid phase enzyme immunoassay and
compare the relative color development of the sample to a
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negative control as the measurable endpoint.

Negative

samples exhibit the greatest color development and
positive samples the least development.

The tests are

packaged containing all reagents and components, and test
procedures are described in directions for use included
with each kit.

Results may be qualitative or semi-

quantitative respectively when determined visually or
using optical density (OD) values.

Test formats, as

determined by the type of solid support used for
immobilization of the antibody, include the MICROTITER®
well, tube tests, and membrane based ELISAs such as the
CITE® cup device, CITE® probe device, SNAP™ test, I.D.
Block™, and the Quik-Card® test.
The FSIS compound evaluation and analytical
capability manual currently lists EZ-SCREEN® immunoassay
methods for chloramphenicol, gentamicin sulfate, neomycin
sulfate, sulfadimethoxine, sulfamethazine, and tylosin as
non-validated screening methods for red meat and poultry
[2.9].

EZ-SCREEN® is a qualitative colorimetric

immunoassay for detection of drug residues in milk, urine,
serum, and feed using the QUIK-CARD® format.

The QUIK-

CARD® system consists of a solid support card containing
two membrane-based test ports; negative control and
sample.

Results are obtained within 10 minutes by visual

comparison of relative color development of the two spots.
The lower detection limit of the assay is 10 ng/ml.

This
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test is marketed by Environmental Diagnostics, Inc. of
Burlington, NC [2.181].

A recent FDA evaluation of the

EZ-SCREEN® chloramphenicol test for milk indicates that
this test performs well when testing fresh milk.

However,

thirty-three percent of previously frozen milk samples
containing one ng/ml provided false negative results.
The primary problem encountered with the test was an
occasional failure of the sample to properly adsorb into
the test membrane [2.154].
In addition to the EZ-SCREEN® test, several other
immunoassays are commercially available for screening food
animal tissues for drug residues.

One such test is the

SIGNAL® Sulfamethazine Detection Test marketed by
SmithKline Beecham Animal Health of Exton, PA.

This test

uses the MICROTITER® well format and may be used
qualitatively or quantitatively.

The SIGNAL® test is

marketed for the detection of sulfamethazine in milk,
muscle, serum, urine, and feeds, but also exhibits a
degree of cross reactivity with a number of other
sulfonamides [2.144].
The IDS Sulfadimethoxine One-Step ELISA is a
quantitative MICROTITER® well ELISA for the detection of
sulfadimethoxine residues in serum, milk, urine, muscle,
liver, kidney, and feed.

International Diagnostics

Systems Corporation of St. Joseph, MI also markets a
qualitative membrane ELISA for detection of
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sulfadimethoxine under the tradename Sulfadimethoxine I.D.
Block™ Testing Device.

Both tests have a lower detection

limit of 10 ng/ml [2.182,2.183].

Other ELISAs available

from this company are sulfamethazine, gentamicin, tylosin,
and neomycin in MICROTITER® well format, and
sulfamethazine and gentamicin in the I.D. Block™ device.
Also immunoassays for forty-two additional therapeutic
drugs or mycotoxins are available from this firm.
IDEXX Laboratories, Inc. of Westbrook, ME markets a
number of ELISAs in one of three membrane-based formats;
the CITE® cup, the CITE® PROBE, and the SNAP™.

The CITE®

cup device holds a membrane filter containing three
discrete test areas and a negative control spot; each test
area is coated with antibody to one sulfonamide.

Two

qualitative assays are available in the cup format, the
CITE® sulfamethazine assay and the CITE® Sulfa Trio™.

The

CITE® Sulfa Trio™ is used for the detection of
sulfadimethoxine, sulfathiazole, and sulfamethazine
residues in milk.
The CITE® PROBE is competitive immunoassay that
visually compares the relative color intensity of a
control spot with a sample spot.

It is packaged as a self

contained kit and can be easily run on-farm.

The CITE®

PROBE utilizes membrane coated antibody spots located on
the end of a probe device.

The probe is moved through a
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series of four development wells supplied with the kit and
the result determined visually or with a densitometer.
CITE® PROBE tests available include gentamicin,
/3-lactam, /3-lactam/sulfamethazine Combo®, /3-lactam
/tetracycline Combo®, and tetracycline.

The /8-lactam

PROBE test does not use antibodies to specifically bind
the analyte(s) but rather a penicillin-binding protein
bound to the membrane matrix [2.184],
tests are however, true ELISAs.

Other CITE® PROBE

The CITE® PROBE

tetracycline test is a multi-residue screening test for
chlortetracycline, oxytetracycline, and tetracycline
residues in milk.

Assay time is 5 minutes.

The limits of

detection in milk are 40 ppb for chlortetracycline and
oxytetracycline, and 20 ppb for tetracycline [2.185].
The SNAP™ /8-lactam test is an enzyme-linked receptorbinding screening test for penicillin G, ampicillin,
cephaprin, amoxicillin, cloxacillin, and ceftiofur
residues in raw whole milk.

The level of sensitivity

varies among the several drugs.

The SNAP testing device

is a single unit containing an antibody coated test area,
control spot, and all necessary reagents.

This recently

introduced test requires only three steps, no reagent
measuring, and provides results in ten minutes [2.186].
ELISAs utilizing test tubes coated with antibody are
available under the LacTek™ brand name from Idetek, Inc.
of Sunnyvale, CA.

LacTek™ screening tests for /8-lactams
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(amoxicillin, ampicillin, cephapirin, cloxacillin,
hetacillin, nafcillin, oxicillin, and penicillin G),
ceftiofur, chloramphenicol, gentamicin, sulfamethazine,
and tetracylines (tetracycline, chlortetracycline, and
oxytetracycline) in milk are available.

For multi-residue

assays, the relative level of sensitivity varies among the
individual drugs from 4-10 ng/ml.

Up to five samples can

be tested simultaneously with an assay time of seven
minutes and only two minutes of actual analyst time.
Results are determined using a dual wavelength
spectrophotometer [2.187].
Although a number of ELISAs are currently marketed,
at present none are certified or approved by any federal
agency.

However, the FDA has recently issued calls for a

voluntary evaluation of milk residue screening assays,
including immunoassays, and is presently evaluating
screening assays for their performance in detecting j8lactam antibiotic residues.
time [2.188].

Results are pending at this

In several published performance

evaluations, proprietary immunoassays have performed well
at correctly identifying various tissues as containing
above or below tolerance [2.143,2.144,2.157,2.167,2.168,
2.176,2.184,2.189].

Although immunoassays in kit form

were only recently available for residue analysis, the
great potential of these tests to improve the efficiency
of drug residue monitoring programs will clearly result in
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a number of additional assays of this type introduced in
the future.

CHROMATOGRAPHIC ANALYSIS

There will be the need at some time to provide a less
equivocable analysis of the residue.

Suspect samples

identified with screening tests require quantitation and
confirmation of the presence of residues exceeding the MRL
in the target tissue; hence rapid tissue extraction,
quantitation, and confirmatory methods must be available
for regulatory purposes.

For many such analyses,

chromatographic methods provide the necessary specificity
and sensitivity required for both qualitative and
quantitative drug analyses.

More recent chromatographic

methodologies can complement microbial or immunoassay
tests in that they have short analysis times overall and
limits of detection in the same concentration range.

THIN LAYER CHROMATOGRAPHY

CLASSICAL THIN LAYER CHROMATOGRAPHY

Thin layer chromatography (TLC) is one of the
simplest and most easily used of the chromatographic
methods and has long been used for separation and analysis
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of drug and other residues.

In classical TLC, an aliquot

of a biological fluid or tissue extract is added onto a
porous layer of adsorbent material.

Each component in the

sample has a characteristic mobility pattern on the TLC
plate for a given procedure.

The sample is resolved into

individual components by the distinctive migration pattern
of each component.

This migration distance is usually

expressed as an Rf value where Rf = (distance traveled by
the component)

(distance traveled by the solvent front).

An Rf value identical to that for a standard provides
presumptive, but not absolute identity of the component.
Visual determination of the migration distance and
relative spot size or intensity may be obtained with
naturally colored or naturally fluorescent compounds.
Other compounds may be visualized by spraying the plate
with specific reagents, charring, or treatment with vapor
phase reagents.

Alternately, TLC plate coatings may

contain a fluorescent indicator with UV absorbing
substances seen as dark areas against the fluorescent
background.

A wide variety of TLC adsorbent materials may

be used for coating of the TLC plate.

Silica gel is most

commonly used, but reversed-phase layers are available
with C2, C8, C18, and phenyl phases bonded to silica
[2.190].
TLC offers several distinct advantages over other
chromatographic procedures for residue analysis.

It's
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ability to analyze several samples simultaneously rather
than serially may provide significant time savings over
other methods of chromatography, and solvent systemdetector compatibility required with LC or GLC for multi
residue analysis is not needed [2.191].

Additionally, TLC

provides reproducible results without the potential LC
problems of column contamination and degradation and TLC
is relatively inexpensive in terms of equipment when
compared to other chromatographic methods.

Further, the

components remain in the absorbent layer and can be
recovered for further analysis.
Several classical TLC techniques are listed in the
FSIS /official methods' of analysis manual for
determination of several veterinary drug residues in red
meat and poultry [2.9],
Site (SOS) test.

One such method is the Sulfa on

This test was developed by the FSIS to

identify swine samples containing violative levels of
sulfamethazine and is commercially available in a kit
format.

SOS methods for urine and plasma are calibrated

so that test readings predict liver or muscle
concentrations exceeding sulfamethazine tolerance.
Sulfonamides are visualized on the TLC plate as areas of
blue-green fluorescence under UV light.

Suspect animals

identified by the SOS test are retained pending
quantitative analysis by GLC/MS [2.9,2.192].

Other

sulfonamides, including sulfadimethoxine, can also be
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detected with the SOS test.

The fluorescent intensity and

characteristic migration location (Rf value) indicates the
approximate concentration and provides presumptive
identification.

This test is a reasonably simple and

accurate method for detecting sulfonamide residues, but
does require mastery of some technical and manipulative
skills.

It is therefore not suited for on-farm use by lay

users with few basic laboratory skills [2.193].
Nevertheless, classical TLC techniques, in general,
lack the precision necessary for residue quantitation of
target tissue at tolerance.

Few published methods for

classical TLC analysis of drug residues in food fish are
available.

A method for TLC determination of residues of

the anesthetic tricaine methane sulfonate (MS-222) in fish
tissues was reported by Allen et al.

The method limit of

detection of 0.2 jug/g and limit of quantitation of 2.0
/jg/g are however above tolerance, making this method less
suitable for residue detection use [2.194].

Squibb et al.

used TLC for separation of SDM and metabolites in channel
catfish plasma, urine, bile, liver, and muscle in a
pharmacokinetic and disposition study [2.195].

Barron and

James used TLC for separation of radiolabelled
sulfadimethoxine and metabolites in lobster tissue
extracts with subsequent quantitation by scintillation
counting [2.196].
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Separation and determination of radiolabelled
substances may also be obtained using TLC with direct
radioscanning or autoradiography.

Because of its speed

and improved instrumentation, direct radioscanning of
developed TLC plates may someday replace scintillation
counting for radioisotope detection and quantitation in
drug and metabolism studies.

TLC may also be combined

with other analytical techniques such as mass spectrometry
or infrared spectrometry to provide more definitive
identification of compounds [2.190].

HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY

A modified planar chromatographic method with
potential use in residue monitoring as a screening and
quantitative method is high performance thin-layer
chromatography (HPTLC).

In this technique, sample and

standard solutions are applied manually or by an automated
spotting device to a silica gel coated HPTLC plate, mobile
phase applied, and computer-assisted densitometer or other
determinative readings obtained following development.
Determination may be effected using optimal wavelength
scanning at visible light absorbance, UV absorbance, or
fluorescence.

To facilitate separation or enhance

detection of analytes, prechromatographic derivatization
is performed or postchromatographic detection reagents may
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be applied to the plate [2.197].

Using these techniques,

HPTLC methods can provide results approaching those
obtained with LC in precision and quantitative accuracy
[2.191,2.198].
Although HPTLC offers several distinct advantages,
relatively few methods are published for HPTLC
determination of veterinary drug residues.

One such HPTLC

technique is the AOAC validated method for simultaneous
multi-sulfonamide residue screening applicable to swine,
turkey, and duck tissues.

This method provides acceptable

accuracy and precision near the official tolerance for six
sulfonamides, but tissue extraction requires
homogenization and multiple liquid-liquid partitioning
steps and is labor- and solvent-use intensive
[2.41,2.191].

The FSIS uses this procedure for multi

sulfonamide detection and quantitation in red meat and
poultry [2.9].

Tao published a rapid HPTLC method for the

determination of flumequine residues in rainbow trout meat
using chloroform extraction with quantitative analysis
using UV detection at 254 nm [2.199].

Reimer and Suarez

used MSPD for the simultaneous extraction of five
sulfonamides from salmon muscle with quantitation by HPTLC
using fluorescence detection following fluorescamine
spray.

The method detection limit for SDM was 0.13 0 /xg/g

[ 2 . 200 ].

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

57

TLC-BIOAUTOGRAPHY

Thin layer chromatography-bioautography (TLCB) is
based on selective tissue extraction, separation of
components by TLC, and bacterial growth inhibition
techniques.

TLCB provides a multiresidue detection method

and can be used to identify individual antibiotics within
a class of antibiotics [2.131].

It has been used in

Canada since 1984 for the confirmation of positive inplant tests of red meat [2.112].

Neidert et al. reported

minimum detectable amounts in fortified muscle samples
(ng/g) as 15 (chlortetracycline) and 30 (oxytetracycline
and tetracycline) as determined by the minimum amount
causing visible inhibition zones on 100% of tests at that
level [2.130].

MacNeil et al. reported TLCB lacked the

sensitivity of LC for oxytetracycline but was of equal
sensitivity with MIT.

STOP had greater or lesser

sensitivity than TLCB depending on the growth medium used
[2.120].

In a related study evaluating the performance of

five screening tests for detection of penicillin G
residues in calves, TLCB had greater sensitivity than the
STOP or CAST, but was less sensitive than the brilliant
black reduction test, Charm II, or LC [2.201].

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout p erm ission .

58

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

For many of the drugs used in aquaculture the method
of choice would be HPLC with UV detection, using a
variable wavelength or diode array detection system.
High performance liquid chromatography (LC) is the most
commonly reported method for quantitation of veterinary
drugs in aquatic species, red meat, and poultry.

Although

LC is commonly used, complex extraction procedures and/or
sample pretreatment are often needed before injection on
conventional reversed phase analytical columns.

Newer

analytical columns employing internal surface reverse
phase or immunoaffinity packing permit direct injection of
plasma and other liquid matrices that cannot ordinarily be
used with conventional LC columns [2.79].

With such

improvements LC procedures may approach screening tests in
speed and simplicity [2.202].

As illustrated in Table 2.1

[2.45-2.97], a variety of analytical columns and mobile
phases are reported for a number of drugs.

Although many

LC techniques have been described over the years, one must
exclude from consideration any strict adherence to LC
methodologies reported prior to 1985.

This fact is in

large measure due to the very different nature of the
solid supports available today when compared to those of
the past.

Reverse phase C18 packing is most commonly used

but other packings reported are dimethyl silica,

R ep ro d u ced with p erm ission o f th e copyright ow ner. Further reproduction prohibited w ithout p erm ission .

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

TABLE 2.1

Compound(s)

REPRESENTATIVE EXTRACTION AND LIQUID CHROMATOGRAPHIC METHODS FOR DRUGS USED IN
AQUACULTURE

Sample Preparation

Analytical Column

Mobile Phase

Tetracycline
fish
Oxytetracycline
Chlortetracycline

homogenization
filtration
SPE using
Amberlite XAD2
resin

A. Wako Gel
(dimethylsilica)
10 pm or
B. Shimadzu Gel
(polystyrene gel)
10 pm

col A. 0.05 M phosphatebuffer - UV @ 370 nm
15 min
ACN 9:1
col B. 0.04 M KH2P04-0.08 M
EDTA-MeOH 1:1:8

Tetracycline
salmon muscle
Oxytetracycline
Chlortetracycline

homogenization
SPE using
Bond Elute CIS

Merck Hibar
0.01 M oxalic acid -ACN LiChroCART RP-18 MeOH
7 pm
73:17:10

Oxytetracycline RBT muscle

homogenization
SPE using
Amberlite XAD2
resin

Hypersil SAS
5 pm

0.1 M citricacid -0.1 M trisodiumUV @ 370 nm
citrate-0.1 M NajEDTA -ACN 8 min
340:5:5:150

5 ng/g

[2.47]

Oxytetracycline RBT muscle &
liver

homogenization
SPE using
Sep-Pak C|8

Shandon
ODS Hypersil
5 pm

[(5 g DAHP + 5 ml DEA)/810 ml UV @ 365 nm
water] -ACN -DMF
8 min
81:19:6

5 ng/g

[2.48]

Oxytetracycline RBT serum,
liver, muscle

homogenization
liquid / liquid
SPE using
Bond Elut Cm

Spheri ODS
5 pm

ACN -DMF -0.01 oxalic acid
27:6:67

UV @ 355 nm
8 min

50 ng/ml Serum
50 ng/g Muscle
100 ng/g Liver

[2.49]

Supelcosil*
LC-18 DB
5 pm

0.005 M phosphatebuffer ACN -THF
81:10:9

UV @ 357 nm
10 min

5 ng/g muscle
10 ng/g liver

[2.50]

Matrix

Oxytetracycline fish liver,
homogenization
muscle, slime, SPE using
hide, vertebrae Bondesif C,or Cl8

table con' d.

Detection Method Limit of Detection
& Analysis Time
20 ng TC, OTC
60 ng CTC
on column

photodiode array 90 ng/g TC
80 ng/g OTC
15 min
500 ng/g CTC

Ref.
[2.45]

[2.46]

@ 355 nm

(Jl
u>
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Oxytetracycline RBT plasma

protein ppt using
trifluoraceticacid

Cyano Spheri-5
MPLC
5 pm

0.02 M oxalic acid MeOH -DMF
95:5:5

Oxytetracycline RBT muscle,
serum, liver,
kidney, bone,
skin

homogenization
liquid / liquid
SPE using
Sep-pak C18

M & S pack C,t

Oxytetracycline fish plasma

Oxytetracycline channel catfish
muscle

4 ng on column

[2.51]

MeOH -ACN -0.2 M oxalic acic UV @ 360 nm
1:1:3.5
12 min

50 ng/g muscle, serum
100 ng/g liver, kidney,
bone, skin

[2.52]

directLC inj and
PLRP-S 100 A
pre-column extraction S pm
with polystyrencdivinylbenzene

0.02 M aqueous H jP04ACN -THF
89:6.3:4.7

UV @350 nm
8.5 min

12 ng/ml

[2.53]

MSPD

0.02 M oxalic acid ACN - MeOH
70:27.5:2.5

photodiodearray 50 ng/g
@ 365 nm
(1.25 ng on column)
6 min

MicroPak Cl(
MCH-10

Oxytetracycline Pacific pink
homogenization
UltraspherreODS
salmon muscle filtration
5 pm
SPE using Bakerbond

UV @ 350 nm
6 min

[2.54]

0.02 M phosphatebuffer -MeOH UV ® 365 nm
19:6
20 min

50 ng/g

[2.55]

cu
Oxytetracycline Pacific pink
homogenization
salmon muscle liquid/ liquid

UltrasphereODS
5 pm

0.025 M aqueous oxalic acid ACN-THF 30:9:1
containing
octanesulfonic acid at 10 m M

UV @ 355 nm
15 min

50 ng/g

[2.56]

OTC, CTC,
CAP, SMM,
SDM, FZD,
DFZ

Nucleosil S Cl8

0.05 M monobasic sodium
phosphate- ACN
65:35

UV @ 265 nm
30 min

50 ng/g OTC, CAP,
SMM, SDM, FZD
100 ng/g CTC
1000 ng/g DFZ

[2.57]

p-Porasil

CHClj- MeOH -HjO -cone
NH4OH
1000:28:2:0.6

UV @ 288 nm
20 min

50 ng/g each

[2.58]

RBT, yellowtail, homogenization
red sea bream, SPE using
eel muscle
Sep-pak C,s

Sulfadimethoxine catfish muscle, homogenization
& Ormetoprim liver, kidney
liquid/ liquid

table con'd.

< J\

o
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Sulfadimethoxine chinook salmon homogenization
Ormetoprim
muscle
SPE using
Sep-Pak C)8

5 pm

Sulfadimethoxine channel catfish
muscle

MSPD

SDM, SMM,
N-acetyl
metabolites

RBT serum,
muscle, liver,
kidney, bile

Sulfadimethoxine coho salmon
flesh

Sulfadiazine
coho salmon
Sulfamerazine muscle
Sulfamethazine
Sulfadimethoxine
Sulfapyridine
Sulfadiazine
Trimcthioprim

ACN -MeOH -0.1 M H5P04
17:10:73

UV @ 280 nm
30 min

MicroPak Clt
MCH-10

0.017 M H3P04-ACN 65:35

photodiode array 50 ng/g
@ 270 nm
(1.25 ng on column)
10 min

[2.60]

homogenization
liquid-liquid
SPE using
Sep-Pak Alumina B

YMC-Pack C„

0.05 M phosphatebuffer -ACN
65:35

UV @ 265
25 min

[2.61]

homogenization
liquid/ liquid

Supelcosil
LC 18-DB
5 pm

aqueous 35% ACN containing
0.1% formic acid

photodiode array 25 ng/g
@ 265 nm
mass spectrometry
11 min

Supelcosil
LC 18-DB

ACN -0.01 M ammonium acetate photodiode array -100 ng/gSDZ
gradient composition
@ 270nm
66 ng/g SMR
57 min
228 ng/g SMT
150 ng/g SDM
48 ng/g SP

Supelcosil
LC 18-DB

0.025 M sodium phosphatewith
hexane sulfonate(pH 2.8) -ACN
with 0.1% triethylamine
77:23 Plasma
80:20 Tissue

ODS Hypersil
5 pm
narrow-bore

0.017 M H jP04-ACN
71:29 muscle
73:27 plasma

MSPD

Atlantic salmon, homogenization
RBT plasma,
liquid/ liquid
muscle, & liver Spin-X filter

Sulfadimethoxine channel catfish
4-N-acetyl SDM muscle and
plasma

table con'd.

Ultrasphere
ion-pair

MSPD

UV @ 270 nm
10 min plasma
20 min tissue

200 ng/g each

50 ng/g serum, muscle,
liver, kidney
100 ng/ml bile

plasma
50 ng/ml SDZ
250 ng/ml TMP
muscle
15 ng/g SDZ
80 ng/g TMP

photodiode array 26 ng/g

(2.59]

[2.62]

[2.63]

[2.64]

[2.65]

® 265 nm
12 min

o\
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Furazolidone

Atlantic salmon homogenization
muscle & liver liquid/ liquid
SPE using
Bond Elut NH]

ODS Hypersil
3 pm

ACN -water
UV @ 400 nm
16:84
8 min
containing0.001 M Na2EDTA&
0.1 M KNOj

5 ng/g

[2.66]

FZD, NFS,
SDM, SMM,
SSZ,
NA, OA, PA,

yellowtail, eel, homogenization
sweet fish, RBT, SPE using
red sea bream Bond Elut C,s

InertsilODS
S pm

0.005 M aqueous oxalic acid ACN
55:45

UV @ 265 nm
25 min

20 ng/g OA
50 ng/gSMM, SDM,
SSZ, NA, PA, FZD
100 ng/g NFS

[2.67]

OA, NA, PA,
FZD, DFZ,
NPN, FMZ,
SDM, SMM,
SSZ, SMR

eel
yellowtail
RBT meat

homogenization
liquid/ liquid
SPE using
Alumina

Nucleosil C|,

THF -ACN - HjP04-water
29:1:0.06:69.94

UV @ 260 nm
40 min

20 ng/g OA
40 ng/g SMR, FZD, NA
60 ng/g SMM, SSZ,
SDM,DFZ
80 ng/g PA, NPN, FMZ

[2.68]

Oxolinic Acid
NalidixicAcid
Piromidic Acid

eel, RBT,
sweetfish,
red sea bream,
yellowtailtissue

homogenization
SPE using
Baker 10 Amino
Cartridge

Nucleosil 3 C„
3 pm

ACN -MeOH -0.01 M oxalic
acid
3:1:6

UV @ 295 nm
8 min

50 ng/g each

[2.69]

Flumequine
Oxolinic Acid

salmon plasma

SPE using
Bond Elut™ Cjor
on-line polystyrenedivinylbenzene

polystyrenedivinylbenzene
PLRP-S
5 pm

ACN -THF 0.02 M orthophosphoricacid
20:15:65

fluorescence
5 ng/ml OA
262 nm excitation 10 ng/ml FEQ
380 nm emission
13 min

[2.70]

Flumequine
Oxolinic Acid

Atlantic salmon liquid/liquid
plasma

fluorescence
3 ng/ml OA
325 nm excitation 5 ng/ml FEQ
360 nm emission
15 min

[2.71]

table con'd.

MOS-Hypersil (C8) 0.025 M oxalic acid -ACN 3 pm
MeOH - THF
gradient composition

0\

to
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Flumequine
Oxolinic Acid

fish muscle,
homogenization
liver, hide,
liquid/ liquid
kidney, intestine or
homogenization
liquid/ liquid
SPE using C2 or
cyano column

PLRP-S polymer
S pm

0.002 M HjP04- ACN -THF
65:20:15

fluorescence
0.5 ng/g OA
260 nm excitation 2 ng/g FEQ
380 nm emission muscle and liver
12 min

12.72]

Flumequine
Oxolinic Acid

Atlantic salmon homogenization
liver
liquid/ liquid
on-line dialysis
on-line SPE using
polystyrenedivinylbenzene

polystyrenedivinylbenzene
PLRP-S
5 pm

ACN -THF 0.02 M orthopliosphoricacid
20:14:66

fluorescence
4 ng/g OA
325 nm excitation 7 ng/g FEQ
365 nm emission
15 min

[2.73]

Flumequine
Oxolinic Acid

Atlantic salmon homogenization
muscle
liquid/ liquid
on linedialysis
on-line SPE using
polystyrenedivinylbenzene

polystyrenedivinylbenzene

UV @ 260 nm
2 ng/g OA
or
3 ng/g FEQ
fluorescence
using fluorescence
325 nm excitation
365 nm emission
13 min

[2.741

S pm

ACN -THF 0.02 M orthophosphoricacid
20:15:65

Flumequine
Oxolinic Acid

salmon & RBT homogenization
muscle & liver liquid/ liquid

PLRP-S polymer
S pm

0.002 M H,P04 ACN -THF
64:21:15

fluorescence
5 ng/g OA
260 nm excitation 10 ng/g FEQ
380 nm emission
12 min

[2.75]

Flumequine

Atlantic salmon homogenization
muscle
liquid/ liquid

ODS Hypersil
3 pm

0.1 M citricacid 'MeOH -ACN - fluorescence
5 ng/g
THF
324 nm excitation
60:30:5:5
363 nm emission
8 min

[2.76]

Flumequine

eel plasma,
aquariawater

Nucleosil

ACN -DMF - [(3g HjP04 + lg
TMAC)/675 ml water]
125:200:675

[2.77]

table con'd.

liquid-liquid

fluorescence
2 ng/ml
245 nm excitation
350 nm emission

<s\
GJ
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Oxolinic Acid

RBT serum

SPE using
Sep-Pak Accell
or liquid/ liquid

Nova-Pak C„
4 pm

Oxolinic Acid

RBT serum,
muscle, liver

serum -direct inj.
muscle, liver
homogenization
SPE using
Bond Elut Cjg

Regis Pinkerton GFF ACN -0.1 M KH2P04
ISRP
1:9
5 pm

UV @ 254 nm
12 min

Oxolinic Acid

salmon muscle

homogenization
liquid/ liquid

PartisilODS-3
5 pm

ACN MeOH -0.01 M oxalic
acid
3:1:6

fluorescence
1-2 ng/g
327 nm excitation
369 nm emission
4 min

[2.80]

Oxolinic Acid

channel catfish
muscle & bile

MSPD

Versapak C„
10 pm

MeOH -0.05 M GAA
gradientcomposition

UV @ 260 nm
65 min

50 ng/g

[2.81]

Nalidixic Acid

channel catfish MSPD
muscle & liver

Versapak C)g
10 pm

MeOH -0.05 M GAA
gradient composition

UV @ 257 nm
radio-label
monitoring
65 min

20 ng/g muscle
60 ng/g liver
using radioactivity

[2.82]

Nalidixic Acid

RBT & amago
salmon serum,
muscle, liver,
kidney, bile

homogenization
liquid/ liquid

ToyoGel
DEAE-2SW

0.015 M phosphatebuffer -ACN
65:35

UV @ 278 nm

Muscle 50 ng/g
serum 50 ng/ml
liver, kidney 100 ng/g
bile 100 ng/ml

[2.83]

Miloxacin
eel, yellowtail,
M-l metabolite red sea bream,
& RBT muscle

homogenization
SPE using
Bond Elut On

L-column ODS

0.05 M Na H2P04-ACN
65:35

UV @ 260 nm or 10 ng/g each
fluorescence
325 nm excitation
365 nm emission
10 min

table con'd.

MeOH - (7.5 g/1 KH2P04•2HjO UV @ 258 nm
+ 2.5 g/1Na2HP04•H20)
15 min
4:6

1 ng/ml

[2.78]

10 ng/ml serum (direct inj) [2.79]
10 ng/g liver, muscle

[2.84]
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Enrofloxacin

Atlantic salmon serum & RBT serum, SPE using Cj
muscle, liver
muscle & liverhomogenization
liquid/ liquid
SPE using C„

PLRP-S polymer
5 pm

0.002 M HjP04 -ACN
8:2

UV ® 289 nm 1 ng/ml serum
or fluorescence 1 ng/g tissue
278 nm excitation using fluorescence
440 nm emission
12 min

[2.85]

Sarafloxacin

fish serum

PLRP-S polymer
5 pm

0.002 M H3P04-ACN -MeOH
72:20:8

fluorescence
5 ng/g
278 nm excitation
440 nm emission
7 min

[2.86]

Enrofloxacin
Sarafloxacin

Atlantic salmon homogenization
muscle, liver
liquid/ liquid

RLRP-S
polymer
5 pm

0.002 M H3P04-ACN -MeOH
73:19:8

fluorescence
5 ng/genrofloxacin
278 nm excitation 10 ng/g sarafloxacin
440 nm emission
8 min

[2.87]

Ciprofloxacin

RBT &
African catfish
plasma

Spherisoib-5
ODS

ACN -DMF - [(1.13 g HjP04 +
0.38 g TMAC)/700 ml water]
1.5:1.5:7

UV ® 278 nm

—

[2.88]

Ampicillin

yellowtail tissue homogenization
SPE using
Sep-Pak Florisil

Nucleosil C„

MeOH-0.02 M N a 2HP040.01 M citricacid
15:42.5:42.5

UV ® 222 nm
40 min

30 ng/g
(3 ng oncolumn)

[2.89]

Thiamphenicol

yellowtail tissue homogenization
liquid/ liquid
SPE using Florisil

TSK gel
ODS-120T

MeOH -water
15:18

UV ® 225 nm
20 min

1.25 ng

[2.90]

Chromatorex ODS
5 pm

MeOH -water
15:85

UV ®
225 & 270 nm
30 min

10 ng/g each

[2.91]

Nucleosil C„

water - ACN
65:35

UV ® 223 nm

100 ng/ml

[2.92]

SPE using
Bond EluteRCj

liquid/ liquid

Thiamphenicol yellowtail muscle homogenization
Florfenicol
liquid/ liquid
Chloramphenicol
SPE using
Sep-Pak Florisil
Florfenicol

Atlantic salmon liquid/liquid
muscle

table con'd.

5 pm

o\
ui
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homogenization
SPE using
diatomaceous earth
liquid/ liquid

MicroPak C,t
MCH-10

water -0.05 N HjP04 -ACN
6:6:88
gradient flow rate

UV @ 290 nm
30 min

low ng/g range

[2.93]

Malachite Green RBT muscle &
liver

homogenization
liquid/ liquid

PLRP-S polymer
5 pm

0.02 M H jP04- ACN -THF
49:40:1

UV @ 615 nm
6 min

1 ng/g muscle
10 ng/g liver

[2.94]

Malachite Green pond &
tap water

SPE using
Baker 10 diol

pBondapak C,8
MeOH - (0.05 M Na acetate +
10 pm
0.1 M GAA)
85:15
and Pb02
postcolumn reactor

UV @ 618 nm
17 min

2.83 ng/L chromatic form [2.95]

Febendazole

Praziquantel

17oi-methyltestosterone

channel catfish
plasma, kidney,
fat, muscle,
bowel contents,
urine

fish muscle,
liver, kidney

Supelcosil LC-18
homogenization
liquid/liquid
5 pm
SPE using Bond Elute
C2 and SI

RBT muscle

homogenization
centrifugation
liquid/liquid
SPE using
Lipidex 5000 &
Sep-Pak silica

water -ACN

2.01 ng/L leuco form
UV @ 210 nm
25 min

1:1

Hypersil C, and
Nucleosil C„
5 pm each
and immobilized
enzyme reactor

MeOH -water
75:25

flumequine
furamizole
furazolidone
glacial acetic acid
nalidixic acid
nifurpirinol
nifurstyrenate
oxolinic acid

OTC
PA
RBT
SDZ
SDM
SI
SMR
SMT

5 ng/g

[2.96]

fluorescence
1 ng/g
340 nm excitation
470 nm emission
or UV @ 254 nm
35 min

[2.97]

Abbreviations (Table 2.1)
ACN
CAP
CTC
DAHP
DEA
DFZ
DMF

acetonitrile
chroramphenicol
chlortetracycline
diammoniumhydrophosphate
diethanolamine
difurazone
dimethylformamide

FEQ
FMZ
FZD
GAA
NA
NPN
NFS
OA

oxytetracycline
piromidic acid
rainbow trout
sulfadiazine
sulfadimethoxine
silica
sulfamerazine
sulfamethazine

SMM
SP
SSZ
TC
THF
TMAC
TMP

sulfamonomethoxine
sulfapyridine
sulfisozole
tetracycline
tetrahydrofuran
tetraethylammoniumchloride
trimethoprim

o\
o\
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polystyrene gel, ion-pair, polystyrene divinylbenzene, and
Regis Pinkerton internal surface reverse phase.

Detection

by UV using fixed or variable wavelength detectors or
diode array is most frequently reported, but fluorescence
detection gives greater sensitivity for the tetracycline
and quinolone antibiotics.

Reported limits of detection

for some of the LC methods listed in Table 2.1 are above
the current MRLs of many countries and only one of the
methods has undergone interlaboratory validation studies
[2.80,2.98].

Therefore, legally defensible LC methods

validated for use about the MRL are needed for the
analysis of veterinary drugs and their important
metabolites in edible fish tissues.

GAS CHROMATOGRAPHY

There are a limited number of publications involving
the application of gas liquid chromatography (GLC) to the
analysis of veterinary drugs used in aquaculture [2.99,
2.203-2.207].

Many of the compounds used therapeutically

in aquaculture are of high molecular weight, relatively
non-volatile, and thermally labile; therefore chemical
derivatization is generally required to obtain sufficient
volatility and stability for GC analysis.

Additionally,

the methylation of sulfonamides with diazomethane prior to
GLC produces N'-methyl and ring-methyl derivatives.

The
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formation ratio of the two isomers is variable and the
ring-methyl derivative does not elute from the GLC column.
The incorporation of deuterium or 13C labelled sulfonamides
prior to derivatization and the use of isotopic ratios
corrects for variable isomer formation but increases the
cost and complexity of the analysis [2.208],
As a result of the extensive sample preparation and
cleanup necessary prior to derivatization, GLC is not as
frequently utilized as LC in drug residue analysis.

Early

reports by Allen and Sills for the GC analysis of the fish
anesthetic quinaldine used a packed column and an alkali
flame detector and had a limit of quantitation of 0.01
Mg/g [2.203,2.204].

A method for determination of

sulfamethazine residues in swine muscle is the only AOAC
OMA method for the GLC determination of a veterinary drug
residue in animal tissue [2.41].

A GLC-MS method for

determination of chloramphenicol residues at the low
parts-per-billion level in shrimp tail muscle has since
undergone interlaboratory validation and is in press
[2.99-2.208].

A multi-residue GLC method for thirty-six

veterinary drugs in red meat and poultry has been reported
[2.209],

A number of these drugs or related compounds are

also used in aquaculture and the methods could potentially
be applied to food fish tissues.

Additionally, techniques

employing GLC separation and mass spectrometric detection
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of quinolone antibacterials in fish tissue are described
in the following section.

HASS SPECTROMETRY

'Absolute' confirmation of the presence of a compound
as required for regulatory action may often be secured
using gas liquid chromatography/mass spectrometric
detection and confirmation (GLC/MSD). Although such
methods provide quantitation and identity confirmation, a
GLC/MSD method for sulfamethazine residues in swine
tissues is the only AOAC OMA validated method available
[2.41].

Only two methods were found in the literature for

GLC/MSD determination of veterinary drug residues in
aquatic animals.

Takatsuki reported a GLC/MSD method for

oxolinic acid and a similar multi-residue GLC/MSD method
for determination of oxolinic acid, nalidixic acid, and
piromidic acid in silver salmon using selected ion
monitoring [2.205,2.206].

In both methods, reduction of

oxolinic acid, nalidixic acid, and piromidic acid with
tetrahydroborate (sodium borohydride) gives compounds that
are sufficiently volatile for GLC.

The method was

reported capable of performing quantitative analyses with
a detection limit of 0.003 fiq/g, but the classical sample
preparation technique is complex and time consuming.
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Liquid chromatography/mass spectrometric detection
(LC/MSD) is becoming more available and because of
simplified sample preparation requirements, may someday
exceed GLC for the purpose of confirming many of the polar
drugs used in aquaculture.

At present however, only two

reported applications of LC/MSD determination of
veterinary drugs in aquaculture products could be found.
Pleasance et al. determined sulfadimethoxine residues to
0.025 Mg/g in salmon flesh using LC/MSD and LC/MSD/MSD via
a ion-spray interface [2.62].

A thermospray LC/MSD method

reported by Horie et al. provided quantitation and
identification of residues of naladixic acid, oxolinic
acid, and piromidic acid in sweet fish and yellowtail
muscle to 0.05 jug/g [2.210].

Thermospray LC/MSD is a

relatively mild ionization method and only molecular
weight information from MH+ ions is generally obtained.
Since fragment ions are not produced, the additional
molecular and structural information useful in
identification of organic compounds is lacking.
Nonetheless, the combination of molecular weight,
chromatographic retention time, and UV spectrum
information should provide sufficient verification for
regulatory purposes.
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OTHER RESIDUE DETECTION METHODS

Veterinary drug residues have also been readily
detected by a variety of other means.

In this regard, the

fluorescence of tetracyclines under UV light has been used
as an indicator of previous tetracycline treatment.

This

technique has been used for the detection of
oxytetracycline residues in bone and injection sites, but
fluorescence is non-specific and persists in bone for an
extended time after treatment [2.120,2.211].

Because of

its persistence in bone, oxytetracycline has been used for
long term identification of released fish in stocking
studies [2.212].
Experimental methods using radiolabelled drug and
liquid scintillation counting [2.114,2.195,2.196,2.213,
2.214] or whole body autoradiographic studies [2.2152.218] have been used to provide information on
pharmacokinetic behavior, metabolite formation,
disposition, depletion rate, and extraction efficiencies
for compounds used in aquaculture.

These methods are,

however, unsuited for use in routine drug residue
analysis.
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METHODS OF ISOLATION

Determinative technologies for residue analysis
require the use of tissue isolation methods that are
simple, fast, and efficient.

Sample preparation,

isolation, and cleanup are becoming the major ratelimiting factors in sample analysis as improvements in
analytical methods proceed [2.219].

This fact is

especially important in light of efforts to introduce
rapid screening tests such as immunoassays.

The choice of

a sample extraction method for a particular application is
dependent upon what the analyst must or needs to
accomplish and is determined by several interrelated
factors.
a.

These include the following variables:

The sample size available or necessary to obtain a

given limit of detection with the analytical
instrumentation available.
b.

Matrix characteristics and the availability of

existing methods for analyte isolation from the specific
matrix.
c.

Specificity requirements of the analysis; i.e.,

isolation of a single compound within a drug class,
several compounds within a drug class, or several drug
classes from a single sample.
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d.

Number of samples analyzed daily and turn-around time

requirements.
e.

Overall cost of the method including supplies and

disposables, time and labor involved, and the costs of the
instrumentation that will be applied [2.220].
Several approaches have been used over the years for
the preparation, isolation, and cleanup of veterinary
drug, pesticide, and environmental contaminant residues
from aquatic matrices.

Historically, the classical

approach to isolation of drugs from tissues has most often
been reported [Table 2.1].

This approach involves tissue

homogenization followed by liquid-liquid partitioning of
the homogenate, with or without additional cleanup or
concentration steps.

Liquid-liquid partitioning may also

be used with biological fluids.

Homogenization and

liquid-liquid partitioning methods may provide adequate
separation of the drug from matrix but are often expensive
in terms of time, labor, material use, and organic solvent
disposal costs.

Such approaches also tend to be highly

nonspecific in their isolation of the target drug(s).
Furthermore, these traditional isolation methods may
be generating more contamination than they are
satisfactorily removing.

Table 2.2 provides an indication

of the problem by listing the volumes of solvent required
and waste solvent produced for extraction of various drugs
from aquatic animal tissues.
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TABLE 2.2

COMPARATIVE SOLVENT USE AND HASTE PRODUCTION OF REPRESENTATIVE EXTRACTION
METHODS FOR DRUGS USED IN AQUACULTURE

Compounds

Matrix

Sample Preparation

Organic Solvent
Used
(ml)

Organic Waste
(ml)

Aqueous
Waste
(ml)

Reference

100

-0-

350

[2.45]

tetracycline
oxytetracycline
chlortetracycline

fish

homogenization
SPE using Amberlite XAD2

tetracycline
oxytetracycline
chlortetracycline

salmon muscle

homogenization
SPE using Bond Elute Cl8

29

20

90

[2.46]

oxytetracycline

RBT muscle

homogenization
SPE using Amberlite XAD2

825

750

430

[2.47]

oxytetracycline

RBT muscle & liver

homogenization
SPE using Sep-Pak C,8

10

5

47

[2.48]

oxytetracycline

RBT serum, liver, and
muscle

Homogenization
liq / liq
SPE using Bond Elut Cl8

5

5

50 (serum)
100 (tissue)

[2.49]

oxytetracycline

fish liver, muscle,
slime, hide, vertebrae

homogenization
SPE using
Bondasil C8 or C18

11

9

82

[2.50]

oxytetracycline

RBT plasma

protein precipitation using
trifluoracetic acid

-0-

-0-

-0-

[2.51]

oxytetracycline

channel catfish muscle

MSPD

16

8

-0-

[2.54]

table con'd.
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sulfadimethoxine
ormetoprim

catfish muscle, liver,
kidney

homogenization
liq / liq

10

9

-0 -

[2 .58]

sulfadimethoxine
ormetoprim

chinook salmon muscle

homogenization
SPE using Sep-Pak C,8

25

5

10

[2.59]

sul fadimethoxine

channel catfish muscle

MSPD

16

8

-0-

[2.60]

furazolidone

Atlantic salmon muscle
& liver

homogenization
liq / liq
SPE using Bond Elut NH2

57

22

30

[2.66]

OA, NA, PA,
FZD, DFZ, NPN,
FMZ, SDM, SMM,
SSZ, SMR

eel, yellowtail, RBT
meat

homogenization
liq /liq
SPE using Alumina

367

95

70

[2.68]

OA, NA, PA

eel, RBT, sweetfish,
red sea bream,
yellowtail tissue

homogenization
SPE using Baker 10 Amino
cartridge

65

55

-0-

[2.69]

flumequine
oxolinic acid

salmon plasma

SPE using Bond Elute C2

10

10

6

[2.70]

flumequine
oxolinic acid

Atlantic salmon liver

homogenization
liq / liq
on-line dialysis
on-line SPE using
polystyrene-divinylbenzene

5

5

19

[2.71]

flumequine
oxolinic acid

Atlantic salmon muscle

homogenization
liq / liq
on-line dialysis
on-line SPE using
polystyrene-divinylbenzene

10

10

50

[2.74]

table con'd.

ui
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flumequine

Atlantic salmon muscle

homogenization
liq / liq

43

-0-

flumequine

eel plasma, aquaria
water

liq / liq

4

1

oxalinic acid

RBT serum

SPE using Sep-Pak Accell
or liq / liq

4.2
4

-0-

RBT serum
muscle, liver

direct injection
homogenization
SPE using Bond Elute C18

oxolinic acid

salmon muscle

oxolinic acid

30

[2.76]

0

[2.77]

9
3

[2.78]

0

JQ10

rCF

-0;

[2.79]

5

75

homogenization
liq / liq

26

2

-

0

[2.80]

channel catfish muscle,
bile

MSPD

16

8

-

0

[2.81]

nalidixic acid

channel catfish muscle,
liver

MSPD

16

8

-

0

[2.82]

naladixic acid

RBT & Amago salmon
serum, muscle, liver,
kidney, bile

homogenization
liq / liq

260

60

300

[2.83]

enrofloxacin

Atlantic salmon & RBT
serum
muscle, liver

SPE
homogenization
liq / liq
SPE using C„

2

2

4

61

42

8

oxolinic acid

-

-

-

-

-

-

-

[2.85]

sarafloxacin

fish serum

SPE

2

2

4

[2.86]

enrofloxacin
sarafloxacin

Atlantic salmon muscle,
liver

homogenization
liq / liq

11

11

1

[2.87]

table con'd.
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ciprofloxacin

RBT & African catfish
plasma

liq / liq

ampicillin

yellowtail tissue

fenbendazole

malachite green

3

0.6

-0-

[2.88]

homogenization
SPE using Sep-Pak Florisil

134

130

-0-

[2.89]

channel catfish plasma,
kidney, fat, muscle,
bowel contents, urine

homogenization
SPE using diatomaceous
earth
liq / liq

49

12

7

[2.93]

pond & tap water

SPE using Baker 10 diol

2

2

-0-

[2.95]

See Table 2.1 for list of abbreviations

78

Many of these solvents are of greater toxicological and
environmental concern than the compounds they are used to
isolate.

During extraction and isolation procedures, much

of this solvent volume is evaporated into the atmosphere,
which contaminates millions of cubic feet of air, and
solvents are often not disposed of properly, which leads
to further contamination of the atmosphere, aquifers, and
aquatic habits and resources.
As previously mentioned, a further problem with
excessive use of solvents is that they make these methods
very expensive to perform.

The purchase price and

subsequent disposal costs of organic solvents and wastes
can be limiting factors in analyses performed by
government agencies operating on a restricted budget.
Employee costs can also be a limiting factor in residue
analysis.

Present official methods generally require

extensive training of laboratory technicians in order to
guarantee consistent, reliable results and most such
methods are not amenable to automation.

Therefore, costs

for materials and labor can limit the number of samples
which can be consistently analyzed to provide adequate
regulatory enforcement and consumer protection from
illegal residues and to provide a statistically sound
evaluation of the magnitude of contamination.
Any method for the isolation of drugs or other
chemical contaminants must take these factors into
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consideration.

Thus, extraction methods that use large

sample sizes and, thus, require large volumes of organic
solvent to adequately perform residue isolation are
becoming increasingly unacceptable.

All of the above

problems indicate that the use of classical
homogenization/extraction and determinative methods for
screening purposes should be severely curtailed and phased
out as new more appropriate methods are developed and
validated for sample screening.

EVOLVING METHODS OF RESIDUE ANALYSIS

Recent advances in the field of residue analysis
offer several promising techniques as possible solutions
to the problems caused by outmoded and complex analytical
methods.

Four techniques, solid phase extraction (SPE),

immunoaffinity, supercritical fluid extraction (SFE), and
matrix solid phase dispersion (MSPD), are receiving
particular attention because they have the potential to
greatly reduce analysis costs and reduce analyst-generated
waste and pollution.

All of these methods may prove

useful for a given application.

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

80

SOLID PHASE EXTRACTION

In the SPE process, a compound is isolated from a
liquid sample based on its relative solubility in the
liquid mobile phase compared to its solubility in a solid
support-bound liquid stationary phase of differing
polarity or its affinity to a solid support stationary
phase of differing polarity.

Isolation is accomplished by

passing the analyte dissolved in solvent (organic or
aqueous) through a column containing the stationary phase
with subsequent elution using an appropriate solvent.
Several solid phase extraction methods have been developed
to facilitate the extraction and cleanup of biological
liquid and tissue samples.
For plasma, acceptable residue recovery may be
obtained using protein precipitation and direct LC
injection without prior cleanup with SPE [2.51].

However,

the many impurities present can affect the chromatogram
and accumulate on the LC analytic column, thus resulting
in increasing back pressure and decreased column life.
SPE cleanup helps avoid these problems and works well with
biological fluids such as serum, plasma, urine, and
cerebral spinal fluid.

In addition, SPE extraction and

analysis can be automated and done on-line [2.70,2.71,
2.74] and/or with on-line dialysis and column switching.
However, before SPE can be used with solid tissue (e.g.,
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muscle and liver), a separate homogenization step and
often multiple filtration, sonication, centrifugation, and
liquid-liquid cleanup steps are required.

While SPE may

improve cleanup of these solid tissue samples, the
additional labor and materials costs make SPE less
suitable, in some cases.
Solid phase extraction methods published for fish
tissues are often combinations of SPE with other methods
such as homogenization, liquid-liquid partition,
filtration, sonication, and centrifugation (Table 2.1).
Because choice of SPE column depends on the matrix and on
the particular compound of interest, a wide range of solid
phase columns of differing polarities have been used for
drug extraction in fish and include C2, C8, C18, NH2,
amberlite resins, and PLRP (polystyrene-divinylbenzene)
polymers (Table 2.1).

IMMUNOAFFINITY

The simplest method of extraction however, is one
that requires minimal or no sample manipulation.

These

are the methods that /extract' the drug directly from the
sample matrix by means of specific or selective antibodies
or receptors.

High performance immunoaffinity

chromatography (HPIAC) is one such method that combines
immunoassay and LC.

Immunoaffinity techniques may be
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either single or multi-residue methods depending on the
specificity of the antibody and the number of specific
types of antibodies immobilized on the beads.

These

techniques may be categorized as 1) single antibody/single
analyte, 2) single antibody/multi-analyte, or 3) multi
antibody/multi-analyte [2.221,2.224].
In HPIAC, a flow-through cartridge containing
antibody immobilized on glass or porous beads is used in
place of an LC analytical column.

Following sample

injection, the drug (antigen) is captured on antibodycoated beads, the cartridge washed to remove unbound
material, and the drug eluted from the cartridge.
Detection may be by UV or other LC detection methods.

The

cartridge is regenerated by passage of several volumes of
equilibrium buffer.

Assay formats other than the on/off

format that may be used include sequential, competitive,
or sandwich assays.

The sandwich assay format uses a

second enzyme-tagged antibody to form a three-part layer
consisting of tagged antibody, bound antibody, and
immobilized antibody.

The limits of detection of the

on/off, competitive, and sandwich assay are 100-500 ng, 10
ng, and 10 pg respectively [2.221].

These methods are

most applicable to aqueous solutions of the drugs, such as
urine, serum, plasma, or

tissue homogenate supernatant.

Immunoaffinity isolation and chromatography provides
great specificity for the target analyte(s) and the
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ability to concentrate the analyte(s) to the level
required for detection and measurement.

The specificity

of antigen-antibody bonding, although not absolute, is
much greater than physico-chemical isolation and
separation systems now available.

While immunochemistry

methods typically possess high specificity, cross
reactivity with other drugs or their metabolites or
naturally occurring compounds in the sample can occur and
lead to false positive results.

A further concern is that

the drug may remain bound to sample proteins or be in
complexes that do not bind with a given antibody, leading
to false negative results or a reduced response.

This is

especially of concern for drugs like the tetracyclines
that possess both high protein binding and complex
formation potential [2.220].
Immunoaffinity isolation techniques have most
commonly been used for sample cleanup prior to
conventional analysis.

One such clean-up method uses a

small syringe barrel or column containing antibody-coated
beads or Sepharose™. The sample is applied to the column
to isolate and concentrate the target analyte and the
column washed to remove unbound sample material.
Following elution, the isolate may be analyzed off-line by
GC-MS [2.225,2.226] or another determinative method
[2.222].

Such columns may also be fashioned in a co

column arrangement with SPE, MSPD or other methods of
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isolation to provide a highly selective extraction
process.

Applications of immunoaffinity isolation or

chromatography to veterinary drug residue analysis have
been limited but techniques are reported for
nortestosterone and methyltestosterone in beef muscle
[2.225]; the jS-agonists clenbuterol, salbutamol,
terbutaline, cimaterol, and mabuterol in bovine and
porcine urine and liver [2.226]; the anabolic agents
zeranol and its metabolite /3-zearalanol in calf urine
[2.227]; and chloramphenicol residues in milk, eggs, and
swine muscle [2.228,2.229].
Although the application of immunoaffinity techniques
to the isolation and analysis of veterinary drug residues
is a recent development, this technique has great
potential for improving single or multi-residue drug
analysis in aquatic and other species.

High performance

liquid chromatography compatible cartridges containing
"flow through" porous beads coated with Protein A or
Protein G for antibody immobilization have recently become
commercially available [2.221,2.230].

The main limitation

to greater use of immunochemical techniques for residue
isolation and analysis is a lack of commercially
availability antibodies to many of the veterinary drugs of
interest as residues [2.223].
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SUPERCRITICAL FLUID EXTRACTION

With the supercritical fluid extraction (SFE)
process, supercritical fluids (usually supercritical
carbon dioxide [SC-C02]) are used in place of organic
solvents to extract residues.

The solubility of a

compound in a supercritical fluid is determined in part by
the density of the extracting fluid.

Therefore, the

solubility of compounds in SC-C02 can be varied by changes
in temperature and pressure or the addition of organic
solvent modifiers [2.231].

Carbon dioxide becomes a

supercritical fluid if handled above its critical
temperature and pressure.

Although several other

compounds have suitable critical points and could be used
for SFE, C02 is naturally occurring, easily obtainable,
inexpensive, non-flammable, non-toxic and can be vented to
the atmosphere.

Therefore, the use of SC-C02 as an

extracting fluid or chromatography mobile phase eliminates
the need for large volumes of organic solvents
[2.232,2.233].
The majority of reported SFE applications have been
for lipophilic environmental pollutants such as pesticides
and polycyclic aromatic hydrocarbons which are readily
soluble in SC-C02 [2.233,-2.236].

However, various other

lipophilic chemicals and associated tissue lipids are also
soluble in the non-polar liquid SC-C02, and are co
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extracted and concentrated once the pressurized C02 is
brought back to atmospheric pressure.

Because the

extracts contain contaminating lipid-soluble materials, a
pre- or post-extraction cleanup step is usually needed
before samples can be injected onto analytical instruments
such as LC or GLC apparatuses.

Cleanup is usually

accomplished with gel permeation chromatography or
Florisil adsorption chromatography [2.233].

In-line

cleanup could be conducted by using disposable or reusable
SPE cartridges or newer disc SPE technologies and changing
the pressures of the supercritical fluid.

Coupling this

system directly to an LC/MSD type interface or a GLC/MSD
interface could provide a complete analytical process for
the desired analysis [2.237].

A newly introduced

automated system combining SFE and supercritical fluid
chromatography (SFC) is also available.

Detection for SFC

is by one of the several types of gas or liquid phase
detectors.
The application of SFE to the isolation of polar
drugs from animal tissues poses an additional problem.
Extraction of these compounds from animal tissues is
complicated by the fact that polar drugs are likely to
have greater solubility in the aqueous phase of the tissue
than in the non-polar SC-C02 extracting fluid.

Thus, a

decreased extraction efficiency of polar compared to non
polar compounds results.

The solubility of polar analytes
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in SC-C02 may however be enhanced by the addition of co
solvents such as methanol or ethanol to the SC-C02
extracting fluid [2.232,2.238].

Unfortunately, the

addition of such extraction modifiers to SC-C02 also
enhances the recoveries of lipids and other non-polar
compounds, thus decreasing the selectivity of the
extraction [2.235-2.236].
Only four reports of SFE/SFC of polar veterinary
drugs used in food animals could be found.

Ramsay et al.

isolated sulfamethazine, trimethoprim, and three steroids
from homogenized and freeze-dried fortified swine kidney
using SFE with a gradient mixture of methanol(0-20%)/SCC02.

SFC/tandem mass spectrometry was carried out using a

moving belt interface.

The detection limits of the assay

were above tolerances for these compounds [2.237].
Perkins et al. examined the use of SFC for the
simulatanous analysis of nine sulfonamides in standard
solutions.

Sulfamethazine analysis was also examined in

porcine kidney tissue fortified at 3.3 pg/g.
of detection was UV absorbance or MS.

The method

Interface of the LC

with MS was accomplished by moving belt or thermospray
techniques [2.238].

In a similar study, the same authors

examined SFC-MS analysis of standard solutions of four
veterinary drugs - chloramphenicol, furazolidone,
levamisole, and lincomycin [2.239].

Cross et al. studied

the solubility of six sulfonamides in various SFE media
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and their extraction from chicken liver and swine muscle
following blending of the tissues with sand.

LC analysis

of extracts indicated highly variable recoveries among
sulfonamides and ranged from 27-97% [2.232],
More work will be necessary to further develop the
SFE/SFC process.

The application of these techniques to

fish tissues [2.234] has been quite limited.

However,

these processes have the potential to provide a near
solventless, in-line, automated process for the rapid
analysis of chemical residues from edible aquatic
resources.

MATRIX SOLID PHASE DISPERSION

Of the three techniques being considered, matrix
solid phase dispersion, in particular, has the strongest
potential to meet the demands of future residue monitoring
of aquatic resources for drugs and environmental
pollutants.

In general terms, the process involves

blending a tissue sample (0.1-1.0 g) with lipophilic
polymer-derivatized silica particles (e.g., octadecylsilyl
[ODS]-derivatized silica [C,8]), which simultaneously
disrupts and disperses the sample.

This blend of C18 and

tissue becomes part of a potentially multiphasic column
that possesses unique chromatographic character.

Elution

of the MSPD column with a solvent or solvent sequence can
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provide a high resolution fractionation of target analytes
that can be further purified by simultaneous use of co
columns of Florisil, silica, alumina, C18 or other silicabonded phases.

The final eluate can, in most cases, be

directly analyzed or further concentrated or manipulated
to meet the demands of the individual analysis.

The

extracts obtained from these methods are most often
detected by LC (in the case with drugs) or GLC with
electron capture detection (in the case with pesticides)
or mass spectrometry.

Additionally, when reconstituted in

an appropriate buffer, the extract can also be used in
immuno- [2.144,2.172] or other receptor assays.
Additionally, the MSPD process is generic and can be
modified for a particular application by 1) a change in
the eluting solvent or solvent sequence, 2) use of a
different polarity polymer or solid support, and 3)
blending of the Ci8/tissue in the presence of modifiers
such as chelators, acids, bases, etc.
MSPD could also be used in conjunction with SFE.

The

water in biological matrices often interferes with the SFE
extraction process and analysts have used samples blended
with diatomaceous earth to remove water from the sample
[2.233].

However, blending samples first with polymer-

coated silicas, as is done in the MSPD process, would
remove water and provide an initial stage of fractionation
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at the point of elution of the analytes with supercritical
fluid and modifiers.
In general, the three main advantages of MSPD are 1)
it allows for rapid turnover of samples and hence, access
to timely data on residue levels present in samples, 2)
because of its required small sample size, it considerably
decreases solvent use compared to the classical methods,
which in turn decreases environmental contamination and
increases worker safety, and 3) it is suitable for
robotics automation.

Therefore, MSPD has the potential to

meet the future demands for conducting drug and pesticide
analysis for large numbers and varieties of samples.

MSPD APPLIED TO AQUATIC RESOURCES

As seen in Table 2.1, MSPD has been used to provide
for single or multiresidue analysis of various veterinary
drugs in several aquatic matrices.

Veterinary drugs

isolated from aquatic animal tissues by this method
include oxytetracycline [2.54], sulfadimethoxine and 4-Nacetylsulfadimethoxine from fortified channel catfish
muscle [2.60,2.65,2.144], and oxolinic acid as an incurred
residue from channel catfish muscle and bile [2.81].
Reimer and Suarez reported a multi-residue method for MSPD
isolation with HPTLC or LC analysis of five sulfonamides
in fortified salmon muscle [2.63,2.200].

Jarboe et al.
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[2.82] have demonstrated its applicability to the
isolation of incurred residues of nalidixic acid from
channel catfish muscle and liver.

Walker and Barker

evaluated the performance of several enzyme immunoassays
for the detection of sulfadimethoxine residues using MSPD
extracts of fortified channel catfish muscle as well
[2.144].

Other compounds used in aquaculture or related

compounds have been extracted from various non-aquatic
matrices using MSPD methods [2.172,2.240] and these
methods could potentially be applied to aquatic matrices.
Pesticides extracted and isolated from aquatic animal
tissues by this method include 14 chlorinated hydrocarbon
pesticides from fortified whole oyster homogenate and
crayfish hepatopancreas [2.241,2.242], 9 chlorinated
pesticides from fortified catfish muscle [2.243], and a
variety of agricultural chemicals from natural fish kills
[2.244].

These isolation methods are a significant

advance in the ability to screen more samples because of
their simplicity and efficiency.

DISCUSSION

Methods development for residue determination should
focus on rapid screening tests, multiresidue capabilities,
metabolite detection, and improved sensitivity [2.245].

R ep ro d u ced with p erm ission o f the copyright ow ner. Further reproduction prohibited w ithout p erm ission.

92

Further, the use of determinative methods generally
requires a method of isolating the compound(s) of interest
from edible or marker tissues that is rapid, inexpensive,
and does not generate large volumes of organic solvents.
Classical isolation methods using homogenization and/or
liquid-liquid partitioning of biological tissues and
fluids may be sufficient for some applications but are
poor for screening purposes because they are often
lengthy, involving multiple steps and use large volumes of
solvents (Table 2.2).

Solvent disposal is becoming

increasingly expensive and environmentally unsound.
Therefore, methods using low solvent volumes are
desirable.

A main purpose of this review was to present a

case for phasing out existing official methods in favor of
newer technologies that require less sample, less solvent,
less employee time, and less cost per sample.

Newer

techniques such as supercritical fluid extraction, solid
phase extraction, immunoaffinity, and MSPD offer
alternative isolation strategies.

When compared to the

classical methods, these new methods greatly reduce labor
and solvents costs and improve throughput.

There are a

few drawbacks to the new methods and more work is needed
to further develop SPE, SFE, immunoaffinity, and MSPD for
use with the many different types of matrices that may
contain residues of chemical contaminants.

However, of
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the three new methods, MSPD shows tremendous potential for
integration into a residue monitoring program.
MSPD methods have been published for the isolation of
a wide range of compounds in a variety of matrices
indicating this approach may provide a generic technique
for single or multiresidue extraction of drugs,
environmental pollutants, and their metabolites.

In

particular, MSPD has already been used to provide a twostep process for the single or multiresidue analysis of
various veterinary drugs and agricultural pesticides in
several aquatic matrices.

This process, when compared to

classical methods, has been estimated to reduce solvent
use by up to 98% and analysis time by 97%.

Furthermore,

once the MSPD column is prepared, the process of solvent
elution, collection, and analysis can be automated by the
use of robotics.

Cost of analysis is decreased because

less solvent is needed and fewer laboratory technicians
need to undergo training.

Safety and environmental

protection are increased because less solvent is needed.
Finally, data is generated more quickly because of the
ease of the process and its potential to be automated.
These features of MSPD make it a general and perhaps
significantly useful method in designing future residue
analysis screening programs for aquatic as well as other
food animal resources.
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CHAPTER 3
EXTRACTION AND ENZYME IMMUNOASSAY OF
SULFADIMETHOXINE RESIDUES IN
CHANNEL CATFISH {Ictalurus punctatus) MUSCLE
INTRODUCTION

Disease is the most important limiting factor in
intensive aquaculture and necessitates the use of
antibacterial and other therapeutic agents to maintain the
health and production of cultured species [3.1].

Few

drugs are approved for food fish use in the US [3.2] but a
number of chemicals not approved in the US are widely
employed in other countries [3.3,3.4].

Large amounts of

imported cultured seafood are consumed in the US but are
not required to pass unified, continuous federal
inspection [3.5,3.6].

The US Food and Drug Administration

has begun monitoring imported and domestic aquaculture
products for selected drugs [3.7], but a lack of
appropriate analytical methods limits residue monitoring
efforts.

There is presently little information concerning

the level of drug residues in domestic or imported
cultured fish or the magnitude of human exposure to these
residues.

Public concern over exposure to potentially

harmful residues and an increase in the consumption of
seafood has led to calls for a seafood inspection program
121
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similar to those that exist for red meat and poultry
[3.5,3.6].
Present and pending seafood inspection programs
require analytical methods for identification of fish
containing illegal chemical residues in edible tissues.
Accordingly, regulatory agencies will need methods that
are sensitive, specific, and practical for this purpose
[3.8].

Traditional residue screening methods, such as

microbial inhibition tests and chromatographic methods as
presently used in poultry and red meat inspection, lack
one or more of these characteristics.

There is also a

lack of practical residue screening methods available for
use by the producer in a field setting for the pre-harvest
detection of violative drug residues.

Field testing could

reduce the condemnation of harvested fish and subsequent
producer losses and impact in a positive manner the
function of a food fish drug monitoring program by a
reduction in the marketing of fish with over-tolerance
residue levels.

However, there are no such methods

available for field use at present.
Screening tests may be directed to the detection of a
class of compounds or to a specific compound.

The limited

number of drugs approved for use in the US for aquaculture
permits residue detection programs for domestically reared
catfish to focus on a small number of therapeutic
compounds.

The high specificity of immunochemical assays,
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such as enzyme-linked immunosorbent assays (ELISA), make
them well suited for the detection of a single compound of
interest.

The recent commercial availability of several

ELISA-based tests for sulfadimethoxine (SDM) provides an
opportunity for their application to the detection of SDM
residues in various food animal tissues.

These rapid,

easy to use, relatively inexpensive, and sensitive tests
may be used, depending on test format, in field settings
or regulatory laboratories.

Thus, application of

appropriate extraction and determinative techniques to
food animal tissues would allow for a more efficient
monitoring program by decreasing the turnaround time,
increasing the number of samples analyzed, and providing a
method for preharvest residue determination on site.
Sulfadimethoxine (SDM) is the sulfonamide component
of the potentiated sulfonamide Romet-30® and is commonly
used in channel catfish aquaculture.

It is one of only

two systemic antibacterial agents available in the U.S.
for use in food fish.

The withdrawal period of this drug

for catfish, when used according to label instructions, is
three days [3.9].

However, a number of factors can affect

the ultimate SDM residue levels in muscle tissue of
treated fish and include water temperature and medicated
feed intake variation [3.10-3.12].

Off-label use, such as

prophylactic administration, may also result in violative
SDM residues in marketed catfish.
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Recently introduced technology, utilizing matrix
solid phase dispersion (MSPD) for extraction [3.13,3.14]
and enzyme immunoassay for detection and quantitation
[3.15], may accommodate the need for rapid, practical, and
efficient extraction and the sensitivity and specificity
requirements of detection needed in a screening assay.
Drug extraction from animal tissues is a limiting factor
in the utility of a screening test for field use, and is a
labor, solvent, and time cost factor in a regulatory
screening laboratory.

MSPD, when compared to classical

extraction methods, greatly reduces extraction time and
greatly reduces the tissue mass and hence the solvent
volumes needed for drug isolation.

The MSPD procedure and

its application to the isolation of a variety of drugs,
including several sulfonamides, from various matrices have
been reported [3.16-3.19].
This study examines the use of MSPD derived extracts
of SDM fortified channel catfish muscle in four enzyme
immunoassays for the detection of SDM residues at tissue
concentrations of 0, 25, 50, 100, and 250 ng/g.

This

paper presents the first application of MSPD technology
for the isolation, with subsequent determination by
immunoassay, of SDM as a residue in channel catfish
muscle.
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EXPERIMENTAL

REAGENTS AND EXPENDABLE MATERIALS

(a) SOLVENTS.— Liquid chromatography (LC) grade
solvents from commercial sources were used without further
purification.
(b) CHEMICALS.— Note:

Wear rubber gloves and

protective clothing when handling.

Sulfachloropyridazine,

sulfadiazine, sulfadimethoxine (SDM), sulfamerazine,
sulfamethazine, sulfapyridine, sulfaquinoxaline,
sulfathiazole, p-aminobenzoic acid, folic acid,
tetracycline, chlortetracycline, oxytetracycline,
erythromycin, lincomycin, flumequine, oxolinic acid,
nalidixic acid, thiamphenicol, novobiocin, and ampicillin
were obtained from Sigma Chemical Co., (St. Louis, MO).
Enrofloxacin was obtained as Baytril® Injection
(Haver/Diamond Scientific, Shawnee, KS)/ Ormetoprim was
graciously supplied by Dr. Ronald Thune.
(c) 4-N-ACETYLSULFADIMETHOXINE.— synthesized
according to the

procedure of Nielsen [3.20].

Identity

confirmed with high performance liquid chromatography and
direct probe, chemical ionization, positive ion mass
spectrometry.
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(d)

MSPD COLUMN MATERIAL — preparative grade C18, 40

/tin, 18% carbon load, endcapped; obtained from Analytichem
International (Harbor City, CA).

The C18 was cleaned prior

to use with sequential washings of 2 volumes each of
hexane, dichloromethane, and methanol; then vacuum
aspirated until dry.

Stored at room temperature in a

closed container until use.
(e)

SAMPLE COLUMNS — 10 ml disposable plastic

syringe barrels (Becton Dickinson Co., Franklin Lakes,
N.J.) were washed with hot soapy water, triple rinsed with
each of tap water, double distilled water, and methanol;
air dried prior to use.

Whatman no. 1, 1.5 cm paper

filters were placed proximally and distally to the tissueCjg blend to secure this material in place within the
column.

A syringe plunger, modified by removal of the

rubber tip, was used to pack material in the column.

A

modified plastic pipet tip (100 fil) was placed on the
syringe tip to direct and control flow rate through the
column.

SAMPLES

Channel catfish, with no history of drug
administration, were obtained from an indoor recirculating
water culture system.

Skinless fillets were stored frozen

(-20°C) and used within 1 month.

Samples had
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concentrations of SDM less than 25 ng/g as determined by
LC analysis of MSPD extracts [3.19].

A total of 60

fortified muscle samples (dorsal epaxial muscle group)
were extracted and evaluated in each of four ELISA test
systems.

Three fish were used; four samples from each

fish were analyzed at each of the five SDM concentrations
tested.

EXTRACTION PROCEDURE

A 0.5 g portion of catfish fillet was placed in a
clean polystyrene weighing boat and injected with 5 fil of
SDM stock solution (concentrations of 0, 2.5, 5, 10, 25 /xg
SDM/ml methanol) to give tissue concentrations of 0, 25,
50, 100, and 250 ng/g.

The samples were allowed to stand

2 minutes, placed in a glass mortar containing 2 g of C18,
and blended using a glass pestle until a homogenous
mixture was obtained (-1 min.).

The resulting blend was

then placed in a column previously fitted with a 1.5 cm
disc paper filter frit, another paper filter was placed on
top of the packing, and the packing was compressed to a
volume of -4.5 ml using a modified syringe plunger.
The tissue-Clg blend was washed with 8 ml of hexane
and the wash was discarded.

The column was then placed

over a clean 12 ml glass vial and the SDM eluted using 8
ml of dichloromethane.

The DCM extract was placed in a
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35°C water bath and evaporated to dryness under nitrogen.
The eluent was reconstituted by the addition of 100 p.1 of
methanol and vortexed.

Four hundred fil of a buffer

appropriate for the test was added to give a final volume
of 500 fil, and vortexed.

Depending on the assay level of

sensitivity, this solution was either used directly or
further diluted 10-fold with buffer.

ELISA PROCEDURES

MSPD extracts of SDM fortified catfish muscle and
sulfonamide standards were analyzed by four commercially
available ELISAs.

These test kits are based on the

principle of direct, competitive solid phase enzyme
immunoassay and comparison of the relative color
development of the sample with a negative control.
Negative samples exhibit the greatest color development
and positive samples the least development.

The tests

were packaged containing all reagents and components, and
test procedures were described in directions for use
included with each kit.

Results may be qualitative or

quantitative, respectively, when determined visually or
using optical density (OD) values.

Test kits were stored

at 4°C when not in use; all reagents and components were
allowed to come to room temperature (23°C-29°C) prior to
use.
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(a)

SIGNAL® SULFAMETHAZINE DETECTION TEST (SIGNAL) —

(SmithKline Beecham Animal Health, Exton, PA); a
quantitative MICROTITER® well format.

The MSPD extract in

SIGNAL buffer was used without further dilution.

The

SIGNAL test is marketed for the detection of
sulfamethazine in milk, muscle, serum, urine, and feeds
but also exhibits a degree of cross-reactivity with SDM
and several other sulfonamides.

Test Procedure:

20 fil of

sample was placed in the bottom of a test well and 100 fil
sulfamethazine enzyme conjugate added.

The solutions were

mixed by gentle tapping and incubated at room temperature
for 20 minutes.

The sample wells were emptied and washed

3 times using the supplied wash solution.

150 fil of

substrate was then added to each well and incubated at
room temperature for 30 minutes and OD values were
obtained.
(b)

IDS SULFADIMETHOXINE ONE-STEP ELISA (IDS)—

(International Diagnostics Systems Corp., St. Joseph, MI);
a quantitative MICROTITER® well ELISA for the detection of
SDM residues in serum, milk, urine, muscle, liver, kidney,
and feed.

Same procedure as for the SIGNAL test except

the substrate incubation time was 10 minutes prior to
reading.

This test has a lower detection limit of 10 ng

SDM/ml, therefore the MSPD extract and SDM standards were
diluted 1:9 with supplied buffer to obtain an appropriate
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test concentration for the detection of tissue
concentrations of 100 ng SDM/g.
(c)

CITE® SULFA TRIO™ (CITE)— (IDEXX Laboratories,

Inc., Westbrook, ME); a qualitative assay for the
detection of sulfdimethoxine, sulfathiazole, and
sulfamethazine residues in milk by use of a CITE cup
device.

This device contains a membrane filter with a

negative control spot and three discrete test areas, each
coated with antibody to one sulfonamide.
was used without further dilution.

The MSPD extract

Test procedure:

The

CITE device is wetted using 15 drops of supplied wash
solution and allowed to completely absorb.

Sample (240

/xl) and conjugate solution (240 fil) were combined, poured
into the CITE device, and incubated for 3 minutes at room
temperature.

The prefilter was discarded, the membrane

washed using -2 ml of wash solution, and 3 drops of
substrate solution were applied to the test spots.

The

device was then incubated at room temperature for 2
minutes, 15 drops of stop solution were added, and the
result was visually determined.
(d)

EZ-SCREEm:SULFADIMETHOXINE (EZ-SCREEN) —

(Environmental Diagnostics, Inc., Burlington, NC); a
qualitative assay for detection of SDM residues in milk,
urine, serum, and feed using the QUIK-CARD® format.

The

QUIK-CARD® system consists of a solid support card
containing two membrane-based test ports; negative control
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and sample.

Results are obtained within 10 minutes by

visual comparison of relative color development of the two
spots.

The lower detection limit of the assay is 10 ng

SDM/ml.

Therefore, the MSPD tissue extract was diluted

1:9 with supplied buffer to obtain an appropriate test
concentration for the detection of tissue SDM
concentrations of 100 ng/g or greater.

Test procedure:

One drop of diluted extract was applied to the sample spot
and one drop of negative control solution to the control
spot and allowed to absorb.

One drop of enzyme solution

was applied to all test sites and allowed to absorb.

One

drop of negative control was then applied to all test
sites, absorbed, and excess fluid cleaned from around test
sites.

Two drops of substrate solution were then applied

to all test sites, incubated at room temperature for 5
minutes, and results were evaluated visually.

RESULT DETERMINATION

The ability of an assay to accurately identify
samples containing SDM above tolerance is essential for
its use as a screening test.

The United States Food and

Drug Administration (FDA) tolerance for total SDM residues
in channel catfish muscle is 100 ng SDM/g [3.21].
Therefore, samples containing SDM concentrations less than
100 ng/g were considered negative and those samples
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containing 100 ng SDM/g or greater were considered
positive in this study.
SIGNAL and IDS analyses of extracted fortified muscle
samples and standards were performed with a Dynatech
MR5000 ELISA plate reader (Dynatech Laboratories,
Alexandria, VA);

absorbance was measured in dual

wavelength mode, test filter of 630 nm and reference
filter of 490 nm.

The mean of duplicate wells was used

for determination of test results.
A decision point for the determination of muscle
samples containing greater than or equal to 100 ng SDM/g
tissue was developed using the upper end of an interval
expected to contain 95% of the OD sample/OD blank
observations for muscle samples containing 100 ng SDM/g.
This interval was obtained using the 95% t distribution of
mean OD sample/OD blank values for MSPD extracted muscle
samples containing 100 ng SDM/g.

This interval was

calculated using (mean ± t*(std. dev.)] where t* is the a/2
t value for 11 degrees of freedom and alpha is equal to
0.05.

The higher end (lower concentration) of this

interval was used as a decision point such that OD
sample/OD blank values less than or equal to the decision
point were called positive and values greater than the
decision point were negative.
CITE and EZ-SCREEN test results were evaluated
visually by 2 independent evaluators in a single blind
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manner.

Evaluation criteria for the determination of

positive or negative results were used as given in the
product information sheet for the EZ-SCREEN test.

The

criteria for the CITE test as furnished in the product
information sheet indicated a sample is positive if the
SDM spot is lighter in color than the negative control
spot.

However, when using MSPD extracts of muscle samples

containing no SDM, the control spot was often darker in
color than the SDM spot.

Therefore, the procedure and

evaluation criteria used for the CITE test were modified
by using undiluted extract and declaring only samples that
exhibited no color development as positive responses.
Performance as indicated by sensitivity, specificity,
efficiency, and positive and negative predictive values
was determined from these results.

RESULTS AND DISCUSSION

PRECISION

Precision was evaluated using intra-assay and inter
assay variation of the two quantitative MICROTITER® well
test systems.

Percent agreement of results between the

two evaluators was used as an indicator of the variability
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of response for the two qualitative membrane-based visual
tests.
INTRA-ASSAY VARIATION — The within-run precision or
the precision of duplicate wells of the same sample run in
the same assay under the same conditions.

It represents

the variability inherent in the test that results from
variations in test components and analytical
instrumentation.

Intra-assay variation is defined as the

coefficient of variation (CV) of duplicate wells and is
calculated for each of five concentrations examined and
overall.
The CV of optical density values at each
concentration, both MSPD extracted samples and standards,
was calculated using the mean OD value for the
concentration and an estimate of the standard deviation
(SD) of duplicates made by pooling the results of
duplicate wells of the individual samples [3.22].
estimate of SD was made by:

The

SD = v (ED2)/N , where D =

difference between duplicates, and N = number of
observations (wells).

Overall intra-assay variation for

the assay is the mean CV of the five individual
concentrations.

Results are presented in Table 3.1 with

overall intra-assay variability of 5.6% and 7.7%
respectively for the SIGNAL and IDS tests using MSPD
extracted samples and 3.6% and 7.1% for SDM standards.
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TABLE 3.1

INTRA-ASSAY VARIATION (CV)
MSPD extracted
samples

SDM standards

SDM
concentration
(ng/g)

SIGNAL

IDS*

SIGNAL1’

IDS*

0

5.2

6.0

6.0

5.2

25

5.4

7.3

---

6.3

50

3.7

6.8

2.6

9.9

100

9.8

10.5

2.2

7.6

250

3.9

7.7

3.5

6.5

Overall CV
(mean ± SD)

5.6
± 2.5

7.7
± 1.7

3.6
± 1.7

7.1
± 1.8

*
t
$

N= 24 wells / cone
N= 6 wells / cone
N= 10 wells / cone
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This variability between duplicates is less than 10% as
recommended by Feldcamp and Smith [3.23].
EVALUATOR VARIABILITY — This is expressed as the
percent agreement of the two evaluators for the two
visually determined tests (CITE, EZ-SCREEN) for 60 MSPD
extracted samples.

The formula for calculating %

agreement was:
% agreement = (# samples with same result/total # samples)
X 100.

The results presented in Table 3.2 show an overall

evaluator agreement rate of 77% for the CITE test and 95%
for the EZ-SCREEN test.

There was considerable variation

in agreement depending on tissue concentration examined.
The CITE test exhibited variable color development of the
SDM test spot when testing samples containing less than
100 ng SDM/g.

This was especially noticeable at

concentrations of 25 and 50 ng SDM/g tissue as indicated
by a higher number of evaluator disagreements at these
concentrations.

The EZ-SCREEN test had 100% agreement

between evaluators at concentrations of 0, 25, and 250 ng
SDM/g and 3 disagreements/24 samples at the borderline
concentrations of 50 and 100 ng SDM/g.

Both tests had

100% agreement in evaluator results for samples containing
250 ng SDM/g.
INTER-ASSAY VARIATION — This represents the variation
among different samples of the same concentration and
includes variables associated with intra-assay variation,
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TABLE 3.2

THE % AGREEMENT BETWEEN OBSERVERS FOR VISUALLY
EVALUATED TESTS USING MSPD EXTRACTED SAMPLES

Test*

*
$

Tissue
concentration
(ng/g)

CITE

EZ-SCREEN

0

92 (1)

100 (0)

25

58 (5)

100 (0)

50

42 (7)

83 (2)

100

92 (1)

92 (1)

250

100 (0)

100 (0)

overall*

77 (14)

95 (3)

() Number disagreed upon/12 samples
() Number disagreed upon/60 samples
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extraction, tissue variation, sample incubation time,
operator error and other factors.

The incubation time

effect can be normalized by transforming the data using
sample OD/Blank OD values.

Inter-assay variation for each

of the 5 concentrations was determined for both MSPD
extracted samples and standards using OD and sample
OD/blank OD values. Inter-assay variation for each
concentration is defined as the CV of twelve individual
samples extracted and assayed at different times.

It was

calculated for each concentration using the mean and SD of
duplicate well means.

Overall inter-assay variation was

obtained by averaging the individual concentrations' CV's.
The inter-assay variation of the SIGNAL and IDS
assays is presented in Table 3.3 for MSPD extracted
samples and standards using both optical density and
sample OD/blank OD values.

The inter-assay variation

increases with increasing concentration.

This is the

result of a decreasing mean OD or sample OD/blank OD value
that occurs with increasing concentration, while the SD of
these means remains relatively constant over all
concentrations.

This is likely representative of the

inherent variability of extraction, measurement, and the
assay itself.

The repeatability of the assays for

extracted samples, as indicated by the overall inter-assay
variation of sample OD/blank values, was 7.9 ± 2.4% for
SIGNAL and 16.6 ± 7.0% for IDS.

This range is typical of
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TABLE 3.3

INTER-ASSAY VARIATION (CV)
MSPD extracted samples*
Optical density
(CV)

Standards1*

Sample OD/Blank OD
(CV)

Optical density
(CV)

Sample OD/Blank OD
(CV)

Tissue SDM
concentration

*

t

$

(ng/g)

SIGNAL

IDS

SIGNAL

IDS

SIGNAL

IDS

0

13.7

14.9

--

--

2.8

16.3

25

14.1

16.1

6.1

9.8

--

11.5

--

5.6

50

13.6

13.5

5.6

11.4

3.8

14.0

4.0

6.4

100

13.1

23.6

9.3

21.8

2.4

19.0

4.2

12.6

250

17.7

31.9

10.5

23.4

3.0

20.5

4.3

9.9

Overall CV
(mean ± SD)

14.4
± 1.9

20.0
± 7.7

7.9
± 2.4

16.6
± 7.0

3.0
± 0.6

16.3
± 3.6

4.2
± 0.1

8.6
± 3.3

SIGNAL

IDS

--

N = 12 samples/concentration; duplicate wells means
N = 6 wells/concentration for SIGNAL
N = 10 wells/concentration for IDS

u>
id
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ELISAs [3.24-3.26].

Inter-assay variation of standards

using sample OD/blank OD values was about one-half of the
variation for the extracted samples and represents the
between run variation of the assay itself.

Optical

density values of individual MICROTITER® wells obtained
using MSPD extracts of fortified catfish muscle are
presented in Appendixes A and B for the IDS and Signal
assays respectively.

TEST PERFORMANCE

The criteria used to evaluate test performance of the
four assays were sensitivity, specificity (including
cross-reactivity), efficiency, positive predictive value,
and negative predictive value.

Sensitivity and

specificity are fundamental parameters of test performance
while efficiency and predictive values provide an
estimation of the likelihood of a test result being
correct [3.27].

Formulas used to calculate performance

parameters are given in Figure 3.1.

Test performances for

individual concentrations and overall are given in Tables
3.4 and 3.5.
SENSITIVITY — Sensitivity is the ability of a test to
correctly identify samples containing greater than or
equal to 100 ng SDM/g tissue.
criteria for a screening test.

It is the most important
For an assay to be useful
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SDM > 100 ng/g
present____________ absent
Test
Result

positive

true positive
(TP)

false positive
(FP)

negative

false negative
(FN)

true negative
(TN)

Sensitivity
Specificity
Efficiency
Predictive value (+)
Predictive value (-)
FIGURE 3.1

[TP/ (TP + FN) ] X
[TN/ (TN + FP) ] X
[(TP + TN)/total
[TP/ (TP + FP) ] X
[TN/(TN + FN)] X

100
100
# tests] X 100
100
100

2 X 2 CELL MATRIX ILLUSTRATING THE FOUR
POSSIBLE TYPES OF TEST RESULTS AND FORMULAS
FOR CALCULATING PERFORMANCE PARAMETERS.
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TABLE 3.4

RESULTS & PERFORMANCE FROM THE ANALYSIS OF
MSPD EXTRACTED CATFISH MUSCLE*
ELISA result

Test1*

True
Negative

False
Positive

Blank

SIGNAL

12

0

100

IDS

12

0

100

CITE

21

3

88

EZ-SCREEN

24

0

100

SIGNAL

12

0

100

IDS

12

0

100

CITE

19

5

79

EZ-SCREEN

24

0

100

SIGNAL

9

3

75

IDS

10

2

83

CITE

11

13

46

EZ-SCREEN

20

4

83

25

50

100

250

True
Positive

False
Negative

tissue
concentration
ng/g

Sensitivity

%

SIGNAL

12

0

100

IDS

12

0

100

CITE

23

1

96

EZ-SCREEN

23

1

96

SIGNAL

12

0

100

IDS

12

0

100

CITE

24

0

100

EZ-SCREEN

24

0

100

Specificity
%

12 samples/concentration
Signal, IDS; duplicate wells using sample/blank optical
density values with result determined using 95 % t distribution
decision point
CITE, EZ; 2 independent visual determinations/sample
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TABLE 3.5

OVERALL PERFORMANCE FROM THE ANALYSIS OF MSPD
EXTRACTED CATFISH MUSCLE*
Predictive value

*
t
$

Testtt

Sensitivity
%

Specificity
%

Efficiency
%

+ test
%

- test
%

SIGNAL

100

92

95

89

100

IDS

100

94

97

92

100

CITE

98

71

82

69

98

EZSCREEN

98

94

96

92

99

60 samples/test; 12 at each of 5 concentrations
(0,25,50,100,250 ng/g)
Signal, IDS; duplicate wells using mean sample/blank optical
density values; result determined using 95 % t distribution
decision point
CITE, EZ; 2 independent visual determinations/sample
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as a screening test it must identify such samples with a
high degree of accuracy.

Sensitivity is defined as the

percent of correctly identified positive samples (true
positives) of the total number of known positive samples
tested.

Performance results show all four assays had

overall sensitivities of 98-100% for MSPD extracted
samples containing violative levels of SDM and 100%
sensitivity for samples containing 2.5 times (250 ng
SDM/g) the FDA tolerance. This indicates that these
assays, using MSPD extracts, can be used to accurately
identify catfish muscle samples that contain violative SDM
residues.
SPECIFICITY — The ability of a test to correctly
identify negative samples.

Muscle samples containing SDM

at concentrations below the FDA tolerance of 100 ng SDM/g
were considered negative in this study and included
concentrations of 0, 25, and 50 ng SDM/g muscle.
Specificity was calculated as the percent of true negative
samples of the total number of known negative samples
examined.

The SIGNAL, IDS, and EZ-SCREEN tests correctly

identified all samples containing 0 and 25 ng SDM/g as
negative.

For samples containing half of tolerance (50 ng

SDM/g) these assays had specificities of 75%, 83%, and 83%
respectively.

Difficulty in evaluating negative samples

(<100 ng SDM/g) with the CITE test, as a result of
variable color development of the SDM test spot at these
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concentrations, resulted in a higher rate of false
positive results than with the other tests.

CITE

specificities were 88%, 79%, and 46% for concentrations of
0, 25, and 50 ng SDM/g.
The specificity of a test is important in reducing
the number of confirmatory tests needed as a result of
false positive results.

The specificity of antibiotic

screening tests for milk has been demonstrated to vary
considerably among assay kits and has been related to the
presence of inflammatory conditions of the mammary gland
[3.28,3.29].

What effect the inflammatory process has on

the specificity of drug screening tests used with tissues
from sick fish is unknown.
CROSS-REACTIVITY — The specificity of an assay may be
influenced by its cross-reactivity with other compounds.
Cross-reactivity was examined using standard solutions in
test buffer at concentrations of 0.1, 1, 10, and 100 /xg/ml
for eight sulfonamides and fifteen other therapeutic
compounds that are used in aquaculture in the US and
worldwide or that may be present as feed contaminants.
The N-acetyl metabolite of SDM may comprise a large
portion of the total SDM residue present in edible
tissues.

Therefore, to accurately assess total tissue SDM

residues, a SDM residue screening assay should also detect
N-acetyl SDM present in edible tissues or in biological
fluids used as reference tissues.

The relative
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contribution of this metabolite to total SDM residue
varies among species and tissues.

In channel catfish, SDM

is present in bile almost entirely in the N-acetyl form
(>90% of total SDM residues) but SDM is present in plasma
and muscle primarily (>95%) as parent compound [3.30].

In

rainbow trout, however, N-acetyl SDM accounts for over
half of the total SDM residue in muscle [3.31].

In this

study, all four assays detected the N-acetyl metabolite
equally as well as the parent compound.
Cross-reactivity for the quantitative tests (SIGNAL
and IDS) was evaluated by a comparison of concentrations
causing a fifty percent inhibition in color development of
sample wells compared to blank wells when using standard
solutions (EC-50).

Cross-reactivity for the qualitative

tests (CITE and EZ-SCREEN) was determined visually over a
range of concentrations.

Results are presented in Table

3.6.
The SIGNAL test is marketed for the detection of
sulfamethazine residues in several biological matrices but
was found to cross-react to varying degrees with a number
of other sulfonamides.

This test should be considered a

sulfonamide class assay rather than one specific for
sulfamethazine.

The sulfonamides demonstrating the

highest level of reactivity in this test were
sulfamethazine, sulfamerazine, SDM, and N-acetyl SDM.
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TABLE 3.6

CROSS-REACTIVITY WITH ELISAS*
EC-50
(fig/ml)

Minimum detectable
concentration
(fig/ml)

SIGNAL

IDS

CITE*

EZ-SCREEN

Su1fadimethoxine

0.25

.004

.025*

.01

N-acetyl SDM

0.25

.004

.025*

.01

Sulfachlorpyridazine

8

76

10

Sulfadiazine

5

—

—

Sulfamerazine

<0.1

—

—

Sulfamethazine

<0.1

—

—

Sulfapyridine

10

—

—

Sulfaquinoxaline

45

100

7.6

—

—

p-Aminobenzoic Acid

—

—

—

Folic Acid

—

—

—

Ampicillin

—

—

—

Ormetoprim

—

86

Erythromycin

—

—

—

Lincomycin

—

—

—

Enrofloxacin

—

—

—

Flumequine

—

—

—

Oxolinic Acid

—

—

—

Nalidixic Acid

—

—

—

Chlortetracycline

—

—

—

Oxyt et racyc 1ine

—

—

—

Tetracycline

—

—

—

Novobiocin

—

—

—

Thiamphenicol

—

—

—

Sulfonamide

Sulfathiazole

*
t
$
—

—

100

Cross-reactivity determined using standardsolutions
in test
buffer
cross-reactivity for SDM spot only
lowest concentration examined
EC-50 greater than 100 pg/ml or no reactivity up 100 pg/ml
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The IDS test was quite sensitive to SDM and N-acetyl
SDM with EC-5Os for these compounds of 4 ng SDM/ml.

The

IDS test had no appreciable reactivity with other
sulfonamides.

The CITE and EZ-SCREEN tests were also

quite sensitive and specific havinq no substantial crossreactivity for the compounds tested.
Fourteen of the non-sulfonamide compounds examined
showed no cross-reactivity up to concentrations of 100
lig/ml.

Ormetoprim exhibited no reactivity in the SIGNAL

and CITE tests but had a low level of reactivity in the
IDS assay with a EC-50 of 86 Atg/ml and in the EZ-SCREEN
test with a minimum detectable level of 100 /xg/ml.

Romet®

medicated feed for catfish contains ormetoprim at a
concentration of 420-1650 \igjg feed depending on feeding
rate [3.32].

This level may confound SDM test results for

feed extracts of ormetoprim contaminated or medicated
feeds.

The expected therapeutic level of ormetoprim in

catfish muscle (0.8 ftgfg) is well below the minimum
detectable levels of these tests for ormetoprim [3.33].
Cross-reactivity of a test for compounds within a
class of drugs is advantageous for a test intended as a
drug class detection test.

However, to accurately

interpret test results the relative level of cross
reactivity of the test with compounds within the class of
drugs must be known.

Additionally, tests marketed for the

detection of a single compound (i.e. sulfamethazine in
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milk) often do not include information on cross-reaction.
While cross-reactivity does not invalidate the use of a
single compound detection test, it may cause
misinterpretation of a positive result if a cross-reacting
compound(s) is present and the level of cross-reaction is
not known.
EFFICIENCY — is the percentage of all test samples
that were correctly identified for a given population.
Efficiencies of 82-97% are shown in Table 3.5.
POSITIVE PREDICTIVE VALUE AND NEGATIVE PREDICTIVE
VALUE — indicates the probability of positive or negative
results being correct.

Positive predictive values ranged

from 69% for the CITE to 92% for IDS and EZ tests.
Negative predictive values were 98-100% for all tests
indicating a high level of confidence can be placed in
negative results for these tests.

Predictive value

results and comparisons of performance using single or
duplicate wells and OD or % blank values are presented in
Tables 3.7 and 3.8.
The purpose of the present study was to evaluate the
performance of commercially available immunoassays for the
detection of violative levels of SDM residues in channel
catfish muscle using MSPD derived extracts.

To fully

utilize the speed and simplicity of newer determinative
methods such as immunoassays in a drug monitoring program,
rapid and simple drug isolation methods are needed.
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TABLE 3.7

OVERALL PERFORMANCE COMPARISONS OF
SINGLE/DUPLICATE NELLS AND OF OPTICAL DENSITY/%
BLANK VALUES FROM THE ANALYSIS OF MSPD
EXTRACTED CATFISH MUSCLE*
Predictive Value

Test

Sensitivity
%

Specificity
%

Efficiency
%

+ test

- test

optical
density

98

93

95

90

99

% blank

100

90

94

87

100

optical
density

96

92

93

88

97

% blank

100

94

97

92

100

optical
density

100

58

75

62

100

% blank

100

72

83

71

100

optical
density

100

58

75

62

100

% blank

100

92

95

89

100

IDS
single
well

duplicate
wells

Sicraal
single
well

duplicate
wells

60 samples/test; result determined using 95 % t distribution
decision points
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TABLE 3.8

COMPARISONS OF INDIVIDUAL CONCENTRATION RESULTS
AND PERFORMANCES FROM THE ANALYSIS OF MSPD
EXTRACTED CATFISH MUSCLE* USING
SINGLE/DUPLICATE HELLS AND OPTICAL DENSITY/
% BLANK VALUES
ELISA result*

tissue
concentration
ng/g
blank

True
Negative

False
Positive

Specificity
%

optical
density

19

5

79

% blank

24

0

100

optical
density

10

2

83

% blank

12

0

100

optical
density

24

0

100

% blank

24

0

100

optical
density

12

0

100

% blank

12

0

100

Test*
Sitmal
single
well

duplicate
wells

IDS
single
well

duplicate
wells

t

Signal, IDS; duplicate wells using sample/blank optical density
values with result determined using 95 % t distribution decision
point

table con'd
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ELISA result*
tissue
concentration
ng/g

True
Negative

False
Positive

Specificity
%

optical
density

13

11

54

% blank

19

5

79

optical
density

6

6

50

% blank

12

0

100

optical
density

24

0

100

% blank

24

0

100

optical
density

12

0

100

% blank

12

0

100

Test*
Sicmal

25

single
well

duplicate
wells

IDS
single
veil

duplicate
wells

t

Signal, IDS; duplicate wells using sample/blank optical density
values with result determined using 95 % t distribution decision
point

table con'd
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ELISA result*
tissue
concentrat ion
ng/g
50

True
Negative

False
Positive

Specificity
%

optical
density

10

14

42

% blank

9

15

38

optical
density

5

7

42

% blank

9

3

75

optical
density

19

5

79

% blank

17

7

71

9

3

75

Test*
Signal
single
well

duplicate
wells

IDS
single
well

duplicate
wells
optical
density

___________________% blank__________ 10_________ 2____________83
t

Signal, IDS; duplicate wells using sample/blank optical density
values with result determined using 95 % t distribution decision
point
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Classical methods for the isolation of sulfonamide
residues from animal tissues are complex and lengthy
procedures that require multiple steps involving
homogenization of the sample in aqueous or organic
solvents, protein precipitation, centrifugation, pH
adjustments, transfer of the supernatant, counter-current
extraction, back-extraction, and/or solid phase isolation.
The primary disadvantages of these traditional methods are
that they are costly in terms of labor and solvent use,
and they limit the number of samples analyzed due to their
complexity and the time needed to complete the extraction.
MSPD eliminates many of the steps and overcomes many of
the difficulties associated with classical extraction
techniques.

The MSPD theory and process have been the

subject of recent reviews [3.13,3.14].

In general, its

main advantages are that it is a relatively rapid method
that allows for the analysis of a larger n umbe r of
samples, it considerably decreases solvent use because of
the small sample size (0.5g) required, and is amenable to
automation.
The performance results obtained using fortified
samples indicate MSPD extracts of catfish muscle could be
used in the SIGNAL, IDS, CITE, or EZ-SCREEN tests for
screening catfish muscle samples for violative SDM
residues.

The SIGNAL and IDS tests are well suited for

screening large numbers of samples in a properly equipped
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laboratory.

The IDS tests' large difference in color

between positive and blank samples might also permit its
use as a visually determined qualitative test but requires
further evaluation.

Either the CITE or EZ-SCREEN tests

could be used in a laboratory for regulatory purposes or
used on-site to determine the advisability of harvesting
treated fish that possibly contain violative levels of
SDM.

The CITE test, as used in this study, was less

desirable because of the higher number of false positive
results.

This may be a matrix-specific effect and could

possibly be rectified by sample dilution and a change in
result evaluation criteria.

It should be emphasized that

the performances of these tests using muscle extracts
should not be extended to milk or other matrices.
Further studies of the applicability of these
procedures to catfish muscle containing incurred SDM
residues are planned but were outside the scope of present
methods development research.
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CHAPTER 4
EXTRACTION AND LIQUID CHROMATOGRAPHIC
ANALYSIS OF SULFADIMETHOXINE AND
4-N-ACETYLSULFADIMETHOXINE RESIDUES IN
CHANNEL CATFISH {Ictalurus punctatus)
MUSCLE AND PLASMA
INTRODUCTION
The demand for fisheries products has greatly
increased in the last 10 years and continued growth is
expected [4.1,4.2].

As a result aquaculture is a large

and rapidly growing industry and will play an increasingly
important role in meeting the global demand for edible
aquatic resources as wild fishery landings approach their
biological limits [4.2].

The use of antibacterial drugs

in intensive fish culture systems is commonly practiced
and is necessary for control of infectious bacterial
disease outbreaks [4.3].

However, the use of

antibacterials creates the potential for drug residue
problems in cultured fish.

In the U.S., fish products are

not required to pass continuous federal inspection.
Regulatory authority for seafood safety is divided among a
number of local, state, and federal agencies [4.4].
Public perceptions that uninspected seafood may contain
harmful chemicals [4.1], the increase in seafood
consumption, and the growth of aquaculture have led to
calls for the establishment of a federal seafood
160
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inspection program similar to the ones that now exist for
red meat and poultry [4.4,4.5].
Pending U.S. federal legislation concerning
establishment of such an inspection program for seafood
will require analytical methods for extraction, screening,
quantitation, and confirmation of chemical residues in
food fish [4.6].

At present there are few analytical

methods that have been validated for use in seafood for
detection of violative residues of the many therapeutic
compounds used in aquaculture domestically or worldwide
[4.5].

Therefore, methods are needed that are practical,

sensitive, and specific for enforcement of the nation's
present and anticipated future regulatory limits for
chemical residues in aquatic food resources.
Drug residue violations in the United States red meat
and poultry industries most frequently result from a
failure by the producer to observe the stated withdrawal
time for an approved drug [4.7,4.8].

If a similar trend

holds for aquaculture, the greatest number of residue
violations would be expected for approved drugs that have
been used by the producer in a manner not in accordance
with label directions.

Therefore, methods development

efforts for extraction and detection of drug residues in
domestically produced aquaculture products should focus
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initially on the limited number of approved compounds used
in cultured fish in the US.
There are presently only three systemic antibacterial
agents that are approved for use in aquaculture in the
United States; and only two of these are currently
marketed.

One of these, Romet-30®, is a potentiated

sulfonamide containing sulfadimethoxine (SDM) and
ormetoprim (OMP) in a 5:1 ratio.

The channel catfish is

the major aquaculture species in the US accounting for 56%
of the total US aquacultural production in 1988 [4.2] and
360 million pounds produced in 1990 [4.9] and Romet-30® is
frequently used in this species for the control of enteric
septicemia of catfish.

Therefore, practical methods for

detection, quantitation, and confirmation of SDM and OMP
residues in channel catfish are urgently needed.
A number of analytical methods have been reported for
SDM and OMP residues in edible aquatic tissues [4.104.21],

However, no methods are available for the

simultaneous quantitation of SDM and its primary
metabolite, 4-N-acetylsulfadimethoxine (N-acetyl SDM), in
channel catfish muscle.

Further, several of the methods

lack the sensitivity needed for detection of SDM residues
at tolerance.

Methods employing classical extraction

techniques involving homogenization, liquid-liquid
partitioning, and/or other sample preparation steps are
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lengthy and use relatively large volumes of organic
solvent.

One purpose of this study was to develop a

practical, accurate, and precise method for rapidly
extracting and quantifying SDM and N-acetyl SDM residues
in channel catfish muscle and plasma at tissue
concentrations about the FDA tolerance of 100 ng/g.
Additionally, a method using small volumes of solvent was
desired.

This paper presents a simplified matrix solid

phase dispersion (MSPD) extraction procedure for use with
biological fluids and the first application of MSPD and
microbore analytical column technology for the
simultaneous extraction and high performance liquid
chromatographic (LC) analysis of SDM and its primary
metabolite as residues in channel catfish muscle and
plasma.

EXPERIMENTAL

REAGENTS AND EXPENDABLE MATERIALS

(a)

SOLVENTS — Liquid chromatography grade from

commercial sources was used without further purification.
Phosphate buffer (0.017M) for LC mobile phase was prepared
by placing 1.143 ml of orthophosphoric acid (44.6N) in
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triple-distilled water sufficient to make 1 L total
volume.
(b) WATER — For LC analyses triple-distilled and
passed through a Modulab™ Polisher I water purification
system (Continental Water Systems Corp., San Antonio, TX)
(c) CHEMICALS — Note:

Wear rubber gloves and

protective clothing when handling.

Sulfadimethoxine (SDM)

and Sulfamethoxazole (SMX) were obtained from Sigma
Chemical Co., (St. Louis, MO).
(d) 4-N-ACETYLSULFAJDIMETHOXINE.— synthesized
according to the procedure of Nielsen [4.22].

Identity

confirmed with high performance liquid chromatography and
direct probe, chemical ionization, positive ion mass
spectrometry.
(e) STANDARD SOLUTIONS — Separate stock solutions of
SDM, N-acetyl SDM, and SMX were prepared by dissolving 40
mg of compound in 50 ml methanol.

Fortification solutions

at concentrations of 5, 10, 20, 40, & 100 ngj ml were
prepared for each compound by diluting stock solutions in
methanol and were stored in the dark at 4°C
(f) MSPD COLUMN MATERIAL — preparative grade C18/ 40
frn, 18% carbon load, end capped (Analytichem Bondesil™,
Part No. 1221-3013)? obtained from Varian Associates
(Harbor City, CA).

The C18 was cleaned prior to use by

washing with 2 volumes of dichloromethane; then vacuum
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aspirated to remove excess solvent.

Stored at room

temperature in a closed container until use.
(g) MSPD EXTRACTION COLUMNS
MUSCLE EXTRACTIONS — 10 ml disposable plastic syringe
barrels (Becton Dickinson Co., Franklin Lakes, NJ) were
washed with hot soapy water, triple rinsed with each of
tap water, double distilled water, and methanol; air dried
prior to use.

Whatman no. 1, 1.5 cm paper filters were

placed proximally and distally to the tissue-C18 blend to
secure this material in place within the column.

A

syringe plunger, modified by removal of the rubber tip,
was used to compact material in the column.
PLASMA EXTRACTIONS --0.8 X 4 cm disposable
polypropylene chromatography columns containing a 35 p
polyethylene frit were used as supplied without further
cleanup (Poly-Prep column, cat. no. 731-1550, Bio-Rad
Laboratories, Richmond, CA).
A plastic pipet tip (100 /xl), modified by removing -1
cm from the proximal and distal ends, was placed on the
syringe or column tip to direct and control flow rate
through the column.
(h ) SAMPLES

MUSCLE — Drug-free channel catfish were obtained from
an indoor recirculating water culture system.

Skinless

fillets were stored frozen (-20°C).
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PLASMA — Market sized channel catfish, with no
history of drug administration, were captured by seining
from a local commercial catfish farm.

Blood samples were

taken by venipuncture of the caudal vein.

Heparinized

blood samples were centrifuged and plasma stored at -20°C
in glass tubes.
Muscle and plasma samples were found to be free of
SDM concentrations greater than 25 ng/g as determined by
LC analysis of MSPD extracts [4.19].

Three fish were used

for muscle and plasma fortification studies; two samples
from each fish were analyzed at each of the five SDM and
N-acetyl SDM concentrations tested.

All samples were used

within 1 month.

EXTRACTION PROCEDURE

(a)

MUSCLE — 0.5 g of catfish fillet was placed in a

clean polystyrene weigh boat, allowed to reach ambient
temperature, and injected with 5 pil each of separate SDM
and N-acetyl SDM fortification solutions (concentrations
of 0, 5, 10, 20, 100 pig SDM or N-acetyl SDM/ml methanol)
appropriate to achieve tissue concentrations of 0, 50,
100, 200, and 1000 ng/g of each compound.

SMX was added

as an internal standard by the injection of 5 pi of a 100
pig SMX/ml methanol fortification solution to give a tissue
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concentration of 1000 ng/g.

The samples were allowed to

stand 2 minutes, placed in a glass mortar containing 2 g
of Cjg, and blended using a glass pestle until a homogenous
mixture was obtained (-1 min.).

The resulting blend was

then placed in a column fitted with a 1.5 cm disc paper
filter frit, another paper filter placed on top of the
packing, and the packing compressed to a volume of ~4.5 ml
using a modified syringe plunger.
The tissue-CIg blend was washed with 8 ml of hexane
and the wash discarded.

The column was placed over a

clean 12 ml glass vial and the three sulfonamides eluted
using 8 ml of dichloromethane (DCM).

The DCM extract was

placed in a 35°C water bath and evaporated to dryness
under nitrogen.

The eluent was reconstituted by the

addition of 500 fil of mobile phase, vortexed, and
sonicated (Bransonic® 1200, Branson Ultrasonic Corp.,
Danbury, CT) for 7 minutes.

The sample extract was

transferred to a 1.5 ml polypropylene test tube (Micro
Tube, cat. no. 72.690.475, Sarstedt, Inc., Newton, NC),
centrifuged for 5 minutes at 15,600 X g (Centra-M,
International Equipment Co., Needham Hts., MA), and the
supernatant was filtered using a 0.45 jLim syringe filter
(Nalgene®, cat. no. 176-0045, Rochester, NY) into an LC
autosampler vial.
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(b) PLASMA — 0.5 ml aliquots of catfish plasma were
placed in 1.5 ml polypropylene test tubes and 5 pi each of
SDM and N-acetyl SDM fortification solutions
(concentrations of 0, 5, 10, 20, 40, 100 fig/ml methanol)
were added to achieve plasma concentrations of 0, 50, 100,
200, 400, and 1000 ng/g of each compound.

5 /il of a 100

pg SMX/ml methanol fortification solution was added to
each tube as an internal standard and vortex mixed.
Plasma samples were extracted using a modification of
the MSPD procedure.

The C18 was weighed (400 mg), placed

in a Poly-Prep column, and 100 pi of plasma added.

The

plasma and C18 were vortex mixed for 30 sec; then packed to
a volume of -0.8 ml using a glass rod.

The snap-off tip

was removed from the column, a modified pipette tip placed
on the tip, and the column placed over a 6 ml glass tube.
The plasma-C18 blend was washed with 2 ml of hexane and the
wash discarded.

The column was then placed over a clean 6

ml glass tube and the three sulfonamides eluted using 2 ml
of DCM.

The DCM extract was placed in a 35°C water bath

and evaporated to dryness under nitrogen.

The eluent was

reconstituted by the addition of 250 pi of mobile phase,
then processed as with the muscle extracts.
(c) SOLID PHASE EXTRACTION — 100 pi of catfish plasma
fortified with SMX at 1000 ng/ml, and SDM and N-acetyl SDM
at 200 ng/ml each was diluted to 2 ml with 0.017 M aqueous
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phosphoric acid and applied to the top of a Poly-Prep
column containing 400 mg of Clg.

Positive pressure was

applied to the head of the column using a bulb syringe to
achieve a flow of -1 ml/min through the packing bed.

Wash

and elution solvents and sample processing were performed
as with the plasma MSPD procedure.

LIQUID CHROMATOGRAPHIC ANALYSIS

(a) APPARATUS — All analyses were performed using a
Hewlett Packard 1090 liquid chromatograph equipped with a
variable volume auto-injector and a photodiode array
detector set at 265 nm (20 nm bandwidth), reference
spectrum of 450 nm (100 nm bandwidth), and spectrum range
of 210-320 nm.

LC control, data acquisition, and peak

integration were performed using Hewlett-Packard HPLC30
ChemStation Software (DOS Series)(Part No. G1300-900006).
A reversed phase narrow-bore column packed with
octadecylsilyl (ODS) derivatized silica (200 X 2.1 mm, ODS
Hypersil, 5 (m, Part No. 799160D-572, Hewlett-Packard,
Wilmington, DE) maintained at ambient temperature was used
for all analyses.
(b) SOLVENT — The mobile phase was a mixture of 0.017
M aqueous H3P04 (pH 2.4)(PB) and acetonitrile (ACN)
delivered at an isocratic flow rate of 0.4 ml/min.
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Solvent ratios of 71:29 (PB:ACN) for muscle analysis and
73:27 for plasma analysis were used.

The mobile phase was

filtered over a 0.45 pm membrane filter (FP Vericel™,
Prod. No. 66480, Gelman Sciences, Inc., Ann Arbor, MI) and
degassed with helium before use.

A 10 /il aliquot of

muscle extract or a 25 pi aliquot of plasma extract was
injected for LC analysis.

DATA ANALYSIS

(a) LINEARITY OF RESPONSE — Five-point calibration
curves for SDM and N-acetyl SDM for standards and
extracted samples were constructed by plotting the peak
height ratio of analyte to internal standard (SMX) using
data derived from duplicate sample injections.
(b) LIMITS OF DETECTION AND QUANTITATION— The method
detection limit (MDL) is defined as the minimum
concentration that can be reliably identified with 99%
confidence that the analyte concentration is greater than
zero.

The MDL was estimated by determining the

concentration that corresponds to Student's

value

multiple of the standard deviation of instrument values
for replicate samples containing 1-5 times the estimated
MDL.

The MDL was computed using the following equation:
MDL = t' (S)
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where t* is the Student's t value for n-1 degrees of
freedom (n = 12) and a = 0.01; S = pooled standard
deviation of peak height ratios for MSPD extracts of
samples containing 50 and 100 PPB analyte [4.23].

The MDL

peak height ratio value was converted to tissue
concentration in PPB by linear regression using three
point calibration curves developed with MSPD extracts of
muscle or plasma samples.

The practical limit of

quantitation was estimated as the concentration equal to
two times the MDL.
(c)

INTRA-ASSAY VARIABILITY — The within-run

precision or the precision of replicate injections of the
same sample run under identical chromatographic
conditions.

Intra-assay variation was calculated for both

MSPD extracted samples and standards for each of five
concentrations examined and overall.

The intra-assay

variation at each concentration is defined as the
coefficient of variation (CV) of triplicate injections of
the same sample (n=6 samples/concentration), and was
calculated using the mean and standard deviation (SD) of
peak height ratios for these injections.

The CVs of the

six samples were averaged to obtain a CV for each
concentration.

Overall intra-assay variability of the

method, at the concentrations examined in this study, was
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determined by averaging the CVs for the five
concentrations examined.
(d) INTER-ASSAY VARIABILITY — The variation among
samples containing the same concentration of analyte and
internal standard; extracted and analyzed under identical
conditions on different days.

Inter-assay variation for

each of five concentrations was determined for both MSPD
extracted samples and standards using mean peak height
ratio values of duplicate injections.

Inter-assay

variation at each concentration is defined as the CV of
six samples extracted and assayed on six different days.
Overall inter-assay variation (± SD) of the method was
obtained by averaging the individual concentrations' CVs.
(e) RECOVERY — Recovery was evaluated by two methods.
Absolute recovery was determined for SDM with tritium
labelled SDM (Charm Sciences, Inc., Madden, MA) using
liquid scintillation counting data (Packard TRI-CARB®
4640, Packard Instrument Co., Inc., Downers Grove, IL).
Relative recovery of SDM and N-acetyl SDM was determined
by a comparison of analyte:internal standard peak height
ratios of MSPD extracted fortified samples to peak height
ratios of standard solutions.
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RESULTS AND DISCUSSION

CHROMATOGRAPHIC SYSTEM

The mobile phase (MP) composition reported by Long et
al. [4.19] of phosphate buffer and acetonitrile at a ratio
of 65:35 did not provide adequate resolution of the three
sulfonamides when used with a narrow-bore column
containing hypersil ODS.

Additionally, endogenous

compounds in muscle and plasma extracts eluted very
closely to the sulfonamides and interfered with peak
resolution.

Modification in the MP solvent ratio from

29:71 to 27:73 (ACN:PB) resulted in adequate separation of
the sulfonamide and interfering peaks such that they did
not affect quantitation for muscle or plasma extracts.
SMX was chosen as the internal standard because of its
favorable elution time and a UV absorbance maximum similar
to those of the analytes.

SDM was the latest eluting of

the sulfonamides at ~5.8 minutes for plasma samples and
~5.2 min for muscle extracts.

A late eluting endogenous

compound required run times of 12 minutes for plasma and
muscle extracts.

Representative liquid chromatograms of

MSPD derived extracts of blank and sulfonamide fortified
channel catfish muscle and plasma, and MSPD extracts of
muscle and plasma from channel catfish fed Romet®-30
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medicated feed are shown in Figures 4.1-4.6.

Figures 4.7-

4.9 show the UV absorbance spectra of SDM and N-acetyl SDM
in non-extracted standards and in MSPD extracts of
incurred muscle and plasma.

The absorbance maxima of SDM

and N-acetyl SDM were 265 and 270 nm, respectively.

A

comparison of the UV spectra of standards to those
obtained with MSPD extracts indicates excellent peak
purity.

LINEARITY OF RESPONSE

A linear response was observed for daily five point
calibration curves for standards and MSPD extracts of
muscle and plasma using mean peak height ratio values of
duplicate injections (concentrations of 50-1000 PPB).
Correlation coefficients > 0.999 were obtained for all
calibration curves using standard solutions.

Daily

standard curves for MSPD extracted muscle and plasma
samples had correlation coefficients ranging from 0.993 1.0 with average daily values of 1.0 for SDM in both
matrices and 0.997 and 0.998 for N-acetyl SDM in muscle
and plasma.
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LIQUID CHROMATOGRAM OF MSPD EXTRACT OF CHANNEL CATFI8H MU8CLE FROM ROMET®
FED CATFISH; CALCULATED CONCENTRATIONS OF 507 ng SDM/g AND
55 ng N-ACETYL SDM/g; FORTIFIED WITH SMX AS INTERNAL STANDARD AT 1000 ng/g.
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mln

LIQUID CHROMATOGRAM OF M8PD EXTRACT FROM CHANNEL CATFISH PLASMA FORTIFIED
WITH SMX AT 1000 ng/ml, AND N-ACETYL SDM AND SDM AT 400 ng/ml EACH.
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LIQUID CHROMATOGRAM OF MSPD EXTRACT OF CHANNEL CATFISH PLASMA FROM ROMET®
FED CATFISH; CALCULATED CONCENTRATIONS OF 1158 ng 8DM/ml AND 379
ng N-ACETYL SDM/ml; FORTIFIED WITH SMX AS INTERNAL STANDARD AT 1000 ng/ml.
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LIMITS OF DETECTION AND QUANTITATION

The MDL estimates were 26 ng/g for SDM in channel
catfish muscle and 33 ng/ml in plasma.

The MDLs for N-

acetyl SDM were 26 ng/g and 11 ng/ml respectively for
muscle and plasma.

Practical limits of quantitation were

52 ng/g for SDM and N-acetyl SDM in muscle, 66 ng SDM/ml
plasma, and 22 ng N-acetyl SDM/ml plasma.

INTRA-ASSAY VARIABILITY

Current recommendations for the precision of animal
drug residue assays are for the repeatability of a method
not to exceed 10% at concentrations greater than or equal
to tolerance (100 PPB) or 20% at concentrations less than
tolerance [4.24].

The repeatability of the method as

determined by the CV of triplicate injections was <10% for
SDM and N-acetyl SDM at concentrations of 50-1000 PPB for
all muscle and plasma extracts and standards (Table 4.1).

INTER-ASSAY VARIABILITY

The reproducibility of the method varied from -25%
for SDM and N-acetyl SDM at concentrations of 50 ng/g
muscle to 5% for muscle containing 400 ng N-acetyl SDM/g
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TABLE 4.1

INTRA-ASSAY VARIATION (CV)
MSPD Extracts1,
Standards*

*
f

Muscle

Plasma

SDM
concentration
(ng/g)

SDM

N-acetyl SDM

SDM

N-acetyl SDM

SDM

N-acetyl SDM

50

5.3

5.8

8.4

5.6

9.1

6.5

100

4.2

3.7

4.9

2.8

5.1

6.6

200

1.4

0.9

3.9

1.1

4.9

3.5

400

0.8

0.7

1.7

1.4

1.4

1.7

1000

0.6

0.5

0.9

0.4

0.7

0.6

Overall CV
(mean ± SD)

2.5
± 2.2

2.3
±2.2

4.0
± 3.0

2.2
± 2.1

4.3
± 3.4

3.8
± 2.7

N = 6 (triplicate injections)
N = 6 extractions/cone. (triplicate injections)

00
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using the mean peak height ratio values for duplicate
injections.

The overall daily variation among samples

containing 50-1000 PPB SDM was 13% for muscle and 14% for
plasma extracts, and 11% and 10% for N-acetyl SDM in
muscle and plasma samples (Table 4.2).

RECOVERY OF METHOD

Absolute recovery of tritiated SDM at a tissue
concentration of 150 PPB was 79% ± 4% for muscle and 67% ±
5% for plasma.

The mean relative recoveries of SDM and N-

acetyl SDM based on a comparison of the peak height ratios
of standard solutions and extracted spiked tissues were
97% ± 4% and 91% ± 3% for SDM in muscle and plasma and
126% ± 5% and 112% ± 6% for N-acetyl SDM in muscle and
plasma.

The high relative recovery of N-acetyl SDM was

consistent across all concentrations examined and may
result from an increased extraction efficiency of the
acetylated compound compared to the two non-acetylated
compounds.

The 4-N-acetylated sulfonamides (except

sulfapyrimidines) have decreased aqueous solubility
compared to the parent compounds [4.25] and would be
expected to have different solubility in extracting
solvents than the parent compounds.

The use of standard

curves developed with peak height ratio values for
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TABLE 4.2

INTER-ASSAY VARIATION (CV)
MSPD Extracts+
Standards*

*
t

Muscle

Plasma

SDM
concentration
(ng/g)

SDM

N-acetyl SDM

SDM

N-acetyl SDM

SDM

N-acetyl SDM

50

9.0

11.8

24.5

25.5

21.0

16.0

100

5.8

3.8

12.8

5.9

16.6

7.9

200

4.4

4.4

13.2

11.9

13.9

10.5

400

3.9

3.3

6.9

5.0

11.0

8.3

1000

2.5

1.7

6.6

8.8

9.1

7.6

Overall CV
(mean ± SD)

5.1
± 2.5

5.0
± 4.0

12.8
± 7.3

11.4
± 8.3

14.3
± 4.7

10.1
± 3.5

N = 6 (using mean of duplicate injections)
N = 6 extractions/conc. (using mean of duplicate injections)

H
00
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fortified tissues eliminated the extraction inequity
problem and resulted in near 100% agreement between known
tissue concentration and calculated tissue concentration
for SDM and N-acetyl SDM.

Therefore, quantitation of N-

acetyl SDM should be performed using standard curves
developed with fortified samples.
The modified MSPD method for plasma extraction had a
lower absolute recovery than the MSPD method for muscle.
However, the plasma method offers several advantages.

The

technique of vortex-mixing a biological fluid, such as
plasma, with

in the extraction column eliminates the

need for manual blending of the sample and C18 and transfer
of the blended material from mortar to column that is
required with the MSPD method for solid tissues.

For

tissues not requiring mechanical disruption of tissue
architecture, this adaptation greatly speeds the
extraction process and makes it more amenable to
automation.

The need for mortar and pestle cleanup and

concerns about possible carryover are also eliminated with
this modification.

Additionally, the small sample size

required (100 /xl) is advantageous in experimental studies
involving small animals such as fish and rodents.

The

modified MSPD method has also been used with milk for the
extraction of several /3-lactam antibiotics (unpublished
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data) and the method potentially can be applied to other
biological fluids and compounds.
For comparison of the plasma MSPD method with solid
phase extraction (SPE), fortified catfish plasma was
extracted using a packing of 400 mg of CI8 in a Poly-Prep
column (n=3).

SPE yielded recovery and chromatography

similar to that obtained with the plasma MSPD method.
However, SPE required an additional sample dilution step
and more importantly, flow of the diluted sample and
solvents through the SPE column required either positive
column head pressure or aspiration.

While chromatography

and recovery were similar with both methods, the ability
to utilize gravity flow of solvents is a distinct
advantage in some laboratories and essential for field
applications.
A tiered approach to residue monitoring utilizes
rapid screening assays for examining large numbers of
samples and subsequent quantitation and/or confirmation of
identified suspect samples.

We previously presented an

evaluation of commercially available enzyme immunoassays
for screening channel catfish muscle for SDM residues
using MSPD derived extracts [4.10].

A number of other

techniques have been used for detection and quantitation
of sulfonamides in animal tissues.

A 1981 review of

analytical methods for sulfonamides in animal tissues is
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available [4.11,4.12].

More recently, several methods for

single or multiresidue analysis of sulfonamide residues in
fish tissues have been published [4.13-4.21].
Several classical multi-residue methods for the
isolation of SDM from fish tissues have been reported.

An

extraction method reported by Horie et al. yielded
recoveries of 73-80% for SDM fortified at 1 /xg/g muscle in
several fish species.
0.05 /xg/g [4.13].

The limit of detection for SDM was

Nose et al. reported a multi-residue

method for three fish species that provided SDM recoveries
of 88-92% from muscle tissue fortified at 0.5 /xg/g.
method of recovery determination was not provided.

The
The

lower limit of detection for SDM was 0.06 /xg/g [4.14].
Horie et al. published a multi-residue method for the
determination of eight antibacterials in the muscle of
five species of cultured fish.

Recovery of SDM varied

among species from 82-87% at a tissue concentration of 1
/xg/g.
[4.15].

The detection limit of the method was 0.05 /xg/g
An extraction and LC method reported by Ueno et

al. for sulfamonomethoxine, SDM, and their N-acetylated
metabolites provided SDM recoveries of 88 and 81% from
rainbow trout plasma and muscle fortified at 2 PPM,
respectively.

This study was the only method found in the

literature for extraction and analysis of N-acetyl SDM in
fish tissues.

N-acetyl SDM recoveries were 83 and 89%
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from muscle and plasma.

The method of recovery

determination was not provided.

The detection limits were

0.05 /xg/g and limits of quantitation were 0.5 /xg/g for
both compounds [4.16].
Two methods are reported for the simultaneous
extraction and LC analysis of SDM and OMP in fish tissue.
Weiss et al. reported a mean recovery of 97 % for SDM in
catfish muscle.
[4.17],

The limit of quantitation was 0.05 /xg/g

Walisser et al. reported a mean relative

recovery, using peak height ratio comparisons, of 55% for
SDM from chinook salmon muscle fortified at 0.5-6 /xg/g.
The minimum detectable concentration was 0.2 /xg/g [4.18],
Several MSPD methods have been reported for the
isolation of SDM from fish tissues.

Long et al. reported

a relative recovery of 101% based on peak height ratios
for SDM in catfish muscle using a single residue MSPD
extraction procedure.
0.05 /xg/g [4.19].

The minimum detectable limit was

In two studies, Reimer & Suarez used

MSPD for the simultaneous extraction of five sulfonamides
from salmon muscle with quantitation by thin layer
chromatography (TLC) or LC.

For TLC, the method detection

limit (MDL) of SDM was 0.13 /xg/g and recovery was 63% at
concentrations of 0.5 and 2 /xg/g.

In a second study, they

reported 75% recovery for SDM fortified at 0.4-5 fig/g and
a MDL of 0.15 /xg/g using LC analysis [4.20,4.21].
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Tolerances for animal drugs as set by the United
States Food and Drug Administration (FDA) are often based
on total residue present, including parent drug and all
metabolites, in edible tissues (4.24].

The FDA tolerance

for total SDM residues in channel catfish muscle is 100
nU/5 [4.26].

The primary metabolite of SDM in channel

catfish is 4-N-acetylsulfadimethoxine [4.27].

The

relative contribution of this metabolite to total SDM
residue varies among tissues and species.

In channel

catfish, N-acetyl SDM accounts for over 90% of total SDM
residue in bile but in muscle and plasma SDM is present
mainly (>95%) as parent compound [4.27].

However, in

rainbow trout muscle the N-acetyl metabolite accounts for
over half of total SDM residue [4.28].

Additionally, the

ratio of parent SDM:N-acetyl SDM at tissue concentrations
approaching tolerance is not known.

Under the FDAs

general food safety requirements, individual metabolite
identification, concentration, and persistence should be
obtained for metabolites comprising 100 ppb or >10% of the
total residue (whichever is lower) at zero withdrawal
[4.29],

Extraction, detection, quantitation, and

confirmatory methods should, therefore, be capable of
simultaneous extraction or analysis of the parent drug and
it's important metabolites at tolerance for such use and
in situations where marker residues are not determined.
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The USDA has indicated that a method of residue
analysis should take no more than 48 hours to perform
[4.24].

The MSPD procedure and LC method as used in this

study can easily be run in less than a half-workday.

The

sensitivity and recovery of SDM with this method is
comparable to recoveries reported with published methods
for SDM in fish tissues [4.13-4.21].

However, most of

these studies used classical methods of analyte isolation
involving homogenization, liquid-liquid partitioning, and
multiple sample cleanup steps.

With improvements in

determinative methods a major limiting factor in a residue
monitoring program becomes the isolation of the analyte(s)
from tissues.

Classical methods of extraction are the

backbone of present residue monitoring programs and have
withstood the test of time but are time, labor, and
solvent use intensive and limit the number of samples that
can be practically analyzed in a day.

Additionally,

several of the methods lack the sensitivity required for
detection of SDM residues at present tolerance.

Newer

methods of analyte isolation that eliminate many of the
disadvantages of traditional extraction methods are needed
if we are to fully benefit from recent advances in
determinative aspects of residue analysis.
One such isolation method is the MSPD procedure.

The

MSPD theory and process have been the subject of recent
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reviews [4.30,4.31].

In general, its main advantages are

that it provides a more rapid and solvent sparing
isolation method than do classical methods, provides
adequate recovery at tolerance, and is amenable to
automation.

Therefore, the use of MSPD allows one to

examine a larger number of samples per day and reduces
labor and solvent costs.

Solvent purchase and disposal

costs and potential environmental contamination problems
increasingly dictate that solvent use in routine
analytical methods be reduced.

The combined use of MSPD

and a microbore analytical column often yields a greater
than 50% reduction in solvent use compared to classical
extraction and analysis techniques.
The extraction and LC methods presented in this study
provide procedures to simultaneously analyze SDM and its
major metabolite in channel catfish muscle and plasma.
These methods provide rapid and simple extraction with
adequate recovery of analytes, quantitation at tolerance
with acceptable accuracy and precision, and minimal
solvent use.

The applicability of these procedures to

channel catfish muscle and plasma samples containing
incurred SDM residues are presented in Chapter 5.
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CHAPTERS
PLASMA/MUSCLE RATIOS OF SULFADIMETHOXINE
RESIDUES IN CHANNEL CATFISH (Ictalurus punctatus)
INTRODUCTION
Pending federal legislation concerning mandatory
seafood inspection will require a variety of analytical
methods for the detection, quantitation, and confirmation
of chemical residues in food fish [5.1].

A tiered

approach to residue monitoring [5.2] uses rapid screening
assays for an initial examination of large numbers of
samples and more definitive methods of analysis for
quantitation and identification of chemical residues in
samples identified with screening assays.

Thus,

regulatory agencies will need practical methods that are
rapid, accurate, precise, and specific for these purposes.
Traditional screening methods, such as microbial
inhibition tests and chromatographic methods, as are
presently used in poultry and red meat inspection, lack
one or more of these characteristics.

Additionally, there

is a lack of screening methods available for use by the
producer in a field setting for the pre-harvest detection
of illegal drug residues.

Screening methods compatible

with field use could impact in a positive manner the
function of an aquatic animal drug residue monitoring
program by reducing the marketing of fish containing
199
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violative drug residues, would help prevent economic loss
to producers resulting from the condemnation of large lots
of harvested fish, and as part of a quality assurance
program, help allay consumer concerns regarding
aquaculture product safety.
One technique with potential field use application as
a residue screening method is the enzyme-linked
immunosorbent assay (ELISA).

Enzyme-linked immunosorbent

assays for detection of chemical residues are relatively
inexpensive, easy to use, require no special equipment,
and are presently commercially available for a range of
compounds [5.3,5.4].

They also provide the sensitivity

and specificity required for residue monitoring at
tolerance [5.5].

Nonetheless, a major limiting factor in

the practical use of these tests for residue detection in
tissues is the need for analyte extraction from tissue
samples prior to testing.
To facilitate the implementation of ELISAs for
chemical residue monitoring several strategies for analyte
extraction from target tissues have been used.

These vary

from simple tissue maceration [5.6] to matrix solid phase
dispersion [5.5,5.7].

However, the simplest residue

screening method is one that requires no tissue
extraction, but rather uses the presence of the drug
and/or its metabolite(s) in a readily accessible reference
biological fluid to indicate the presence of violative
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residues in a target tissue(s).

However, before such a

technique can be implemented, a relatively constant
relationship between the drug concentration in the target
tissue and the reference biological fluid must be
demonstrated.

This is necessary because a relatively

constant relationship between marker residue and target
tissue residue concentration among animals is needed to
provide the sensitivity and specificity required of a
residue screening assay.
Biological fluids have been proposed as specimens for
pre- or postmortem residue monitoring in several food
animal species and the tissue concentration relationships
for several sulfonamides in domestic food animal species
have been evaluated [5.8-5.13].

However, little

information regarding such drug concentration
relationships in fish species is available in the
literature.

Several studies have examined the

pharmacokinetic and tissue depletion behavior of
sulfonamides in a limited number of fish species [5.145.18], but none have examined the concentration ratio of
total sulfadimethoxine residues in biological fluids and
target tissues over the range of tissue concentrations
expected in channel catfish.
The determination of such a drug concentration ratio
would permit the use of a readily obtainable biological
fluid such as plasma to predict the presence of violative
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drug residues in edible tissues.

This could enhance the

application of an on-site test and increase throughput in
a regulatory laboratory.

The determination of such ratios

must include data on total residue including the relative
contribution by the parent compound and its important
metabolites.

Such information is relevant in relating

concentration of the chemical species detected by the
screening assay (marker compounds) to drug residue
concentration in the tissue of interest.
We previously evaluated the performance of several
commercially available ELISAs for detection of
sulfadimethoxine in channel catfish muscle about the US
Food and Drug Administration tolerance of 100 ng/g
[Chapter 3,5.5].

All of the ELISAs examined cross-reacted

equally well with the parent sulfonamide and its primary
metabolite in channel catfish, 4-N-acetylsulfadimethoxine
(N-acetyl SDM).

Therefore, to use such ELISAs with plasma

to identify fish containing violative SDM tissue levels
one must first know the ratio of total SDM residue in
plasma, including parent and cross-reacting metabolites,
to total SDM residue in muscle.
Romet-30®, a potentiated sulfonamide containing
sulfadimethoxine (SDM) and ormetoprim (OMP) in a 5:1
ratio, is one of only two systemic antibacterial agents
currently marketed for use in aquaculture in the United
States.

Romet-30® is frequently used in channel catfish
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aquaculture for the control of enteric septicemia and
other infectious bacterial diseases of catfish.

The

channel catfish is the major aquaculture species in the US
and accounted for 56% of the total US aquacultural
production in 1988 [5.19] with 360 million pounds produced
in 1990 [5.20].

Drug residue violations in the United

States' red meat and poultry industries most frequently
result from a failure by the producer to observe the
stated withdrawal time for an approved drug [5.21,5.22].
If a similar trend holds for aquaculture, the greatest
number of residue violations would be expected for
approved drugs that have been used by the producer in a
manner not in accordance with label directions.
Therefore, practical methods for detection, quantitation,
and confirmation of SDM and OMP residues in channel
catfish are urgently needed.
The purpose of the present study was to determine the
concentration ratio of total SDM residues, including the
parent compound and its N-acetyl metabolite, between
channel catfish plasma and muscle to enable the use of
plasma drug concentration as an indicator of muscle drug
concentration.

This paper presents the first report of

such tissue concentration ratios over the range of SDM
tissue concentrations expected when Romet®-30 is used
according to label instructions.

Additionally,

information regarding sulfadimethoxine depletion in
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channel catfish administered Romet®-30 at a water
temperature of 27°C is provided.

EXPERIMENTAL

REAGENTS AND EXPENDABLE MATERIALS

(a) SOLVENTS — Commercially obtainable liquid
chromatography grade solvents were used without further
purification.
(b) WATER — Triple-distilled and passed through a
Modulab™ Polisher I water purification system (Continental
Water Systems Corp., San Antonio, TX) used for LC
analyses.
(c) CHEMICALS — Note:

Wear rubber gloves and

protective clothing when handling.

Sulfadimethoxine (SDM)

and Sulfamethoxazole (SMX) were obtained from Sigma
Chemical Co., (St. Louis, MO).
(d) 4-N-ACETYLSULFADIMETHOXINE — The procedure of
Nielsen [5.23] was used for synthesis.

Identity confirmed

with high performance liquid chromatography and direct
probe, Cl, positive ion mass spectrometry.
(e) STANDARD SOLUTIONS — Stock solutions of SDM, Nacetyl SDM, and SMX were prepared and serially diluted in
methanol to provide separate fortification solutions for
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each compound.

Fortification solutions of 5, 10, 20, 40,

100, 200, 500, 1000, & 2000 /ig/ml were prepared for SDM;
4, 10, 20, 50, 100, & 200

for N-acetyl SDM; and 100

Mg/ml for the internal standard SMX.

All solutions were

stored in the dark at 4°C.
(e) FORTIFIED MUSCLE MID PLASMA EXTRACTS — Extracts
of fortified muscle and plasma for daily standard
calibration curves were obtained as follows:
MUSCLE — 0.5 g of catfish muscle was injected with 5 nl
each of separate SDM and N-acetyl SDM fortification
solutions appropriate to give tissue concentrations
(SDM:N-acetyl SDM) of 50:0, 100:0, 200:0, 400:40,
1000:100, 2000:200, 5000:500, and 10000:1000 ng/g.

SMX

was added as an internal standard by the injection of 5 fil
of a 100 ng SMX/ml methanol fortification solution to give
a tissue concentration of 1000 ng/g.

The samples were

processed and extracted by MSPD as described in chapter 4.
PLASMA — 0.5 ml aliquots of catfish plasma were placed in
1.5 ml polypropylene test tubes and 5 nl each of separate
SDM and N-acetyl SDM fortification solutions were added to
achieve plasma drug concentrations of 50:0, 100:0, 200:0,
400:40, 1000:100, 2000:200, 5000:500, 10000:1000, and
20000:2000 ng/g (SDM:N-acetyl SDM).

Five ^1 of a 100 ng

SMX/ml methanol fortification solution was added to each
tube as an internal standard, vortex mixed, and extracted
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using a modification of the MSPD procedure as given in
chapter 4.

EXPERIMENTAL ANIMALS, DRUG ADMINISTRATION, AND SAMPLING

Eighty-four laboratory-reared male and female channel
catfish (Ictalurus punctatus) with a mean body weight of
59 ± 15 g were obtained from an indoor recirculating water
culture system and assigned to seven circular fiberglass
tanks, each containing 200 liters of water.

The fish were

maintained under flow-through conditions with a 13.5 hour
light : 10.5 hour dark photoperiod.

Water temperature was

maintained at 27 ± 1°C, pH of 8.41 ± .04, and total
hardness of 20 mg/1.

The fish were allowed to acclimate

for 4 weeks prior to drug administration.
Experimental fish were fed commercial non-medicated
catfish pellets (Grow Big Floater, SF Services, Inc.,
North Little Rock, AR) at a rate of 2% of body weight once
daily before and after the drug treatment period.

Romet®-

30 (Hoffman-La Roche, Inc., Nutley, NJ) medicated channel
catfish feed (Grow Big Floater R-30 Medicated, SF
Services, Inc., North Little Rock, AR) containing SDM and
ormetoprim at concentrations of 0.42% and 0.084%
respectively was fed free-choice at a rate of 1% of body
weight once a day for five consecutive days to six tanks
of fish.

This feeding rate provided a daily dose of 50 mg
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Romet®-30/kg fish body weight.

Control fish were fed the

commercial non-medicated feed throughout the experiment.
Groups of 12 fish (1 tank) plus 2 control fish were
sacrificed at sampling times of 6, 12, 24, 48, 72, and 96
hours following the fifth day of medicated feed
administration.

Blood was collected from the caudal vein

with a heparinized syringe and the plasma separated and
placed in 1.5 ml polypropylene test tubes (Micro Tube,
cat. no. 72.690.475, Sarstedt, Inc., Newton, NC).
Skinless muscle fillets were obtained and stored in WhirlPak® sample bags (Nasco).

All samples were stored frozen

at -20°C and analyzed within 2 months following
collection.

EXTRACTION PROCEDURE

(a) MUSCLE — 0.5 g of catfish fillet was placed in a
glass mortar containing 2 g of CI8.

Sulfamethoxazole (SMX)

was added as an internal standard by the injection of 5 /il
of a 100 jug SMX/ml methanol fortification solution to give
a SMX tissue concentration of 1000 ng/g.

The muscle

samples were allowed to stand 2 minutes and extracted
using the matrix solid phase dispersion (MSPD) technique
reported in Chapter 4.
(b) PLASMA — 0.5 ml aliquots of catfish plasma were
placed in 1.5 ml polypropylene test tubes and 5 pi of a
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100 ng SMX/ml methanol fortification solution added to
each tube as an internal standard and the sample was
vortex mixed.

Plasma samples were extracted using a

modification of the MSPD procedure as given in Chapter 4.

LIQUID CHROMATOGRAPHIC ANALYSIS

(a) APPARATUS — All analyses were performed using a
Hewlett Packard 1090 liquid chromatograph equipped with a
variable volume auto-injector and a photodiode array
detector set at 265 nm (20 nm bandwidth), reference
spectrum of 450 nm (100 nm bandwidth), and spectrum range
of 210-320 nm.

LC control, data acquisition, and peak

integration were performed using Hewlett-Packard HPLC30
ChemStation Software (DOS Series)(Part No. G1300-900006).
A reversed phase narrow-bore column packed with
octadecylsilyl (ODS) derivatized silica (200 X 2.1 mm, 0DS
Hypersil, 5 /im, Part No. 799160D-572, Hewlett-Packard,
Wilmington, DE) maintained at ambient temperature was used
for all analyses.
(b) SOLVENT — The mobile phase was a mixture of 0.017
M aqueous H3P04 (pH 2.4)(PB) and acetonitrile (ACN)
delivered at an isocratic flow rate of 0.4 ml/min.
Solvent ratio's of 70:30 (PB:ACN) for muscle analysis and
73:27 for plasma analysis were used.

The mobile phase was
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filtered over a 0.45 pm. membrane filter (FP Vericel™,
Prod. No. 66480, Gelman Sciences, Inc., Ann Arbor, MI) and
degassed with helium before use.

A 10 pi aliquot of

muscle extract or a 25 pi aliquot of plasma extract was
injected for LC analysis.

DATA ANALYSIS

(a) DAILY CALIBRATION CURVES — Daily calibration
curves for SDM and N-acetyl SDM for both standards and
extracted fortified muscle and plasma samples were
constructed by plotting the peak height ratio of analyte
to internal standard (SMX) using data derived from single
sample injections.
(b) DETERMINATION OF TISSUE CONCENTRATION — Tissue
concentrations of experimental plasma and muscle samples
were determined by the internal standard method using
calibration curves obtained with extracts of fortified
plasma or muscle.

The concentrations of samples

containing <1000 PPB analyte were determined using five
point daily calibration curves derived from fortified
tissue extracts containing 50-1000 PPB.

The

concentrations of samples containing >1000 PPB analyte
were determined using daily calibration curves of
concentrations of 50-20000 PPB.
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Experimental tissue samples containing drug
concentrations less than the method detection limit (MDL)
were reported as zero.

Samples containing drug

concentrations greater than the MDL but less than the
practical limit of quantitation (LOQ) (i.e. trace
quantities) were reported in Tables 5.1-5.6 as the
estimated concentration value.

However, samples in the

above two categories were not used for calculation of
plasma:muscle concentration ratios.

For samples

containing trace drug quantities, the estimated
concentration was used for calculation of mean drug
concentration values at each sampling period.

RESULTS AND DISCUSSION

Considerable variation in total SDM tissue
concentration among individual fish within a sampling
period was observed (Tables 5.1-5.6).

Total SDM

concentrations in individual experimental fish ranged from
1.4-24.8 fig/ml and 0.6-12.6 ;xg/g for plasma and muscle,
respectively, for the twelve fish sampled at the six hour
post-dose sampling period.

Mean total SDM residue

concentrations for plasma and muscle samples for this same
period were 9.1 fig/ml and 5.3 fig/g and relative standard
deviations of 82.3% and 80.7% respectively.

Similar large
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TABLE 5.1

SULFADIMETHOXINE RESIDUES* AND PLASMA:MUSCLE RATIOS - 6 HOURS POST-DOSE

_______ N-acetyl SDM___________________SDM________________ Total SDM Residue
Fish # ---------Plasma
Muscle
0.53
1.43
1
0.16
2
0.52
0.74
3
2.52
4
0.11
0.42
0.39
5
0.79
6
0.47
1.74
0.72
7
1.89
8
0.66
1.95
0.33
1.14
9
10
0.11
0.38
0.06
11
0.20
12
0.69
2.35
0.41
Mean
1.28

*

P:M
2.7
3.2
3.4
3.7
2.0
3.7
2.6
2.9
3.5
3.4
3.7
3.4
3.2

Plasma
10.29
1.19
22.34
1.20
1.67
7.30
13.24
12.51
12.51
1.16
1.23
9.35
7.83
6.78

0.26
0.5
SD
0.81
16%
RSD
63%
87%
64%
0.08
0.1
1.96
SEM
0.24
concentration in parts per million

Muscle
8.54
0.74

4
P:M
•**

11.89
0.79
1.11
4.64
9.10
7.31

1.9
1.5
1.5

24.86
1.62
2.47

1.6
1.5
1.7

6.57
0.59
0.51

1.9
2.0
2.4

9.04
15.13
14.46
13.66

6.28

1.5

11.70

4.84
4.01
83%
1.16

1.7
0.3

9.11
7.50
82%
2.16

1.2
1.6

19%
0.1

Plasma
11.72
1.71

1.54
1.43

Muscle
9.07
0.90

P:M
1.3
1.9

12.63
0.90
1.50
5.11
9.82
7.97
6.90
0.70
0.56
6.96

2.0
1.8
1.6
1.8
1.5
1.8
2.0
2.2
2.5

4.24
81%

1.7
1.8
0.3
17%

1.22

0.1

5.25

I

ro
H

H
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TABLE 5.2

SULFADIMETHOXINE RESIDUES* AND PLASMAsMUSCLE RATIOS - 12 HOURS POST-DOSE

SDM

N--acetyl SDM
Fish #
13
14
15
16
17
18

Plasma
1.80
2.60
0.23
1.40
1.34
0.14

Muscle
0.68
0.77
0.05
0.43
0.88

19
20
21

0.12
0.14

(0.04)

0.22

22
23
24

1.94
2.29
0.20

(0.04)
1.13

Mean
SD
RSD
SEM

1.04
0.96
93%

()
***

0.28

---

P:M
2.6
3.4
4.6
3.2
1.5
***
***
***
***

Plasma
5.62
16.53
0.48
6.09
6.46
0.24
0.21
0.42
0.60

---

1.7
4.1
***

0.38

3.0

19.98
17.28
0.38
6.19

0.41
108%
0.12

1.2
40%
0.5

7.52
122%
2.17

0.55

Total SDM Residue

Muscle
3.75
9.19
0.25
3.06
6.08
0.18
0.24

P:M
1.5

Plasma
7.42

Muscle
4.43

P:M
1.7

1.8
2.0
2.0

9.95
0.29
3.49
6.95
0.18
0.27

1.9
***

0.9

19.13
0.71
7.48
7.80
0.38
0.33

0.18
0.38

2.4
1.6

0.57
0.82

0.18
0.42

***
***

10.64
8.36
0.26
3.55

21.92
19.58
0.58

11.78

1.9

8.92
0.26

2.2
***

7.23
8.41
116%
2.43

3.93
4.40
112%
1.27

1.8

4.02
113%
1.16

1.9
2.1
1.5
1.7
0.4
26%
0.1

1.1
1.3

concentration < the method limit of detection
trace level £ method limit of detection and < limit of quantitation
unable to accurately determine due to value(s) < limit of quantitation

2.1
1.1
***
***

0.4
22%
0.2

to

H
to
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TABLE 5.3

SULFADIMETHOXINE RESIDUES4 AND PLASMA:MUSCLE RATIOS - 24 HOURS POST-DOSE

N--acetyl SDM
Fish #
25
26

Plasma
0.43
0.62

27
28
29
30
31
32
33
34
35
36
Mean
SD
RSD

1.95
(0.04)
0.46

SEM
— ()
***
t

(0.04)+
0.08
0.21
0.05
0.47
1.66

Muscle
0.17
0.32
0.77
---

0.22
-----

0.07
-- -

0.14
0.61

---

---

0.55

0.21
0.26
126%
0.08

0.66
120%
0.20

SDM
Plasma
1.67
5.54
13.44

Muscle
1.17
3.50
9.04

(0.03)
2.17
3.22*
0.17
0.48
0.13
1.92
7.75

---

1.34
0.09+
0.10
0.26
0.08
1.04
3.57

---

---

2.6
0.5

3.02

1.83

4.27

20%

141%

0.2

1.29

2.73
149%
0.82

P;M
2.5
1.9
2.5
***
2.1
***
***
3.2
***
3.4
2.7
***

Total SDM Residue
P:M
1.4
1.6
1.5
***
1.6
35.4+
1.7
1.8
1.6
1.8
2.2
***

Plasma
2.09
6.15
15.39

Muscle
1.34
3.82
9.81

0.07
2.63
3.26+
0.25
0.69
0.18
2.39
9.40

---

1.56
0.09+
0.10
0.33
0.08
1.18
4.18

---

---

P:M
1.6
1.6
1.6
***
1.7
***
***
2.1
***
2.0
2.2
***

1.7
0.2
13%

3.57

2.02

4.91
138%

2.99
148%

1.8
0.3
16%

0.1

1.48

0.90

0.1

concentration < the method limit of detection
trace level £ method limit of detection and < limit of quantitation
unable to accurately determine due to value(s) <limit of quantitation
Outlier - excluded from calculations

to
H
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TABLE 5.4

SULFADIMETHOXINE RESIDUES* AND PLASMA:MUSCLE RATIOS - 48 HOURS POST-DOSE

N-acetvl SDM
Fish #
37

Plasma

Muscle

P?M

------

------

***

38
39
40

------

------

***

------

------

------

41
42
43
44
45
46
47
48
Mean
SD
RSD
SEM
()
***

Total SDM Residue

SDM
Muscle

P:M

------

aaa

------

------

***

------

------

***

a aa

------

------

aaa

------

------

aaa

------

aaa

------

------

***

------

------

***

------

------

aaa

------

------

***

—

------

***

0.06
0.06

------

aaa

0.10
0.13

0.05
0.05

***

***

0.05
0.05

aaa

------

(0.04)
0.07

------

------

***

------

------

***

------

------

***

0.05
0.03

------

aaa

(0.04)

—

aaa

------

***

------

aaa

------

------

aaa

------

aaa

***

0.12

0.09

1.4

0.09
0.03
0.20

0.09

***

— —

aaa

------

------

AAA

------

------

***

------

***

0.02

0.02

1.4

0.05

0. 02

AAA

aaa

0.04
173%
0.01

0.03
192%
0.01

aaa

0.07
149%
0.02

0.03
192%
0.01

AAA

0.08
------

0. 02
0.03
134%
0.01

***
aaa

Plasma

-

aaa

aaa
aaa

Plasma

Muscle

P:M
***

-

aaa

AAA
AAA

concentration < the method limit of detection
trace level t method limit of detection and < limit of quantitation
unable to accurately determine due to value(s) < limit of quantitation
w
H

4^
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TABLE 5.5

SULFADIMETHOXINE RESIDUES* AND PLASMA;MUSCLE RATIOS - 72 HOURS POST-DOSE

N-acetyl SDM___________________SDM________
Fish #

Plasma

49
50
51
52
53
54
55

---------«•*

Muscle
—

-

-----—
-------

P:M
Ratio
***
***
***
***
***
***
***

Plasma

Muscle

P:M
Ratio

Plasma

Muscle

P:M
Ratio

-----

-----

***
***
***
***

-----

0
0
0
0

***
***
***
***

----

---

***
***

---

0
0

----

---

0

------

***
***

***
***
***

***
***
***
***
***
0.05
--***
***
-— —
***
***
------***
***
0.00
Mean
***
***
0.01
SD
***
***
343%
RSD
***
***
0.00
SEM
*
concentration in parts per million
concentration < the method limit of detection
()
trace level £ method limit of detection and < limit of
***
unable to accurately determine due to value(s) < limit
56
57
58
59
60

Total SDM Residue

-—
------

0.05
0
0
0.00
.01
343%

***
***
***
***
***
***
***
***

0.00

***

0
0

quantitation
of quantitation

£
oi
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TABLE 5.6

SULFADIMETHOXINE RESIDUES * AMD PLASMA:MUSCLE RATIOS - 9 6 HOURS POST-DOSE
SDM

N-acetyl SDM
Fish #

Plasma

Muscle

61
62

------

-----

------

------

63
64
65
66

------

-----

--

-----

------

------

P:M
Ratio
***
***
***
***
***

------

------

-----

------

***
***
***
***
***
***

------

-----

***

-----

67
68
69
70
71

-----

------

-----

-----

Mean
SD

--

***

Plasma

Muscle

------

—

—

—

_

-----

—

~

-----

------

------

------

-----

------

-----

------

-----

------

-----

------

-----

------

-----

— —

-----

------

-----

Total SDM Residue
P:M
Ratio
***
***
***
***
***
***
***
***
***
***
***
***
***

P :M
Ratio

Plasma

Muscle

-----

-----

***

------

-----

***

-----

-----

------

-----

-----

-----

-----

-----

------

------

-----

------

------

-----

-----------

______

- —

-----

***
***
RSD
***
***
SEM
*
concentration in parts per million
concentration < the method limit of detection
()
trace level £ method limit of detection and < limit of quantitation
*** unable to accurately determine due to value(s) < limit of quantitation

***
***
***
***
***
***
***
***
***
***
***
***
***

to
H
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variations in tissue antibacterial concentrations have
been reported in other studies with fish fed free-choice
medicated feed containing a potentiated sulphonamide
[5.14,5.24,5.25].
A number of factors can influence the consumption,
metabolism, distribution, and elimination of xenobiotics
in the body [5.26-5.30].

These include individual animal

factors and systemic variation within an experimental unit
attributable to age, weight, sex, and reproductive status.
Variability due to the analytical technique employed may
also contribute to scattering of data, but does not appear
to be the case here.
Additionally, palatability may affect the consumption
of medicated feed and hence actual dose administered per
fish.

Variable medicated feed intake may be partially

responsible for the range of tissue drug concentrations
seen among fish within a single group in this study.

Fish

feeds containing potentiated sulfonamides, such as Romet®30 or Tribrissen® (sulfadiazine-trimethoprim), reportedly
have decreased palatability compared to non-medicated
feeds [5.25,5.30,5.31].

For Romet®-30 medicated feed the

ormetoprim component has been identified as the factor
responsible for decreased palatability [5.31].
In a related study, Walisser et aI. suggested the
variation in drug tissue concentration among individual
Chinook salmon within a group treated with Romet®-30 may
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have been the consequence of hierarchial feeding within a
tank [5.24].

Hierarchial feeding, however, appears not to

be the primary cause of variability of tissue drug
concentration in this study.

In the present study all

experimental fish actively fed on non-medicated feed but
were observed to have reduced feeding activity when given
the Romet®-30 medicated feed.

Further, feeding activity

with the medicated feed was not uniform among all fish
within a tank.

Individual fish fed more actively than

others on the medicated feed although sufficient
quantities of feed were freely available to all fish.
The low palatability of Romet®-30 medicated feeds
also has implications in regards to drug delivery and
efficacy in diseased fish in addition to its effect on
drug residue concentration.

In general, sick fish consume

less medicated feed than healthy fish.

It is conceivable

that the decrease in feed intake by sick fish would be
exacerbated by administration of an unpalatable feed.
Sick fish may, therefore, exhibit greater variability in
medicated feed intake and attain lower and more variable
tissue drug concentrations than the fish in this
experiment.
Nevertheless, despite the large variation in tissue
drug concentrations a mean plasma:muscle drug
concentration ratio of 1.8:1 ± 0.3:1 (SD) was obtained for
fish over all concentration ranges and sampling periods.
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The 95% Cl for the mean plasma:muscle drug concentration
ratio is (1.7:1, 1.8:1).

The plasma:muscle total SDM

concentration ratio in individual fish ranged from 1.3:1
to 2.5:1 with a 95% confidence interval for individual
fish of (1.2:1, 2.4:1).

The general correlation between

plasma and muscle concentrations attained in this study is
illustrated in Figure 5.1.

A correlation coefficient of

0.967 and visual examination of the plot indicate a strong
correlation between plasma and muscle total SDM
concentrations over a large concentration range.

The

points on the graph represent individual fish with plasma
and muscle SDM concentrations above the practical limits
of quantitation of the analytical method.

The plotted

line and its slope were determined by linear regression.
Figure 5.2 illustrates similar results for samples
containing muscle drug concentrations less than 2000 ng/g.
Although samples containing concentrations below the LOQ
were not included in this plot, an examination of total
plasma and muscle concentrations of such samples in Tables
5.1-5.3 indicates the relationship between total SDM
residues in plasma and muscle is maintained at
concentrations about tolerance.

This relatively stable

plasma:muscle ratio should permit the use of plasma drug
concentration to predict violative muscle drug
concentration.
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Such a drug concentration ratio should enable one to
use channel catfish plasma as the test material in an
ELISA to determine qualitatively the presence of violative
muscle residues of SDM.

The number of fish from a Romet®-

30 treated pond required to ensure detection of a residue
violation problem is dependent upon the percentage
violative in the sampled population (pond) and the desired
percent probability of detection [5.2].

Additional field

studies to determine the expected percent violative fish
in a catfish pond treated with Romet®-30 medicated feed
are needed.
Sulfadimethoxine depletion from plasma and muscle
approximates first-order kinetics (Figures 5.3, 5.4) based
on the sampling intervals used in this study.
agreement with data from Squibb et al. [5.16].

This is in
The

calculated half-lives for total SDM residues at a water
temperature of 27°C were approximately 11 hours for muscle
and 13 hours for plasma.

The label withdrawal period for

Romet®-30 following administration to channel catfish is
three days [5.33].

The estimate, based on the total SDM

residue depletion curve using mean tank values, of the
time required for the mean concentration to reach the
tolerance of 100 ng/g muscle is 49 hours.

In this study

however, no fish contained total SDM residues of >0.1 PPM
in muscle by the 48 hour post-dose sampling period.

This

indicates the present three day drug withdrawal period for
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Romet®-30 is adequate for the SDM component for channel
catfish at a water temperature of 27°C.

This is in

agreement with Brown's estimate of an -48 hour mean
depletion time at 28°C [5.17].

All control fish (n=12) in

the study were negative for SDM and the N-acetyl
metabolite at the LODs for the analytical methods
employed.

An evaluation of the performance of commercial

ELISAs when using plasma as a means to identify fish
containing violative SDM residues is planned but was
outside the scope of present research goals.
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CHAPTER 6
SUMMARY AND CONCLUSIONS
The goal of the research presented in preceding
chapters was to develop the analytical methods and basic
pharmacokinetic relationships needed for establishing a
drug residue monitoring and surveillance program for
sulfadimethoxine residues in channel catfish.

The process

applied and the results obtained may serve as a model for
monitoring programs for other veterinary drugs used in
aquaculture.

Screening and quantitative analytical

methods were developed and the relationships between drug
concentrations in tissue compartments were examined.
An effective residue monitoring program should have
analytical methods available for use on two levels - in
regulatory agency laboratories and at the producer level,
i.e. pond-side tests.

One of the major weaknesses of

present residue monitoring programs in general is the
relative lack of qualitative assays available for use on
site by the producer or veterinarian.

Further, there is a

lack of rapid and practical drug residue extraction and
determinative methods available for the analysis of
veterinary drug residues by regulatory agency
laboratories.
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FIELD ANALYSIS OF RESIDUES

On-site qualitative residue detection tests will
permit pre-marketing identification of individual food
animals or treatment groups of animals containing
violative drug residues.

Early identification of such

animals would have a positive impact on ensuring a safe
food supply and help prevent producer losses resulting
from carcass condemnation.

The US Department of

Agriculture Food Safety Inspection Service has indicated
its commitment to developing rapid and practical tests for
such purposes for use in several food animal species.
However, initial methods development efforts have involved
microbial inhibition tests (MIT). Although MITs may be
suitable in some cases, they are generally not amenable to
field use.
Because the effectiveness of a residue monitoring
program begins at the producer level, education of
aguaculturists in proper drug use, maintenance of
treatment records, and observation of recommended drug
withdrawal periods may help prevent the marketing of fish
with violative drug residues.

A problem unique to

aquaculture, however, is the poikilothermic nature of fish
and their temperature-dependent elimination rate for
drugs.

In general, for each 1°C decrease in temperature
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there is a corresponding 10% decrease in drug elimination
rate in fish.

Therefore, at low water temperatures, even

when medications are administered according to label
instructions and the recommended withdrawal time observed,
violative drug residues in harvested fish may result.

As

a result, on-site qualitative tests for detection of such
residues are more urgently needed in aquaculture than in
some other forms of animal agriculture.
An ideal drug residue screening test for field use is
one that is rapid, inexpensive, and simple to run;
requires minimal training and no complex or costly
equipment; and provides adequate sensitivity, specificity,
and ruggedness.

Such an ideal test would require minimal

or no sample extraction.

Although a variety of methods

are available for field use, commercially available ELISA
kits, using a biological fluid as a marker tissue, most
nearly meet the above needs.
One of the research goals for this dissertation was
the determination of an appropriate marker residue in a
biological fluid to indicate drug residue concentration in
channel catfish muscle.

However, a relatively constant

relationship between drug concentration in the target
tissue and the reference biological fluid need first be
demonstrated.

Total sulfadimethoxine (SDH) residue in

plasma was chosen as the marker residue because of the
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relative ease of obtaining plasma samples and the fact
that all commercially available ELISAs for detection of
SDM residues were demonstrated to detect parent SDM and
its primary metabolite, 4-N-acetylsulfadimethoxine (Nacetyl SDM), equally well.

To determine total SDM

residues in plasma and muscle, high performance liquid
chromatographic (LC) methods were developed for both
matrices for the simultaneous analysis of parent SDM and
N-acetyl SDM.

These LC methods were used to determine

plasmarmuscle total drug concentration ratios for
individual fish.

From these data, plasma:muscle

correlations and a 95% confidence interval for
plasma:muscle ratios of individual fish were calculated.
The excellent correlation obtained over a range of
concentrations demonstrates that total plasma SDM
concentration accurately reflects total muscle SDM residue
in the channel catfish.

Thus, the results indicate that,

with an appropriate dilution factor, plasma may be used in
an on-site ELISA or other screening assay to identify
catfish with violative SDM residues.

At present, all

commercially available qualitative ELISAs for SDM have a
detection cut-off of 10 ng/ml.

Therefore, if one uses the

lower end of the 95% confidence interval for plasma:muscle
ratios of individual fish (1.2:1 or 120 ng/ml plasma:100
ng/g muscle) and an assay detection cut-off level of 10
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ng/ml, then plasma diluted by a factor of 1:11
(plasma:buffer) and analyzed by ELISA should correctly
identify >95% of fish containing SDM muscle residues at
tolerance (100 ng/g).

Further, an even greater percent of

fish containing SDM at concentrations well above tolerance
should be accurately identified using this protocol.

This

could be determined pond-side or plasma analysis used in a
regulatory laboratory to greatly increase throughput for
initial screening of samples.

The application of this

protocol to samples containing incurred SDM residues for
the identification of fish containing violative SDM
residue by ELISA analysis of plasma is part of the
continuing research.

LABORATORY ANALYSIS OF RESIDUES

The second part of an effective monitoring program
involves regulatory laboratory function.

The analytical

needs of a regulatory agency are somewhat different than
those of the producer.

The tiered approach to residue

monitoring requires rapid screening tests for an initial
\

examination of large numbers of samples and more
definitive analytical methods for quantitation and
identification of residues in samples identified by
screening assays.

A regulatory laboratory is typically
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presented with animals of unknown treatment history and
must therefore examine samples for a number of unknown
compounds.

To effectively examine such samples for a

range of compounds requires the use of rapid screening
tests.
Animals presented for slaughter and inspection may
have been treated with approved or non-approved compounds.
For detection of approved compounds, marker residues are
often available.

As previously discussed, marker residues

permit the use of a biological fluid for drug residue
screening.

However, for detection of non-approved

compounds, marker residues are often not well defined.
Identification of animals containing such residues
requires an analysis of the target tissue itself.
Screening methods for such tissues are limited, in part,
by the drug extraction process.

Thus, the need for rapid

and efficient extraction of the drug from the target
tissue.
The combined use of matrix solid phase dispersion for
extraction and ELISA for detection allows one to rapidly
and effectively screen large numbers of muscle samples for
violative residues in a laboratory setting.

Further, the

use of an ELISA employing the microtiter well format and
optical density determination allows one to examine a
number of samples simultaneously rather than serially and
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may provide significant time savings over individual
testing.

Chapter 3 presents the results of efforts to

develop a rapid muscle extraction method that provides an
extract compatible with commercially available ELISAs for
the detection of total SDM residues in channel catfish
muscle.

The results presented offer several rapid

screening protocols with excellent sensitivity and
specificity that will permit a regulatory laboratory to
examine large numbers of catfish muscle samples.
For regulatory enforcement, samples identified by
screening tests as suspect require more definitive
quantitation and identification of any drug residue
present.

Quantitation and presumptive identification of

veterinary drug residues is most commonly accomplished
using LC with UV or diode array detection.

An analytical

protocol employing matrix solid phase dispersion
extraction and LC with diode array detection was developed
here for the simultaneous extraction and determination of
SDM and N-acetyl SDM as residues in channel catfish
muscle.

The results of this method development effort are

presented in Chapter 4.

This rapid procedure provides

adequate recovery of the two analytes and accuracy and
precision acceptable for drug residue analysis about
tolerance.

Demonstration of the applicability of this

procedure to samples containing incurred SDM residues is
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provided in Chapter 5.

This protocol should, therefore,

be suitable for use by regulatory agencies for
quantitation and presumptive identification of total SDM
residues in channel catfish muscle.

Further, this LC

method is potentially suitable for use in other fish
species, where information on marker residues is lacking,
for the determination of total SDM residues.

CONCLUSIONS

Protocols were developed and are presented in this
dissertation for the rapid extraction, screening, and
determination of sulfadimethoxine residues in channel
catfish.

Protocols are included for field application or

regulatory laboratory use.

From these data it is possible

to construct a model for a comprehensive tissue residue
monitoring program for aquaculture but with general
applicability to any species of food animal.

Such a model

begins with prevention of violative drug residues by
producer education concerning avoidance of drug residues
in fish and provides the producer with simple analytical
methods for detection of violative drug residues under
field conditions.

Included in this model are rapid and

efficient methods of drug extraction and analysis for use
by regulatory laboratories.

These methods should decrease
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'turnaround tine and increase the number of samples
analyzed by a regulatory agency laboratory as a result of
greater efficiency of residue screening and determinative
protocols.

For these reasons, the use of such a model

should improve the effectiveness of residue monitoring in
channel catfish and in food animals in general.
With additional study to determine possible speciesspecific matrix effects, these protocols may be extended
to other cultured fish species in which Romet-30®medicated feeds may be used.

Such protocols could

facilitate compliance with the Extra-Label Drug Use policy
of the FDA and improve and expand implementation of the
IR-4 initiative for drug approval in minor species such as
fish.

A major concern with these two programs is the

possibility of illegal residues resulting from limited
data relating to drug depletion times and metabolite
profiles in non-approved species and with non-approved
uses.

As a result, the IR-4 initiative generally requires

a procedure for assuring that animals marketed following
experimental drug use contain no residues.

A testing

protocol such as the one provided here offers a reasonable
assurance that such fish are free of unwanted residues and
may facilitate attainment of the IR-4 goal of increasing
the availability of medications for use in minor species.
Further, the process and results offered may serve as a
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new approach for the development of a national aquaculture
products drug residue monitoring program.
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APPENDIX A
OPTICAL DENSITY VALUES OBTAINED WITH
THE IDS SULFADIMETHOXINE ONE-STEP ELISA*
Sample #
OD Well A OD Well B
Mean OD
Mean
______________________________________________ Blank/Sample
0 nq SDM/q
1
6
11
16
21
26
31
36
41
46
51
56

0.817
1.211
1.401
0.962
1.304
0.928
1.197
0.887
1.084
1.025
1.096
0.966

0.822
1.162
1.352
0.952
1.150
0.913
1.164
0.993
0.956
1.210
1.019
0.964

Mean
Standard Deviation
CV f%)f=inter-assav variation)
25 na SDM/a
2
7
12
17
22
27
32
37
42
47
52
57

*
OD
IDS
SDM

0.664
0.920
0.937
0.652
0.703
0.617
0.735
0.595
0.540
0.693
0.737
0.683

0.613
0.948
1.010
0.705
0.687
0.757
0.796
0.650
0.655
0.814
0.740
0.640

0.820
1.187
1.377
0.957
1.227
0.921
1.181
0.940
1.020
1.118
1.058
0.965

1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000

1.064
0.158
14.9%

1.000
0.000
0.0%

0.639
0.934
0.974
0.679
0.695
0.687
0.766
0.623
0.598
0.754
0.739
0.662

0.779
0.787
0.707
0.709
0.566
0.746
0.648
0.662
0.586
0.674
0.698
0.685

0.729
Mean
Standard Deviation
0.117
CV (%)f=inter-assav variation)
16.1%
using matrix solid phase dispersion extracts of
fortified catfish muscle; 10 minute incubation
Optical Density
International Diagnostics Systems, Inc.
sulfadimethoxine

appendix con'd.

0.687
0.067
9.8%
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Sample #

50 nq SDM/q
3
8
13
18
23
28
33
38
43
48
53
58

OD Hell A

OD Hell B

Mean OD

Mean
Blank/Sample

0.516
0.528
0.688
0.571
0.588
0.525
0.555
0.549
0.394
0.510
0.594
0.516

0.452
0.588
0.762
0.584
0.546
0.517
0.586
0.538
0.450
0.610
0.612
0.455

0.484
0.558
0.725
0.578
0.567
0.521
0.571
0.544
0.422
0.560
0.603
0.486

0.591
0.470
0.527
0.603
0.462
0.566
0.483
0.578
0.414
0.501
0.570
0.503

0.551
0.074
13.5%

0.522
0.060
11.4%

0.296
0.519
0.388
0.344
0.206
0.298
0.371
0.358
0.247
0.337
0.331
0.296

0.361
0.437
0.282
0.359
0.168
0.324
0.314
0.381
0.242
0.302
0.313
0.306

0.332
0.078
23.5%

0.316
0.069
21.8%

Mean
Standard Deviation
CV f%)(=inter-assav variation)
100 ncr SDM/a
4
9
14
19
24
29
34
39
44
49
54
59

*
OD
IDS
SDM

0.356
0.504
0.358
0.309
0.224
0.307
0.375
0.346
0.240
0.330
0.344
0.319

0.236
0.534
0.418
0.379
0.188
0.289
0.366
0.370
0.253
0.344
0.317
0.272

Mean
Standard Deviation
CV f%)(=inter-assav variation)
10 minute incubation time
Optical Density
International Diagnostics Systems, Inc.
sulfadimethoxine

appendix con'd.
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Sample #

250 nq SDM/q
5
10
15
20
25
30
35
40
45
50
55
60

*
OD
IDS
SDH

OD Well A

OD Well B

Mean OD

.142
.288
.252
.164
.318
.159
.190
.201
.133
.176
.160
.143

.146
.317
.275
.184
.315
.153
.210
.258
.124
.175
.160
.152

.144
.303
.264
.174
.317
.156
.200
.230
.129
.176
.160
.148

.176
.255
.191
.182
.258
.169
.169
.244
.126
.157
.151
.153

0.200
0.064
31.9%

0.186
0.043
23.4%

Mean
Standard Deviation
CV f% W=inter-assav variation)
10 minute incubation time
Optical Density
International Diagnostics Systems, Inc.
sulfadimethoxine

Mean
Blank/Sample
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APPENDIX B
OPTICAL DENSITY VALUES OBTAINED WITH
THE SIGNAL SULFAMETHAZINE ELISA*
Sample t

0 na SDM/a
1
6
11
16
21
26
31
36
41
46
51
56

OD Well A

OD Well B

Mean OD

Mean
Blank/Sample

1.635
1.329
1.210
1.340
1.921
1.876
1.777
1.744
1.956
1.584
1.612
1.709

1.538
1.296
1.217
1.442
1.629
1.771
1.904
1.821
1.872
1.718
1.532
1.692

1.587
1.313
1.214
1.391
1.775
1.824
1.841
1.783
1.914
1.651
1.572
1.701

1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000
1.000

1.630
0.223
13.7%

1.000
0.000
0.0%

1.330
1.129
1.223
1.187
1.667
1.605
1.636
1.561
1.705
1.473
1.290
1.377

0.838
0.860
1.008
0.853
0.939
0.880
0.889
0.875
0.891
0.892
0.820
0.809

Mean
Standard Deviation
CV (%)(=inter-assay variation)
25 na SDM /a
2
7
12
17
22
27
32
37
42
47
52
57

*
OD
SDH

1.483
1.114
1.305
1.187
1.696
1.630
1.670
1.573
1.682
1.446
1.286
1.373

1.176
1.144
1.141
1.186
1.638
1.579
1.602
1.548
1.T27
1.499
1.293
1.380

Mean
1.432
Standard Deviation
0.202
CV (%)(=inter-assav variation)
14.1%
using matrix solid phase dispersion extracts
fortified catfish muscle; 30 minute incubation
Optical Density
sulfadimethoxine

appendix con'd.

0.880
0.054
6.1%
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Sample #

50 nq SDM/q
3
8
13
18
23
28
33
38
43
48
53
58

OD Well A

OD Well B

Mean OD

Mean
Blank/Sample

1.218
1.003
1.100
1.293
1.553
1.592
1.473
1.475
1.534
1.359
1.211
1.275

1.119
1.067
1.043
1.190
1.515
1.517
1.477
1.442
1.506
1.350
1.282
1.397

1.169
1.035
1.072
1.242
1.534
1.555
1.475
1.459
1.520
1.355
1.247
1.336

0.737
0.789
0.883
0.893
0.864
0.852
0.801
0.818
0.794
0.820
0.793
0.786

1.333
0.181
13.6%

0.819
0.046
5.6%

1.096
0.906
0.919
0.936
1.220
1.208
1.024
1.133
1.276
1.161
0.856
1.035

0.691
0.690
0.757
0.673
0.687
0.662
0.556
0.635
0.666
0.703
0.545
0.608

1.064
0.139
13.1%

0.656
0.061
9.3%

Mean
Standard Deviation
CV (%)(=inter-assav variation)
100 nq SPM/q
4
9
14
19
24
29
34
39
44
49
54
59

*
OD
SDM

1.296
0.885
0.953
0.971
1.247
1.206
1.035
1.268
1.263
1.183
0.825
1.001

0.896
0.926
0.885
0.900
1.193
1.209
1.013
0.997
1.288
1.138
0.887
1.068

Mean
Standard Deviation
CV (%)f=inter-assav variation)
30 minute incubation time
Optical Density
sulfadimethoxine

appendix con'd.
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Sample #

OD Well A

OD Well B

Mean OD

Mean
Blank/Sample

0.742
0.748
0.794
0.682
0.968
1.010
1.200
1.007
1.011
0.888
0.839
0.844

0.665
0.761
0.749
0.698
1.016
1.052
1.248
0.960
1.038
0.921
0.820
0.943

0.704
0.755
0.772
0.690
0.992
1.031
1.224
0.984
1.025
0.905
0.830
0.894

0.443
0.575
0.636
0.496
0.559
0.565
0.665
0.552
0.535
0.548
0.528
0.525

0.900
0.159
17.7%

0.552
0.058
10.5%

250 ppb
5
10
15
20
25
30
35
40
45
50
55
60

*
OD
SDM

Mean
Standard Deviation
CV f%>f=inter-assav variation)
30 minute incubation time
Optical Density
sulfadimethoxine
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